Page last updated: 2024-08-04 07:52:59

phenanthrenes

Description

Phenanthrenes: POLYCYCLIC AROMATIC HYDROCARBONS composed of three fused BENZENE rings. [MeSH]

Cross-References

ID SourceID
PubMed CID168339423
MeSH IDM0016488

Synonyms (2)

Synonym
phenanthrenes
methyl 4-phenylphenanthrene-2-carboxylate

Research

Studies (7,378)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901169 (15.84)18.7374
1990's726 (9.84)18.2507
2000's1999 (27.09)29.6817
2010's2678 (36.30)24.3611
2020's806 (10.92)2.80

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials110 (1.44%)5.53%
Reviews198 (2.60%)6.00%
Case Studies71 (0.93%)4.05%
Observational0 (0.00%)0.25%
Other7,239 (95.02%)84.16%
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
acetylcarnitineO-acylcarnitinehuman metabolite201520159.0low000010
dinitrochlorobenzeneC-nitro compound;
monochlorobenzenes
allergen;
epitope;
sensitiser
1993200425.5low001100
1,2,4-trichlorobenzenetrichlorobenzene2004201016.8low000400
protocatechuic acidcatechols;
dihydroxybenzoic acid
antineoplastic agent;
EC 1.1.1.25 (shikimate dehydrogenase) inhibitor;
EC 1.14.11.2 (procollagen-proline dioxygenase) inhibitor;
human xenobiotic metabolite;
plant metabolite
1982201818.9low020240
dihydro-3-coumaric acidmonocarboxylic acidEscherichia coli metabolite;
human xenobiotic metabolite
1983198341.0low010000
gamma-aminobutyric acidamino acid zwitterion;
gamma-amino acid;
monocarboxylic acid
human metabolite;
neurotransmitter;
Saccharomyces cerevisiae metabolite;
signalling molecule
1991202122.0low004011
4-hydroxybenzaldehydehydroxybenzaldehydeEC 1.14.17.1 (dopamine beta-monooxygenase) inhibitor;
mouse metabolite;
plant metabolite
201620168.0low000010
4-hydroxyphenylacetic acidmonocarboxylic acid;
phenols
fungal metabolite;
human metabolite;
mouse metabolite;
plant metabolite
2004200420.0low000100
4-hydroxybenzoic acidmonohydroxybenzoic acidalgal metabolite;
plant metabolite
2003200321.0low000100
5-hydroxytryptophanhydroxytryptophanhuman metabolite;
neurotransmitter
1969196955.0low010000
acetic acidmonocarboxylic acidantimicrobial food preservative;
Daphnia magna metabolite;
food acidity regulator;
protic solvent
1948202220.6low010031
acetaldehydealdehydecarcinogenic agent;
EC 3.5.1.4 (amidase) inhibitor;
electron acceptor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
mutagen;
oxidising agent;
Saccharomyces cerevisiae metabolite;
teratogenic agent
1999199925.0low001000
acetoneketone body;
methyl ketone;
propanones;
volatile organic compound
EC 3.5.1.4 (amidase) inhibitor;
human metabolite;
polar aprotic solvent
1970202223.1low020511
adenine6-aminopurines;
purine nucleobase
Daphnia magna metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
1964201825.5low042150
agmatineguanidines;
primary amino compound
Escherichia coli metabolite;
mouse metabolite
1986198638.0low010000
ammonium hydroxideazane;
gas molecular entity;
mononuclear parent hydride
EC 3.5.1.4 (amidase) inhibitor;
metabolite;
mouse metabolite;
neurotoxin;
NMR chemical shift reference compound;
nucleophilic reagent;
refrigerant
1974202213.3low010141
anthranilic acidaminobenzoic acidhuman metabolite;
mouse metabolite
1964196460.0low010000
quinacrineacridines;
aromatic ether;
organochlorine compound;
tertiary amino compound
antimalarial;
EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor
1991200128.1low009200
benzaldehydebenzaldehydesEC 3.1.1.3 (triacylglycerol lipase) inhibitor;
EC 3.5.5.1 (nitrilase) inhibitor;
flavouring agent;
fragrance;
odorant receptor agonist;
plant metabolite
2009201114.0low000110
benzenearomatic annulene;
benzenes;
volatile organic compound
carcinogenic agent;
environmental contaminant;
non-polar solvent
1953202028.0low011310120
benzoic acidbenzoic acidsalgal metabolite;
antimicrobial food preservative;
drug allergen;
EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor;
EC 3.1.1.3 (triacylglycerol lipase) inhibitor;
human xenobiotic metabolite;
plant metabolite
1991202314.0low001112
benzyl alcoholbenzyl alcoholsantioxidant;
fragrance;
metabolite;
solvent
1996199628.0low001000
bromidehalide anion;
monoatomic bromine
2007201413.8low000220
1-butanolalkyl alcohol;
primary alcohol;
short-chain primary fatty alcohol
human metabolite;
mouse metabolite;
protic solvent
2000201616.2low001220
carbamatesamino-acid anion1974201828.3low030120
carbon monoxidecarbon oxide;
gas molecular entity;
one-carbon compound
biomarker;
EC 1.9.3.1 (cytochrome c oxidase) inhibitor;
human metabolite;
ligand;
metabolite;
mitochondrial respiratory-chain inhibitor;
mouse metabolite;
neurotoxin;
neurotransmitter;
P450 inhibitor;
probe;
signalling molecule;
vasodilator agent
1973201822.8low122340
formic acidmonocarboxylic acidantibacterial agent;
astringent;
metabolite;
protic solvent;
solvent
201620168.0low000010
carnitineamino-acid betainehuman metabolite;
mouse metabolite
1973201530.5low020020
catecholcatecholsallelochemical;
genotoxin;
plant metabolite
1999202014.9low001440
methanealkane;
gas molecular entity;
mononuclear parent hydride;
one-carbon compound
bacterial metabolite;
fossil fuel;
greenhouse gas
1953202313.6low02113324
cholinecholinesallergen;
Daphnia magna metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
neurotransmitter;
nutrient;
plant metabolite;
Saccharomyces cerevisiae metabolite
2007200717.0low000100
citric acid, anhydroustricarboxylic acidantimicrobial agent;
chelator;
food acidity regulator;
fundamental metabolite
2008201611.0low000140
chlorinehalide anion;
monoatomic chlorine
cofactor;
Escherichia coli metabolite;
human metabolite
1963201725.3low023140
hydrochloric acidchlorine molecular entity;
gas molecular entity;
hydrogen halide;
mononuclear parent hydride
mouse metabolite2005200917.0low000200
coumarincoumarinsfluorescent dye;
human metabolite;
plant metabolite
2006202011.0low000110
salicylic acidmonohydroxybenzoic acidalgal metabolite;
antifungal agent;
antiinfective agent;
EC 1.11.1.11 (L-ascorbate peroxidase) inhibitor;
keratolytic drug;
plant hormone;
plant metabolite
2004202012.1low000860
gallic acidtrihydroxybenzoic acidantineoplastic agent;
antioxidant;
apoptosis inducer;
astringent;
cyclooxygenase 2 inhibitor;
EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor;
geroprotector;
human xenobiotic metabolite;
plant metabolite
202120213.0low000001
4-nitrophenylphosphatearyl phosphatemouse metabolite2001200123.0low000100
hydrogen sulfidegas molecular entity;
hydracid;
mononuclear parent hydride;
sulfur hydride
Escherichia coli metabolite;
genotoxin;
metabolite;
signalling molecule;
toxin;
vasodilator agent
2010201910.3low000120
dihydrolipoic acidthio-fatty acidantioxidant;
human metabolite;
neuroprotective agent
2013201311.0low000010
guaiacolguaiacolsdisinfectant;
EC 1.1.1.25 (shikimate dehydrogenase) inhibitor;
expectorant;
plant metabolite
1981202017.7low015760
n(g),n(g')-dimethyl-l-argininealpha-amino acid2011201113.0low000010
malic acid2-hydroxydicarboxylic acid;
C4-dicarboxylic acid
food acidity regulator;
fundamental metabolite
201320198.0low000030
propionaldehydealpha-CH2-containing aldehyde;
propanals
Escherichia coli metabolite1999199925.0low001000
1-aminocyclopropane-1-carboxylic acidamino acid zwitterion;
monocarboxylic acid;
non-proteinogenic alpha-amino acid
ethylene releasers;
plant metabolite
2010201014.0low000100
4-nitrobenzaldehydebenzaldehydes;
C-nitro compound
1985199932.0low011000
3,4-dihydroxyphenylacetic acidcatechols;
dihydroxyphenylacetic acid
human metabolite1991201920.5low001210
dibenzofurandibenzofurans;
mancude organic heterotricyclic parent;
polycyclic heteroarene
xenobiotic1999201516.7low001110
creatineglycine derivative;
guanidines;
zwitterion
geroprotector;
human metabolite;
mouse metabolite;
neuroprotective agent;
nutraceutical
1963200142.0low010100
cytosineaminopyrimidine;
pyrimidine nucleobase;
pyrimidone
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
1971201335.5low030010
lactic acid2-hydroxy monocarboxylic acidalgal metabolite;
Daphnia magna metabolite
1952202218.8low010731
dihydrolipoamidedithiol;
monocarboxylic acid amide
cofactor;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
1993199331.0low001000
dimethylglycineamino acid zwitterion;
N-methyl-amino acid;
N-methylglycines
Daphnia magna metabolite;
human metabolite;
mouse metabolite
2008200816.0low000100
dimethyl sulfoxidesulfoxide;
volatile organic compound
alkylating agent;
antidote;
Escherichia coli metabolite;
geroprotector;
MRI contrast agent;
non-narcotic analgesic;
polar aprotic solvent;
radical scavenger
1965201730.0low050140
formaldehydealdehyde;
one-carbon compound
allergen;
carcinogenic agent;
disinfectant;
EC 3.5.1.4 (amidase) inhibitor;
environmental contaminant;
Escherichia coli metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
1964202234.3low050121
glycinealpha-amino acid;
amino acid zwitterion;
proteinogenic amino acid;
serine family amino acid
EC 2.1.2.1 (glycine hydroxymethyltransferase) inhibitor;
fundamental metabolite;
hepatoprotective agent;
micronutrient;
neurotransmitter;
NMDA receptor agonist;
nutraceutical
1986202117.6low011231
glyceraldehydealdotriosefundamental metabolite2010201014.0low000100
glycerolalditol;
triol
algal metabolite;
detergent;
Escherichia coli metabolite;
geroprotector;
human metabolite;
mouse metabolite;
osmolyte;
Saccharomyces cerevisiae metabolite;
solvent
1970202123.0low011011
glycolic acid2-hydroxy monocarboxylic acid;
primary alcohol
keratolytic drug;
metabolite
201820186.0low000010
glyoxylic acid2-oxo monocarboxylic acid;
aldehydic acid
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
2008200816.0low000100
glycocyamineguanidinoacetic acids;
zwitterion
bacterial metabolite;
human metabolite;
mouse metabolite;
nutraceutical;
rat metabolite
1991199133.0low001000
hydrogen carbonatecarbon oxoanioncofactor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
1967197254.5low020000
histaminearalkylamino compound;
imidazoles
human metabolite;
mouse metabolite;
neurotransmitter
1955201436.6low040320
hydrogenelemental hydrogen;
elemental molecule;
gas molecular entity
antioxidant;
electron donor;
food packaging gas;
fuel;
human metabolite
1988202314.5low011242
hydroquinonebenzenediol;
hydroquinones
antioxidant;
carcinogenic agent;
cofactor;
Escherichia coli metabolite;
human xenobiotic metabolite;
mouse metabolite;
skin lightening agent
2007201513.0low000110
hydroxylaminehydroxylaminesalgal metabolite;
bacterial xenobiotic metabolite;
EC 1.1.3.13 (alcohol oxidase) inhibitor;
EC 4.2.1.22 (cystathionine beta-synthase) inhibitor;
EC 4.3.1.10 (serine-sulfate ammonia-lyase) inhibitor;
nitric oxide donor;
nucleophilic reagent
2004200420.0low000100
imidazoleimidazole2011201212.5low000020
indoleindole;
polycyclic heteroarene
Escherichia coli metabolite2001201218.3low000210
iodinediatomic iodinenutrient1971201332.2low020020
thioctic aciddithiolanes;
heterocyclic fatty acid;
thia fatty acid
fundamental metabolite;
geroprotector
1993201321.0low001010
methanolalkyl alcohol;
one-carbon compound;
primary alcohol;
volatile organic compound
amphiprotic solvent;
Escherichia coli metabolite;
fuel;
human metabolite;
mouse metabolite;
Mycoplasma genitalium metabolite
1946202241.0low1222921
methanolalkyl alcohol;
one-carbon compound;
primary alcohol;
volatile organic compound
amphiprotic solvent;
Escherichia coli metabolite;
fuel;
human metabolite;
mouse metabolite;
Mycoplasma genitalium metabolite
1946202229.8low122419151
inositolcyclitol;
hexol
1964197355.5low020000
melatoninacetamides;
tryptamines
anticonvulsant;
central nervous system depressant;
geroprotector;
hormone;
human metabolite;
immunological adjuvant;
mouse metabolite;
radical scavenger
200820237.0low000111
croton oilN-acyl-hexosamine1962200151.2low040100
naphthalenenaphthalenes;
ortho-fused bicyclic arene
apoptosis inhibitor;
carcinogenic agent;
environmental contaminant;
mouse metabolite;
plant metabolite;
volatile oil component
1952202316.8low11426748512
nickelmetal allergen;
nickel group element atom
epitope;
micronutrient
1979201818.7low010720
niacinamidepyridine alkaloid;
pyridinecarboxamide;
vitamin B3
anti-inflammatory agent;
antioxidant;
cofactor;
EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor;
EC 3.5.1.98 (histone deacetylase) inhibitor;
Escherichia coli metabolite;
geroprotector;
human urinary metabolite;
metabolite;
mouse metabolite;
neuroprotective agent;
Saccharomyces cerevisiae metabolite;
Sir2 inhibitor
1998201815.8low002240
nitratesmonovalent inorganic anion;
nitrogen oxoanion;
reactive nitrogen species
1972202315.1low022936
nitritesmonovalent inorganic anion;
nitrogen oxoanion;
reactive nitrogen species
human metabolite1972202318.2low011812
nitrous oxidegas molecular entity;
nitrogen oxide
analgesic;
bacterial metabolite;
food packaging gas;
food propellant;
general anaesthetic;
greenhouse gas;
inhalation anaesthetic;
NMDA receptor antagonist;
raising agent;
refrigerant;
vasodilator agent
2009201512.0low000110
orotic acidpyrimidinemonocarboxylic acidEscherichia coli metabolite;
metabolite;
mouse metabolite
1970199342.5low011000
oxalic acidalpha,omega-dicarboxylic acidalgal metabolite;
human metabolite;
plant metabolite
2009201610.3low000120
4-aminobenzoic acidaminobenzoic acid;
aromatic amino-acid zwitterion
allergen;
Escherichia coli metabolite;
plant metabolite
1962200154.2low040100
4-nitrophenol4-nitrophenolshuman xenobiotic metabolite;
mouse metabolite
1988202119.5low010001
palmitic acidlong-chain fatty acid;
straight-chain saturated fatty acid
algal metabolite;
Daphnia magna metabolite;
EC 1.1.1.189 (prostaglandin-E2 9-reductase) inhibitor;
plant metabolite
1991201521.0low001010
parathionC-nitro compound;
organic thiophosphate;
organothiophosphate insecticide
acaricide;
agrochemical;
avicide;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
mouse metabolite
1999199925.0low001000
pentachlorophenolaromatic fungicide;
chlorophenol;
organochlorine pesticide;
pentachlorobenzenes
human xenobiotic metabolite1998202312.3low001571
phenanthreneortho-fused polycyclic arene;
ortho-fused tricyclic hydrocarbon;
phenanthrenes
environmental contaminant;
mouse metabolite
1945202417.5high4169125731834118
phenolphenolsantiseptic drug;
disinfectant;
human xenobiotic metabolite;
mouse metabolite
1991202216.9low003732
phenethylaminealkaloid;
aralkylamine;
phenylethylamine
Escherichia coli metabolite;
human metabolite;
mouse metabolite
201720177.0low000010
phosphoric acidphosphoric acidsalgal metabolite;
fertilizer;
human metabolite;
NMR chemical shift reference compound;
solvent
2005200519.0low000100
phosphoenolpyruvatecarboxyalkyl phosphate;
monocarboxylic acid
fundamental metabolite1973197450.7low030000
phosphorylcholinephosphocholinesallergen;
epitope;
hapten;
human metabolite;
mouse metabolite
2013201311.0low000010
phthalic acidbenzenedicarboxylic acidhuman xenobiotic metabolite1983201618.1low010630
porphobilinogenaralkylamino compound;
dicarboxylic acid;
pyrroles
Escherichia coli metabolite;
metabolite;
mouse metabolite
2008200816.0low000200
propylene glycolglycol;
propane-1,2-diols
allergen;
human xenobiotic metabolite;
mouse metabolite;
protic solvent
2004201315.5low000310
propionic acidsaturated fatty acid;
short-chain fatty acid
antifungal drug2004200420.0low000100
pteridinesazaarene;
mancude organic heterobicyclic parent;
ortho-fused heteroarene;
pteridines
1974197450.0low110000
purinepurine1964202032.0low010010
pyridineazaarene;
mancude organic heteromonocyclic parent;
monocyclic heteroarene;
pyridines
environmental contaminant;
NMR chemical shift reference compound
1965201328.2low011210
pyridoxal phosphatemethylpyridines;
monohydroxypyridine;
pyridinecarbaldehyde;
vitamin B6 phosphate
coenzyme;
cofactor;
EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
2002200222.0low000100
pyridoxinehydroxymethylpyridine;
methylpyridines;
monohydroxypyridine;
vitamin B6
cofactor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
2001201516.0low000110
pyruvic acid2-oxo monocarboxylic acidcofactor;
fundamental metabolite
2000201020.3low001200
quinolinic acidpyridinedicarboxylic acidEscherichia coli metabolite;
human metabolite;
mouse metabolite;
NMDA receptor agonist
2007200717.0low000300
thiosulfatesdivalent inorganic anion;
sulfur oxide;
sulfur oxoanion
human metabolite2004202211.0low000101
sarcosineN-alkylglycine zwitterion;
N-alkylglycine;
N-methyl-amino acid;
N-methylglycines
Escherichia coli metabolite;
glycine receptor agonist;
glycine transporter 1 inhibitor;
human metabolite;
mouse metabolite
2008200816.0low000100
sulfitesdivalent inorganic anion;
sulfur oxide;
sulfur oxoanion
202220222.0low000001
spermidinepolyazaalkane;
triamine
autophagy inducer;
fundamental metabolite;
geroprotector
201720177.0low000010
succinic acidalpha,omega-dicarboxylic acid;
C4-dicarboxylic acid
anti-ulcer drug;
fundamental metabolite;
micronutrient;
nutraceutical;
radiation protective agent
2008201911.0low000120
sulfuric acidsulfur oxoacidcatalyst2009201810.5low000110
sulfur dioxidesulfur oxideEscherichia coli metabolite;
food bleaching agent;
refrigerant
201720177.0low000010
taurineamino sulfonic acid;
zwitterion
antioxidant;
Escherichia coli metabolite;
glycine receptor agonist;
human metabolite;
mouse metabolite;
nutrient;
radical scavenger;
Saccharomyces cerevisiae metabolite
201720177.0low000010
thiamineprimary alcohol;
vitamin B1
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
201520159.0low000010
thyminepyrimidine nucleobase;
pyrimidone
Escherichia coli metabolite;
human metabolite;
mouse metabolite
1964198651.2low040000
toluenemethylbenzene;
toluenes;
volatile organic compound
cholinergic antagonist;
fuel additive;
neurotoxin;
non-polar solvent
1964202226.4low052452
trimethyloxaminetertiary amine oxideEscherichia coli metabolite;
metabolite;
osmolyte
2008200816.0low000100
uracilpyrimidine nucleobase;
pyrimidone
allergen;
Daphnia magna metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
prodrug;
Saccharomyces cerevisiae metabolite
1966200647.8low040100
uric aciduric acidEscherichia coli metabolite;
human metabolite;
mouse metabolite
200920219.0low000101
ureaisourea;
monocarboxylic acid amide;
one-carbon compound
Daphnia magna metabolite;
Escherichia coli metabolite;
fertilizer;
flour treatment agent;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
1963199349.9low061000
isopentenyl pyrophosphateprenol phosphateantigen;
antioxidant;
epitope;
Escherichia coli metabolite;
mouse metabolite;
phosphoantigen
202120213.0low000001
8-hydroxy-2-(di-n-propylamino)tetralinphenols;
tertiary amino compound;
tetralins
serotonergic antagonist1986198638.0low010000
huperzine aquinolone2004200420.0low000100
mentholp-menthane monoterpenoid;
secondary alcohol
volatile oil component1968200732.0low010200
1,10-phenanthrolinephenanthrolineEC 2.7.1.1 (hexokinase) inhibitor;
EC 3.4.19.3 (pyroglutamyl-peptidase I) inhibitor
1951201435.5low041420
1,2-dimethylhydrazinehydrazinesalkylating agent;
carcinogenic agent
1994199430.0low001000
1,5-dihydroxyisoquinolineisoquinolinolEC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor1995199529.0low001000
pk 11195aromatic amide;
isoquinolines;
monocarboxylic acid amide;
monochlorobenzenes
antineoplastic agent2004200420.0low000100
1-aminobenzotriazole2003201417.3low000210
1-anilino-8-naphthalenesulfonateaminonaphthalene;
naphthalenesulfonic acid
fluorescent probe2005202212.6low000521
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridinemethylpyridines;
phenylpyridine;
tetrahydropyridine
neurotoxin2012201212.0low000010
14,15-epoxy-5,8,11-eicosatrienoic acidlong-chain fatty acid1999199925.0low001000
1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-oneoxadiazoloquinoxalineEC 4.6.1.2 (guanylate cyclase) inhibitor2008200816.0low000100
2,2'-dipyridylbipyridinechelator;
ferroptosis inhibitor
1958201425.5low011220
2,4,6-tribromophenolbromophenolenvironmental contaminant;
fungicide;
marine metabolite
2009200915.0low000100
2,4-dichlorophenoxyacetic acidchlorophenoxyacetic acid;
dichlorobenzene
agrochemical;
defoliant;
EC 1.1.1.25 (shikimate dehydrogenase) inhibitor;
environmental contaminant;
phenoxy herbicide;
synthetic auxin
2010201014.0low000100
2,4-dinitrophenoldinitrophenolallergen;
antiseptic drug;
bacterial xenobiotic metabolite;
geroprotector;
oxidative phosphorylation inhibitor
2000201018.3low001200
2-aminofluorene1976197648.0low010000
mercaptoethanolalkanethiol;
primary alcohol
geroprotector2008200816.0low000100
2-aminoethoxydiphenyl borateorganoboron compound;
primary amino compound
calcium channel blocker;
IP3 receptor antagonist;
potassium channel opener
201920214.0low000011
3-aminobenzamidebenzamides;
substituted aniline
EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor1995202017.4low0031240
3-methoxytyraminemonomethoxybenzene;
phenols;
phenylethylamine;
primary amino compound
biomarker;
human blood serum metabolite;
human urinary metabolite
201920195.0low000010
3-methylcholanthreneortho- and peri-fused polycyclic arenearyl hydrocarbon receptor agonist;
carcinogenic agent
1945200349.2low0582100
3-nitropropionic acidC-nitro compoundantimycobacterial drug;
EC 1.3.5.1 [succinate dehydrogenase (quinone)] inhibitor;
mycotoxin;
neurotoxin
2014201410.0low000010
4-amino-1,8-naphthalimidebenzoisoquinoline;
dicarboximide
2000200024.0low001000
4-aminopyridineaminopyridine;
aromatic amine
avicide;
orphan drug;
potassium channel blocker
2011201113.0low000010
homovanillic acidguaiacols;
monocarboxylic acid
human metabolite;
mouse metabolite
2003201913.0low000110
4-nonylphenolphenolsenvironmental contaminant2010201412.0low000110
phenytoinimidazolidine-2,4-dioneanticonvulsant;
drug allergen;
sodium channel blocker;
teratogenic agent
1972197252.0low020000
5,8,11,14-eicosatetraynoic acidlong-chain fatty acid2001200123.0low000100
5,8,11-eicosatriynoic acidacetylenic fatty acid;
icosanoid;
long-chain fatty acid;
polyunsaturated fatty acid
EC 1.13.11.31 (arachidonate 12-lipoxygenase) inhibitor2001200123.0low000100
5-hydroxydecanoatemedium-chain fatty acid2013201311.0low000010
phenanthridonelactam;
phenanthridines
EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor;
immunosuppressive agent;
mutagen
1985202317.6high02715161
tacrineacridines;
aromatic amine
EC 3.1.1.7 (acetylcholinesterase) inhibitor1995201220.5low001010
aa 8611,4-benzoquinones;
acetylenic compound;
primary alcohol
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
ferroptosis inhibitor
1991199927.7low003000
acetaminophenacetamides;
phenols
antipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
cyclooxygenase 3 inhibitor;
environmental contaminant;
ferroptosis inducer;
geroprotector;
hepatotoxic agent;
human blood serum metabolite;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic
1969201823.8low111120
acetazolamidemonocarboxylic acid amide;
sulfonamide;
thiadiazoles
anticonvulsant;
diuretic;
EC 4.2.1.1 (carbonic anhydrase) inhibitor
2000200024.0low001000
acridoneacridines;
cyclic ketone
1995200822.5low001100
5-aminoisoquinolinoneisoquinolines2009200915.0low000100
albendazolearyl sulfide;
benzimidazoles;
benzimidazolylcarbamate fungicide;
carbamate ester
anthelminthic drug;
microtubule-destabilising agent;
tubulin modulator
1993199331.0low001000
alendronate1,1-bis(phosphonic acid);
primary amino compound
bone density conservation agent;
EC 2.5.1.1 (dimethylallyltranstransferase) inhibitor
202220222.0low000001
amantadineadamantanes;
primary aliphatic amine
analgesic;
antiparkinson drug;
antiviral drug;
dopaminergic agent;
NMDA receptor antagonist;
non-narcotic analgesic
2004200420.0low000100
ambroxolaromatic amine2012201212.0low000010
pimagedineguanidines;
one-carbon compound
EC 1.14.13.39 (nitric oxide synthase) inhibitor;
EC 1.4.3.4 (monoamine oxidase) inhibitor
2004200420.0low000100
theophyllinedimethylxanthineadenosine receptor antagonist;
anti-asthmatic drug;
anti-inflammatory agent;
bronchodilator agent;
drug metabolite;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor;
fungal metabolite;
human blood serum metabolite;
immunomodulator;
muscle relaxant;
vasodilator agent
1962200936.8low021100
amobarbitalbarbiturates1974197450.0low010000
amodiaquineaminoquinoline;
organochlorine compound;
phenols;
secondary amino compound;
tertiary amino compound
anticoronaviral agent;
antimalarial;
drug allergen;
EC 2.1.1.8 (histamine N-methyltransferase) inhibitor;
non-steroidal anti-inflammatory drug;
prodrug
1972201029.4low279600
9-anthroic acidanthroic acid2001201217.5low000110
anthralinanthracenesantipsoriatic1975200534.0low010100
antipyrinepyrazoloneantipyretic;
cyclooxygenase 3 inhibitor;
environmental contaminant;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic
1974199042.0low011000
aristolochic acid iaristolochic acids;
aromatic ether;
C-nitro compound;
cyclic acetal;
monocarboxylic acid;
organic heterotetracyclic compound
carcinogenic agent;
metabolite;
mutagen;
nephrotoxin;
toxin
1961201529.9medium144944420
aristolochic acid iaristolochic acids;
aromatic ether;
C-nitro compound;
cyclic acetal;
monocarboxylic acid;
organic heterotetracyclic compound
carcinogenic agent;
metabolite;
mutagen;
nephrotoxin;
toxin
2002200620.9low000700
aspirinbenzoic acids;
phenyl acetates;
salicylates
anticoagulant;
antipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
drug allergen;
EC 1.1.1.188 (prostaglandin-F synthase) inhibitor;
geroprotector;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
plant activator;
platelet aggregation inhibitor;
prostaglandin antagonist;
teratogenic agent
1972201724.3low120320
atrazinechloro-1,3,5-triazine;
diamino-1,3,5-triazine
environmental contaminant;
herbicide;
xenobiotic
2001201814.1low000880
barbitalbarbituratesdrug allergen2006200618.0low000100
bay-k-8644(trifluoromethyl)benzenes;
C-nitro compound;
dihydropyridine;
methyl ester
201420207.0low000020
benzamidebenzamides1998201418.8low001320
benzo(a)pyreneortho- and peri-fused polycyclic arenecarcinogenic agent;
mouse metabolite
1962202418.7low0261943579
bepridilpyrrolidines;
tertiary amine
anti-arrhythmia drug;
antihypertensive agent;
calcium channel blocker;
vasodilator agent
2001200123.0low000100
berberinealkaloid antibiotic;
berberine alkaloid;
botanical anti-fungal agent;
organic heteropentacyclic compound
antilipemic drug;
antineoplastic agent;
antioxidant;
EC 1.1.1.141 [15-hydroxyprostaglandin dehydrogenase (NAD(+))] inhibitor;
EC 1.1.1.21 (aldehyde reductase) inhibitor;
EC 1.13.11.52 (indoleamine 2,3-dioxygenase) inhibitor;
EC 1.21.3.3 (reticuline oxidase) inhibitor;
EC 2.1.1.116 [3'-hydroxy-N-methyl-(S)-coclaurine 4'-O-methyltransferase] inhibitor;
EC 2.1.1.122 [(S)-tetrahydroprotoberberine N-methyltransferase] inhibitor;
EC 2.7.11.10 (IkappaB kinase) inhibitor;
EC 3.1.1.4 (phospholipase A2) inhibitor;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor;
EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
geroprotector;
hypoglycemic agent;
metabolite;
potassium channel blocker
2000201714.4low001130
beta-naphthoflavoneextended flavonoid;
naphtho-gamma-pyrone;
organic heterotricyclic compound
aryl hydrocarbon receptor agonist1985200331.0low051300
bicalutamide(trifluoromethyl)benzenes;
monocarboxylic acid amide;
monofluorobenzenes;
nitrile;
sulfone;
tertiary alcohol
2012201212.0low000010
bisbenzimidazolebibenzimidazole;
N-methylpiperazine
anthelminthic drug;
fluorochrome
2008201015.0low000200
buforminbiguanidesantineoplastic agent;
antiviral agent;
geroprotector;
hypoglycemic agent;
radiosensitizing agent
1988198836.0low010000
butacainebenzoate ester2001200123.0low000100
cacodylic acidorganoarsenic compoundxenobiotic metabolite201620168.0low000010
caffeinepurine alkaloid;
trimethylxanthine
adenosine A2A receptor antagonist;
adenosine receptor antagonist;
adjuvant;
central nervous system stimulant;
diuretic;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor;
environmental contaminant;
food additive;
fungal metabolite;
geroprotector;
human blood serum metabolite;
mouse metabolite;
mutagen;
plant metabolite;
psychotropic drug;
ryanodine receptor agonist;
xenobiotic
1964201227.7low132520
verapamilaromatic ether;
nitrile;
polyether;
tertiary amino compound
1995201719.0low005330
camphor, (+-)-isomerbornane monoterpenoid;
cyclic monoterpene ketone
plant metabolite1974197549.5low020000
cannabinoldibenzopyran2012201212.0low000010
carbamazepinedibenzoazepine;
ureas
analgesic;
anticonvulsant;
antimanic drug;
drug allergen;
EC 3.5.1.98 (histone deacetylase) inhibitor;
environmental contaminant;
glutamate transporter activator;
mitogen;
non-narcotic analgesic;
sodium channel blocker;
xenobiotic
2011201312.0low000020
carisoprodolcarbamate estermuscle relaxant1971197153.0low010000
carbonyl cyanide m-chlorophenyl hydrazonehydrazone;
monochlorobenzenes;
nitrile
antibacterial agent;
geroprotector;
ionophore
1999200124.0low001100
celecoxiborganofluorine compound;
pyrazoles;
sulfonamide;
toluenes
cyclooxygenase 2 inhibitor;
geroprotector;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
2010201611.0low000110
cetyltrimethylammonium ionquaternary ammonium ion2005201912.8low000220
cetylpyridiniumpyridinium ion1974201430.0low010010
chelerythrinebenzophenanthridine alkaloid;
organic cation
antibacterial agent;
antineoplastic agent;
EC 2.7.11.13 (protein kinase C) inhibitor
1989198935.0low010000
chloroquineaminoquinoline;
organochlorine compound;
secondary amino compound;
tertiary amino compound
anticoronaviral agent;
antimalarial;
antirheumatic drug;
autophagy inhibitor;
dermatologic drug
1969202029.4low1621711370
chloroxinemonohydroxyquinoline;
organochlorine compound
antibacterial agent;
antifungal drug;
antiseborrheic
202120213.0low000001
chlorpheniraminemonochlorobenzenes;
pyridines;
tertiary amino compound
anti-allergic agent;
antidepressant;
antipruritic drug;
H1-receptor antagonist;
histamine antagonist;
serotonin uptake inhibitor
1994199430.0low001000
chlorpromazineorganochlorine compound;
phenothiazines;
tertiary amine
anticoronaviral agent;
antiemetic;
dopaminergic antagonist;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
phenothiazine antipsychotic drug
1968200042.6low032000
chlorpyrifoschloropyridine;
organic thiophosphate
acaricide;
agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
environmental contaminant;
insecticide;
xenobiotic
2006201911.0low000220
chlorzoxazone1,3-benzoxazoles;
heteroaryl hydroxy compound;
organochlorine compound
muscle relaxant;
sedative
1996199628.0low001000
ciprofloxacinaminoquinoline;
cyclopropanes;
fluoroquinolone antibiotic;
N-arylpiperazine;
quinolinemonocarboxylic acid;
quinolone antibiotic;
quinolone;
zwitterion
antibacterial drug;
antiinfective agent;
antimicrobial agent;
DNA synthesis inhibitor;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
environmental contaminant;
topoisomerase IV inhibitor;
xenobiotic
202120213.0low000001
platinum tetrachlorideplatinum coordination entitycatalyst;
reagent
2014201410.0low000010
clenbuterolamino alcohol;
dichlorobenzene;
ethanolamines;
primary arylamine;
secondary amino compound;
substituted aniline
beta-adrenergic agonist;
bronchodilator agent;
sympathomimetic agent
1987198737.0low010000
clioquinolmonohydroxyquinoline;
organochlorine compound;
organoiodine compound
antibacterial agent;
antifungal agent;
antimicrobial agent;
antineoplastic agent;
antiprotozoal drug;
chelator;
copper chelator
1958197456.4low050000
clofaziminemonochlorobenzenes;
phenazines
dye;
leprostatic drug;
non-steroidal anti-inflammatory drug
202020204.0low000010
clofiliumbenzenes;
organic amino compound
2002200222.0low000100
4-cresolcresolEscherichia coli metabolite;
human metabolite;
uremic toxin
2009200915.0low000200
cyproheptadinepiperidines;
tertiary amine
anti-allergic agent;
antipruritic drug;
gastrointestinal drug;
H1-receptor antagonist;
serotonergic antagonist
2000200024.0low001000
dapiindolesfluorochrome2001201714.6low000320
dapsonesubstituted aniline;
sulfone
anti-inflammatory drug;
antiinfective agent;
antimalarial;
leprostatic drug
1974197649.0low020000
debrisoquincarboxamidine;
isoquinolines
adrenergic agent;
antihypertensive agent;
human metabolite;
sympatholytic agent
1998199826.0low101000
deferoxamineacyclic desferrioxaminebacterial metabolite;
ferroptosis inhibitor;
iron chelator;
siderophore
2002200222.0low000100
amphetamineprimary amine1974197848.0low020000
diazepam1,4-benzodiazepinone;
organochlorine compound
anticonvulsant;
anxiolytic drug;
environmental contaminant;
sedative;
xenobiotic
1991200424.8low002200
diazoxidebenzothiadiazine;
organochlorine compound;
sulfone
antihypertensive agent;
beta-adrenergic agonist;
bronchodilator agent;
cardiotonic drug;
diuretic;
K-ATP channel agonist;
sodium channel blocker;
sympathomimetic agent;
vasodilator agent
2000200024.0low001000
dibenzothiophenedibenzothiophenes;
mancude organic heterotricyclic parent
keratolytic drug1990201716.2low002250
methylene bromidebromohydrocarbon;
bromomethanes
algal metabolite;
marine metabolite
2002200222.0low000100
dibutyl phthalatediester;
phthalate ester
EC 3.2.1.20 (alpha-glucosidase) inhibitor;
environmental contaminant;
metabolite;
plasticiser;
teratogenic agent
1996201616.8low002030
diclofenacamino acid;
aromatic amine;
dichlorobenzene;
monocarboxylic acid;
secondary amino compound
antipyretic;
drug allergen;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
environmental contaminant;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic
1997200025.5low002000
dichlorodiphenyl dichloroethylenechlorophenylethylene;
monochlorobenzenes
human xenobiotic metabolite;
persistent organic pollutant
2000202214.0low001101
ddtbenzenoid aromatic compound;
chlorophenylethane;
monochlorobenzenes;
organochlorine insecticide
bridged diphenyl acaricide;
carcinogenic agent;
endocrine disruptor;
persistent organic pollutant
1968201525.9low041250
dichlorvosalkenyl phosphate;
dialkyl phosphate;
organochlorine acaricide;
organophosphate insecticide
anthelminthic drug;
antibacterial agent;
antifungal agent;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor
2014201410.0low000010
diethyl pyrocarbonateacyclic carboxylic anhydride1991199431.5low002000
diethylcarbamazineN-carbamoylpiperazine;
N-methylpiperazine
1994199430.0low001000
pentetic acidpentacarboxylic acidcopper chelator1996200125.5low001100
dipyridamolepiperidines;
pyrimidopyrimidine;
tertiary amino compound;
tetrol
adenosine phosphodiesterase inhibitor;
EC 3.5.4.4 (adenosine deaminase) inhibitor;
platelet aggregation inhibitor;
vasodilator agent
1981198143.0low010000
disulfiramorganic disulfide;
organosulfur acaricide
angiogenesis inhibitor;
antineoplastic agent;
apoptosis inducer;
EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor;
EC 3.1.1.1 (carboxylesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
ferroptosis inducer;
fungicide;
NF-kappaB inhibitor
1985198539.0low010000
diuron3-(3,4-substituted-phenyl)-1,1-dimethylurea;
dichlorobenzene
environmental contaminant;
mitochondrial respiratory-chain inhibitor;
photosystem-II inhibitor;
urea herbicide;
xenobiotic
1974200924.0low010300
valproic acidbranched-chain fatty acid;
branched-chain saturated fatty acid
anticonvulsant;
antimanic drug;
EC 3.5.1.98 (histone deacetylase) inhibitor;
GABA agent;
neuroprotective agent;
psychotropic drug;
teratogenic agent
1991199133.0low001000
2,3-dimethoxy-1,4-naphthoquinone1,4-naphthoquinones2008200816.0low000100
domperidonebenzimidazoles;
heteroarylpiperidine
antiemetic;
dopaminergic antagonist
1991199133.0low001000
emodintrihydroxyanthraquinoneantineoplastic agent;
laxative;
plant metabolite;
tyrosine kinase inhibitor
2003202111.7low000231
endosulfancyclic sulfite ester;
cyclodiene organochlorine insecticide
acaricide;
agrochemical;
GABA-gated chloride channel antagonist;
persistent organic pollutant
201720186.5low000020
erythrosine1966196658.0low010000
ethacrynic acidaromatic ether;
aromatic ketone;
dichlorobenzene;
monocarboxylic acid
EC 2.5.1.18 (glutathione transferase) inhibitor;
ion transport inhibitor;
loop diuretic
1990199133.5low002000
etodolacmonocarboxylic acid;
organic heterotricyclic compound
antipyretic;
cyclooxygenase 2 inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
2010201014.0low000100
felodipinedichlorobenzene;
dihydropyridine;
ethyl ester;
methyl ester
anti-arrhythmia drug;
antihypertensive agent;
calcium channel blocker;
vasodilator agent
1995199529.0low001000
fenfluramine(trifluoromethyl)benzenes;
secondary amino compound
appetite depressant;
serotonergic agonist;
serotonin uptake inhibitor
2000200024.0low001000
fenofibratearomatic ether;
chlorobenzophenone;
isopropyl ester;
monochlorobenzenes
antilipemic drug;
environmental contaminant;
geroprotector;
xenobiotic
2013201311.0low000010
fexofenadinepiperidines;
tertiary amine
anti-allergic agent;
H1-receptor antagonist
202120213.0low000001
fluconazoleconazole antifungal drug;
difluorobenzene;
tertiary alcohol;
triazole antifungal drug
environmental contaminant;
P450 inhibitor;
xenobiotic
1988201221.0low110110
flufenamic acidaromatic amino acid;
organofluorine compound
antipyretic;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
2011201311.8low000040
flunitrazepam1,4-benzodiazepinone;
C-nitro compound;
monofluorobenzenes
anxiolytic drug;
GABAA receptor agonist;
sedative
1991200426.5low001100
fluorouracilnucleobase analogue;
organofluorine compound
antimetabolite;
antineoplastic agent;
environmental contaminant;
immunosuppressive agent;
radiosensitizing agent;
xenobiotic
1970202118.4low020341
fluoxetine(trifluoromethyl)benzenes;
aromatic ether;
secondary amino compound
201720177.0low000010
flurbiprofenfluorobiphenyl;
monocarboxylic acid
antipyretic;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
1997199727.0low001000
furazolidonenitrofuran antibiotic;
oxazolidines
antibacterial drug;
antiinfective agent;
antitrichomonal drug;
EC 1.4.3.4 (monoamine oxidase) inhibitor
1974197450.0low010000
furosemidechlorobenzoic acid;
furans;
sulfonamide
environmental contaminant;
loop diuretic;
xenobiotic
201020218.0low000141
gentamicin1997200324.0low001100
glutaraldialdehydecross-linking reagent;
disinfectant;
fixative
2011201113.0low000010
glyburidemonochlorobenzenes;
N-sulfonylurea
anti-arrhythmia drug;
EC 2.7.1.33 (pantothenate kinase) inhibitor;
EC 3.6.3.49 (channel-conductance-controlling ATPase) inhibitor;
hypoglycemic agent
1993202114.6low001121
glyphosateglycine derivative;
phosphonic acid
agrochemical;
EC 2.5.1.19 (3-phosphoshikimate 1-carboxyvinyltransferase) inhibitor;
herbicide
2005200519.0low000100
gossypol1992201419.3low001110
guaifenesinmethoxybenzenes201520206.5low000020
guanidinecarboxamidine;
guanidines;
one-carbon compound
1947199851.5low011000
bis(2-guanidinoethyl)disulfide2004200420.0low000100
1-(5-isoquinolinesulfonyl)-2-methylpiperazineisoquinolines;
N-sulfonylpiperazine
EC 2.7.11.13 (protein kinase C) inhibitor1993199331.0low001000
haloperidolaromatic ketone;
hydroxypiperidine;
monochlorobenzenes;
organofluorine compound;
tertiary alcohol
antidyskinesia agent;
antiemetic;
dopaminergic antagonist;
first generation antipsychotic;
serotonergic antagonist
1977197747.0low010000
heptachlorcyclodiene organochlorine insecticideagrochemical;
antibacterial agent;
antifungal agent;
GABA-gated chloride channel antagonist;
persistent organic pollutant
201720177.0low000010
hexamethoniumquaternary ammonium salt1998199826.0low001000
hexestrolstilbenoid1964196460.0low010000
hexobarbitalbarbiturates1978197846.0low010000
ethidiumphenanthridinesfluorochrome;
intercalator
1976199935.3low012000
hydroxyureaone-carbon compound;
ureas
antimetabolite;
antimitotic;
antineoplastic agent;
DNA synthesis inhibitor;
EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor;
genotoxin;
immunomodulator;
radical scavenger;
teratogenic agent
1977201329.0low010010
hypericin1979200034.5low011000
ibuprofenmonocarboxylic acidantipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
drug allergen;
environmental contaminant;
geroprotector;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
radical scavenger;
xenobiotic
1998200223.7low001200
lidocainebenzenes;
monocarboxylic acid amide;
tertiary amino compound
anti-arrhythmia drug;
drug allergen;
environmental contaminant;
local anaesthetic;
xenobiotic
1987198737.0low010000
idebenone1,4-benzoquinones;
primary alcohol
antioxidant;
ferroptosis inhibitor
1999199925.0low001000
indomethacinaromatic ether;
indole-3-acetic acids;
monochlorobenzenes;
N-acylindole
analgesic;
drug metabolite;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
environmental contaminant;
gout suppressant;
non-steroidal anti-inflammatory drug;
xenobiotic metabolite;
xenobiotic
1977201629.8low034210
iproniazidcarbohydrazide;
pyridines
1969196955.0low010000
avaproazaspiro compound;
biphenylyltetrazole
angiotensin receptor antagonist;
antihypertensive agent;
environmental contaminant;
xenobiotic
201220227.0low000011
isoniazidcarbohydrazideantitubercular agent;
drug allergen
1964197455.0low020000
isoniazidcarbohydrazideantitubercular agent;
drug allergen
1964201739.0low020010
2-propanolsecondary alcohol;
secondary fatty alcohol
protic solvent201520159.0low000010
isoproterenolcatechols;
secondary alcohol;
secondary amino compound
beta-adrenergic agonist;
bronchodilator agent;
cardiotonic drug;
sympathomimetic agent
2009201910.4low000140
juglonehydroxy-1,4-naphthoquinonegeroprotector;
herbicide;
reactive oxygen species generator
1992199630.0low002000
ketoconazoledichlorobenzene;
dioxolane;
ether;
imidazoles;
N-acylpiperazine;
N-arylpiperazine
1988202018.1low113540
ketoprofenbenzophenones;
oxo monocarboxylic acid
antipyretic;
drug allergen;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
environmental contaminant;
non-steroidal anti-inflammatory drug;
xenobiotic
1998199826.0low001000
kinetin6-aminopurines;
furans
cytokinin;
geroprotector
2003200321.0low000100
leflunomide(trifluoromethyl)benzenes;
isoxazoles;
monocarboxylic acid amide
antineoplastic agent;
antiparasitic agent;
EC 1.3.98.1 [dihydroorotate oxidase (fumarate)] inhibitor;
EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor;
hepatotoxic agent;
immunosuppressive agent;
non-steroidal anti-inflammatory drug;
prodrug;
pyrimidine synthesis inhibitor;
tyrosine kinase inhibitor
2005200519.0low000100
2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-onechromones;
morpholines;
organochlorine compound
autophagy inhibitor;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor;
geroprotector
2004202013.8low000530
malathiondiester;
ethyl ester;
organic thiophosphate
202120213.0low000001
mechlorethaminenitrogen mustard;
organochlorine compound
alkylating agent1994199430.0low001000
memantineadamantanes;
primary aliphatic amine
antidepressant;
antiparkinson drug;
dopaminergic agent;
neuroprotective agent;
NMDA receptor antagonist
201820186.0low000010
vitamin k 31,4-naphthoquinones;
vitamin K
angiogenesis inhibitor;
antineoplastic agent;
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor;
human urinary metabolite;
nutraceutical
2002201018.0low000300
meperidineethyl ester;
piperidinecarboxylate ester;
tertiary amino compound
antispasmodic drug;
kappa-opioid receptor agonist;
mu-opioid receptor agonist;
opioid analgesic
1969197154.0low020000
2-mercaptoethylguanidine2004200420.0low000100
metforminguanidinesenvironmental contaminant;
geroprotector;
hypoglycemic agent;
xenobiotic
201420215.3low000012
methadonebenzenes;
diarylmethane;
ketone;
tertiary amino compound
1969197154.2low140000
methoxychlororganochlorine insecticide1976202026.0low010010
methyl parathionC-nitro compound;
organic thiophosphate;
organothiophosphate insecticide
acaricide;
agrochemical;
antifungal agent;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
environmental contaminant;
genotoxin
2008200816.0low000100
methyl salicylatebenzoate ester;
methyl ester;
salicylates
flavouring agent;
insect attractant;
metabolite
2008200915.5low000200
metolachloraromatic amide;
benzenes;
ether;
organochlorine compound
2004200420.0low000100
metoprololaromatic ether;
propanolamine;
secondary alcohol;
secondary amino compound
antihypertensive agent;
beta-adrenergic antagonist;
environmental contaminant;
geroprotector;
xenobiotic
1999199925.0low001000
metronidazoleC-nitro compound;
imidazoles;
primary alcohol
antiamoebic agent;
antibacterial drug;
antimicrobial agent;
antiparasitic agent;
antitrichomonal drug;
environmental contaminant;
prodrug;
radiosensitizing agent;
xenobiotic
1988201918.2low010220
metyraponearomatic ketoneantimetabolite;
diagnostic agent;
EC 1.14.15.4 (steroid 11beta-monooxygenase) inhibitor
1999200323.0low001100
miconazoledichlorobenzene;
ether;
imidazoles
2002200222.0low000100
midazolamimidazobenzodiazepine;
monofluorobenzenes;
organochlorine compound
anticonvulsant;
antineoplastic agent;
anxiolytic drug;
apoptosis inducer;
central nervous system depressant;
GABAA receptor agonist;
general anaesthetic;
muscle relaxant;
sedative
2010201810.0low100110
entinostatbenzamides;
carbamate ester;
primary amino compound;
pyridines;
substituted aniline
antineoplastic agent;
apoptosis inducer;
EC 3.5.1.98 (histone deacetylase) inhibitor
2009200915.0low000100
ethylmaleimidemaleimidesanticoronaviral agent;
EC 1.3.1.8 [acyl-CoA dehydrogenase (NADP(+))] inhibitor;
EC 2.1.1.122 [(S)-tetrahydroprotoberberine N-methyltransferase] inhibitor;
EC 2.7.1.1 (hexokinase) inhibitor
1972200241.3low020100
nabumetonemethoxynaphthalene;
methyl ketone
cyclooxygenase 2 inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
prodrug
2007200717.0low000100
nalidixic acid1,8-naphthyridine derivative;
monocarboxylic acid;
quinolone antibiotic
antibacterial drug;
antimicrobial agent;
DNA synthesis inhibitor
1974197450.0low010000
nifedipineC-nitro compound;
dihydropyridine;
methyl ester
calcium channel blocker;
human metabolite;
tocolytic agent;
vasodilator agent
1993199331.0low001000
niflumic acidaromatic carboxylic acid;
pyridines
2007200717.0low000100
nimodipine2-methoxyethyl ester;
C-nitro compound;
dicarboxylic acids and O-substituted derivatives;
diester;
dihydropyridine;
isopropyl ester
antihypertensive agent;
calcium channel blocker;
cardiovascular drug;
vasodilator agent
2011201113.0low000010
nitroglycerinnitroglycerolexplosive;
muscle relaxant;
nitric oxide donor;
prodrug;
tocolytic agent;
vasodilator agent;
xenobiotic
2007202110.0low000101
nitromide2010201014.0low000100
norfloxacinfluoroquinolone antibiotic;
N-arylpiperazine;
quinolinemonocarboxylic acid;
quinolone antibiotic;
quinolone
antibacterial drug;
DNA synthesis inhibitor;
environmental contaminant;
xenobiotic
201620168.0low000010
ns 1619(trifluoromethyl)benzenes;
benzimidazoles;
phenols
potassium channel opener2007201612.0low000120
n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamidearomatic ether;
C-nitro compound;
sulfonamide
antineoplastic agent;
cyclooxygenase 2 inhibitor
2001200123.0low000100
ofloxacin3-oxo monocarboxylic acid;
N-arylpiperazine;
N-methylpiperazine;
organofluorine compound;
oxazinoquinoline
1997201912.2low001030
oxolinic acidaromatic carboxylic acid;
organic heterotricyclic compound;
oxacycle;
quinolinemonocarboxylic acid;
quinolone antibiotic
antibacterial drug;
antifungal agent;
antiinfective agent;
antimicrobial agent;
enzyme inhibitor
1987198737.0low010000
oxybenzonehydroxybenzophenone;
monomethoxybenzene
dermatologic drug;
environmental contaminant;
protective agent;
ultraviolet filter;
xenobiotic
2006200618.0low000100
quinone1,4-benzoquinonescofactor;
human xenobiotic metabolite;
mouse metabolite
1962201529.0low021410
papaverinebenzylisoquinoline alkaloid;
dimethoxybenzene;
isoquinolines
antispasmodic drug;
vasodilator agent
1967196757.0low010000
4-chlorophenolmonochlorophenol2007201513.0low000110
4-dichlorobenzenedichlorobenzeneinsecticide2014201410.0low000010
1,7-dimethylxanthinedimethylxanthinecentral nervous system stimulant;
human blood serum metabolite;
human xenobiotic metabolite;
mouse metabolite
2009200915.0low000100
pargylinearomatic amine201520159.0low000010
pd 98059aromatic amine;
monomethoxyflavone
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor;
geroprotector
2004200817.2low000400
pentobarbitalbarbituratesGABAA receptor agonist1971197153.0low010000
pentoxifyllineoxopurine1997199926.0low102000
phenacetinacetamides;
aromatic ether
cyclooxygenase 3 inhibitor;
non-narcotic analgesic;
peripheral nervous system drug
1972201323.5low012120
phenobarbitalbarbituratesanticonvulsant;
drug allergen;
excitatory amino acid antagonist;
sedative
1972201338.9low0150010
phenoxybenzaminearomatic amine1968196856.0low010000
phenylmethylsulfonyl fluorideacyl fluorideserine proteinase inhibitor2001200123.0low000100
moxonidineorganohalogen compound;
pyrimidines
1998199826.0low001000
pioglitazonearomatic ether;
pyridines;
thiazolidinediones
antidepressant;
cardioprotective agent;
EC 2.7.1.33 (pantothenate kinase) inhibitor;
EC 6.2.1.3 (long-chain-fatty-acid--CoA ligase) inhibitor;
ferroptosis inhibitor;
geroprotector;
hypoglycemic agent;
insulin-sensitizing drug;
PPARgamma agonist;
xenobiotic
2012201411.0low000020
potassium chlorideinorganic chloride;
inorganic potassium salt;
potassium salt
fertilizer200720229.5low000121
4-aminobenzoic acidaminobenzoate;
aromatic amino-acid anion
Escherichia coli metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
2001200123.0low000100
ag 1879aromatic amine;
monochlorobenzenes;
pyrazolopyrimidine
beta-adrenergic antagonist;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor;
geroprotector
2010201014.0low000100
primaquineaminoquinoline;
aromatic ether;
N-substituted diamine
antimalarial1972200331.7low329100
proadifendiarylmethane2003200321.0low000100
probenecidbenzoic acids;
sulfonamide
uricosuric drug2007200717.0low000100
probucoldithioketal;
polyphenol
anti-inflammatory drug;
anticholesteremic drug;
antilipemic drug;
antioxidant;
cardiovascular drug
1995200522.7low001200
procainamidebenzamidesanti-arrhythmia drug;
platelet aggregation inhibitor;
sodium channel blocker
1971197352.0low020000
propidiumphenanthridines;
quaternary ammonium ion
fluorochrome;
intercalator
1999201318.0low001010
propofolphenolsanticonvulsant;
antiemetic;
intravenous anaesthetic;
radical scavenger;
sedative
2010201312.5low000110
propranololnaphthalenes;
propanolamine;
secondary amine
anti-arrhythmia drug;
antihypertensive agent;
anxiolytic drug;
beta-adrenergic antagonist;
environmental contaminant;
human blood serum metabolite;
vasodilator agent;
xenobiotic
1968200041.0low042000
propyl gallatetrihydroxybenzoic acid1992201023.0low001100
protopinedibenzazecine alkaloidplant metabolite2003202010.0low000120
pyrimethamineaminopyrimidine;
monochlorobenzenes
antimalarial;
antiprotozoal drug;
EC 1.5.1.3 (dihydrofolate reductase) inhibitor
1972201230.6low4618510
1,6-bis(cyclohexyloximinocarbonyl)hexanecarbamate ester;
organonitrogen compound
1993199728.7low003000
ro 31-8220imidothiocarbamic ester;
indoles;
maleimides
EC 2.7.11.13 (protein kinase C) inhibitor1993199331.0low001000
rofecoxibbutenolide;
sulfone
analgesic;
cyclooxygenase 2 inhibitor;
non-steroidal anti-inflammatory drug
2005200519.0low000100
roliprampyrrolidin-2-onesantidepressant;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor
2003201614.5low000110
s-methylisothiopseudouronium2009200915.0low000100
sanguinarinealkaloid antibiotic;
benzophenanthridine alkaloid;
botanical anti-fungal agent
1989198935.0low010000
sb 202190imidazoles;
organofluorine compound;
phenols;
pyridines
apoptosis inducer;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
2010201014.0low000100
sulfadiazinepyrimidines;
substituted aniline;
sulfonamide antibiotic;
sulfonamide
antiinfective agent;
antimicrobial agent;
antiprotozoal drug;
coccidiostat;
drug allergen;
EC 1.1.1.153 [sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming)] inhibitor;
EC 2.5.1.15 (dihydropteroate synthase) inhibitor;
environmental contaminant;
xenobiotic
1972197650.3low030000
spiperonearomatic ketone;
azaspiro compound;
organofluorine compound;
piperidines;
tertiary amino compound
alpha-adrenergic antagonist;
antipsychotic agent;
dopaminergic antagonist;
psychotropic drug;
serotonergic antagonist
1984198838.0low020000
stearic acidlong-chain fatty acid;
saturated fatty acid;
straight-chain saturated fatty acid
algal metabolite;
Daphnia magna metabolite;
human metabolite;
plant metabolite
1999199925.0low001000
vorinostatdicarboxylic acid diamide;
hydroxamic acid
antineoplastic agent;
apoptosis inducer;
EC 3.5.1.98 (histone deacetylase) inhibitor
201420188.3low000030
sulfadimethoxinearomatic ether;
pyrimidines;
substituted aniline;
sulfonamide antibiotic;
sulfonamide
antiinfective agent;
antimicrobial agent;
drug allergen;
environmental contaminant;
xenobiotic
1976197648.0low010000
sulfamethazinepyrimidines;
sulfonamide antibiotic;
sulfonamide
antibacterial drug;
antiinfective agent;
antimicrobial agent;
carcinogenic agent;
drug allergen;
EC 2.5.1.15 (dihydropteroate synthase) inhibitor;
environmental contaminant;
ligand;
xenobiotic
2003200321.0low000100
sulfamethoxazoleisoxazoles;
substituted aniline;
sulfonamide antibiotic;
sulfonamide
antibacterial agent;
antiinfective agent;
antimicrobial agent;
drug allergen;
EC 1.1.1.153 [sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming)] inhibitor;
EC 2.5.1.15 (dihydropteroate synthase) inhibitor;
environmental contaminant;
epitope;
P450 inhibitor;
xenobiotic
201620187.0low000020
sulfanilamidesubstituted aniline;
sulfonamide antibiotic;
sulfonamide
antibacterial agent;
drug allergen;
EC 4.2.1.1 (carbonic anhydrase) inhibitor
2004200420.0low000100
sulfasalazine2008200816.0low000100
sulfisomidinepyrimidines;
sulfonamide antibiotic;
sulfonamide
antiinfective agent2003200321.0low000100
sulfisoxazoleisoxazoles;
sulfonamide antibiotic;
sulfonamide
antibacterial drug;
drug allergen
1973197351.0low010000
sulforaphaneisothiocyanate;
sulfoxide
antineoplastic agent;
antioxidant;
EC 3.5.1.98 (histone deacetylase) inhibitor;
plant metabolite
201420216.5low000011
talipexoleazepine1986199334.0low012000
temozolomideimidazotetrazine;
monocarboxylic acid amide;
triazene derivative
alkylating agent;
antineoplastic agent;
prodrug
201420178.5low000020
terfenadinediarylmethane2002202112.5low000101
tetraethylammoniumquaternary ammonium ion2009200915.0low000100
thalidomidephthalimides;
piperidones
2011201113.0low000010
2,4-thiazolidinedionethiazolidenedione2003202112.0low000101
ticlopidinemonochlorobenzenes;
thienopyridine
anticoagulant;
fibrin modulating drug;
hematologic agent;
P2Y12 receptor antagonist;
platelet aggregation inhibitor
201820186.0low000010
tinidazoleimidazolesantiamoebic agent;
antibacterial drug;
antiparasitic agent;
antiprotozoal drug
2003200321.0low000100
tolbutamideN-sulfonylureahuman metabolite;
hypoglycemic agent;
insulin secretagogue;
potassium channel blocker
2000201316.3low001110
triclosanaromatic ether;
dichlorobenzene;
monochlorobenzenes;
phenols
antibacterial agent;
antimalarial;
drug allergen;
EC 1.3.1.9 [enoyl-[acyl-carrier-protein] reductase (NADH)] inhibitor;
EC 1.5.1.3 (dihydrofolate reductase) inhibitor;
fungicide;
persistent organic pollutant;
xenobiotic
201320179.7low000030
trifluoperazineN-alkylpiperazine;
N-methylpiperazine;
organofluorine compound;
phenothiazines
antiemetic;
calmodulin antagonist;
dopaminergic antagonist;
EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor;
EC 5.3.3.5 (cholestenol Delta-isomerase) inhibitor;
phenothiazine antipsychotic drug
1972200137.5low010100
trihexyphenidylamine1971197153.0low010000
trimethoprimaminopyrimidine;
methoxybenzenes
antibacterial drug;
diuretic;
drug allergen;
EC 1.5.1.3 (dihydrofolate reductase) inhibitor;
environmental contaminant;
xenobiotic
1974197649.0low020000
tyraminemonoamine molecular messenger;
primary amino compound;
tyramines
EC 3.1.1.8 (cholinesterase) inhibitor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
neurotransmitter
201620168.0low000010
urethanecarbamate esterfungal metabolite;
mutagen
1963197454.3low030000
w 72000200024.0low001000
pirinixic acidaryl sulfide;
organochlorine compound;
pyrimidines
2012201212.0low000010
hydrocortisone acetatecortisol ester;
tertiary alpha-hydroxy ketone
1982198242.0low010000
mitomycinmitomycinalkylating agent;
antineoplastic agent
1995199529.0low001000
corticosterone11beta-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
C21-steroid;
glucocorticoid;
primary alpha-hydroxy ketone
human metabolite;
mouse metabolite
2006201912.3low000210
prednisolone11beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
C21-steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone
adrenergic agent;
anti-inflammatory drug;
antineoplastic agent;
drug metabolite;
environmental contaminant;
immunosuppressive agent;
xenobiotic
1981200131.8low122100
estriol16alpha-hydroxy steroid;
17beta-hydroxy steroid;
3-hydroxy steroid
estrogen;
human metabolite;
human xenobiotic metabolite;
mouse metabolite
1974197450.0low010000
reserpinealkaloid ester;
methyl ester;
yohimban alkaloid
adrenergic uptake inhibitor;
antihypertensive agent;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
environmental contaminant;
first generation antipsychotic;
plant metabolite;
xenobiotic
1986198638.0low020000
sorbitolglucitolcathartic;
Escherichia coli metabolite;
food humectant;
human metabolite;
laxative;
metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite;
sweetening agent
1973200729.3low010200
alloxanpyrimidonehyperglycemic agent;
metabolite
1957195767.0low010000
thymidinepyrimidine 2'-deoxyribonucleosideEscherichia coli metabolite;
human metabolite;
metabolite;
mouse metabolite
1970201037.3low041100
piperonyl butoxidebenzodioxolespesticide synergist2002202015.2low000310
bromouracilnucleobase analogue;
pyrimidines
mutagen2008200816.0low000100
hydroxyproline4-hydroxyproline;
L-alpha-amino acid zwitterion
human metabolite;
mouse metabolite;
plant metabolite
1994201520.0low001110
thyroxine2-halophenol;
iodophenol;
L-phenylalanine derivative;
non-proteinogenic L-alpha-amino acid;
thyroxine zwitterion;
thyroxine
antithyroid drug;
human metabolite;
mouse metabolite;
thyroid hormone
1972202318.3low110002
carbacholammonium salt;
carbamate ester
cardiotonic drug;
miotic;
muscarinic agonist;
nicotinic acetylcholine receptor agonist;
non-narcotic analgesic
1996201920.0low002010
spironolactone3-oxo-Delta(4) steroid;
oxaspiro compound;
steroid lactone;
thioester
aldosterone antagonist;
antihypertensive agent;
diuretic;
environmental contaminant;
xenobiotic
1964200639.0low010100
aldosterone11beta-hydroxy steroid;
18-oxo steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
C21-steroid hormone;
mineralocorticoid;
primary alpha-hydroxy ketone;
steroid aldehyde
human metabolite;
mouse metabolite
2009201711.0low000110
prednisone11-oxo steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
C21-steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone
adrenergic agent;
anti-inflammatory drug;
antineoplastic agent;
immunosuppressive agent;
prodrug
1966201924.7low430150
estrone17-oxo steroid;
3-hydroxy steroid;
phenolic steroid;
phenols
antineoplastic agent;
bone density conservation agent;
estrogen;
human metabolite;
mouse metabolite
1962197455.6low050000
dehydroepiandrosterone17-oxo steroid;
3beta-hydroxy-Delta(5)-steroid;
androstanoid
androgen;
human metabolite;
mouse metabolite
1988198836.0low010000
1,2,5,6-dibenzanthraceneortho-fused polycyclic arenemutagen1988200626.8low020300
dichlororibofuranosylbenzimidazole2014201410.0low000010
hydroxyacetylaminofluorene2-acetamidofluorenes1977199638.3low021000
2-acetylaminofluorene2-acetamidofluorenesantimitotic;
carcinogenic agent;
epitope;
mutagen
1953199738.7low066000
adrenochromeindoles2005200519.0low000100
penicillin gpenicillin allergen;
penicillin
antibacterial drug;
drug allergen;
epitope
1974197450.0low010000
pilocarpinepilocarpineantiglaucoma drug2014201410.0low000010
pentylenetetrazoleorganic heterobicyclic compound;
organonitrogen heterocyclic compound
1974200733.5low010100
triiodothyronine2-halophenol;
amino acid zwitterion;
iodophenol;
iodothyronine
human metabolite;
mouse metabolite;
thyroid hormone
202220231.5low100002
isoflurophatedialkyl phosphate1968196856.0low010000
biguanidesguanidines1947198859.2low040000
carbon tetrachloridechlorocarbon;
chloromethanes
hepatotoxic agent;
refrigerant
1968202020.6low020350
cantharidincyclic dicarboxylic anhydride;
monoterpenoid
EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor;
herbicide
201620168.0low000010
alaninealanine zwitterion;
alanine;
L-alpha-amino acid;
proteinogenic amino acid;
pyruvate family amino acid
EC 4.3.1.15 (diaminopropionate ammonia-lyase) inhibitor;
fundamental metabolite
2004202111.8low000221
serineL-alpha-amino acid;
proteinogenic amino acid;
serine family amino acid;
serine zwitterion;
serine
algal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
2005200519.0low000100
desoxycorticosterone acetatecorticosteroid hormone202020204.0low000010
benz(a)anthraceneortho-fused polycyclic arene;
tetraphenes
1953201939.6low0242560
4-nitroquinoline-1-oxideC-nitro compound;
quinoline N-oxide
carcinogenic agent1977199538.0low011000
chloramphenicolC-nitro compound;
carboxamide;
diol;
organochlorine compound
antibacterial drug;
antimicrobial agent;
Escherichia coli metabolite;
geroprotector;
Mycoplasma genitalium metabolite;
protein synthesis inhibitor
1966201845.0low061010
aspartic acidaspartate family amino acid;
aspartic acid;
L-alpha-amino acid;
proteinogenic amino acid
Escherichia coli metabolite;
mouse metabolite;
neurotransmitter
2005201215.5low000110
glutamineamino acid zwitterion;
glutamine family amino acid;
glutamine;
L-alpha-amino acid;
polar amino acid zwitterion;
proteinogenic amino acid
EC 1.14.13.39 (nitric oxide synthase) inhibitor;
Escherichia coli metabolite;
human metabolite;
metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite
1974202222.7low010101
lysineaspartate family amino acid;
L-alpha-amino acid zwitterion;
L-alpha-amino acid;
lysine;
organic molecular entity;
proteinogenic amino acid
algal metabolite;
anticonvulsant;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
1989201420.8low011120
cyanidespseudohalide anionEC 1.9.3.1 (cytochrome c oxidase) inhibitor1970201735.0low030110
physostigminecarbamate ester;
indole alkaloid
antidote to curare poisoning;
EC 3.1.1.8 (cholinesterase) inhibitor;
miotic
1968197055.0low030000
sucroseglycosyl glycosidealgal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
osmolyte;
Saccharomyces cerevisiae metabolite;
sweetening agent
1969200631.0low010200
sucroseglycosyl glycosidealgal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
osmolyte;
Saccharomyces cerevisiae metabolite;
sweetening agent
1969201822.3low010510
ethinyl estradiol17-hydroxy steroid;
3-hydroxy steroid;
terminal acetylenic compound
xenoestrogen2004201714.7low000330
tubocurarinebisbenzylisoquinoline alkaloiddrug allergen;
muscle relaxant;
nicotinic antagonist
1998199826.0low001000
9,10-dimethyl-1,2-benzanthraceneortho-fused polycyclic arene;
tetraphenes
carcinogenic agent1976200836.9low0123300
apomorphineaporphine alkaloidalpha-adrenergic drug;
antidyskinesia agent;
antiparkinson drug;
dopamine agonist;
emetic;
serotonergic drug
1975199141.2low031000
aminopyrinepyrazolone;
tertiary amino compound
antipyretic;
environmental contaminant;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic
1972197252.0low010000
methyltestosterone17beta-hydroxy steroid;
3-oxo-Delta(4) steroid;
enone
anabolic agent;
androgen;
antineoplastic agent
1972197650.0low020000
tetrabenazinebenzoquinolizine;
cyclic ketone;
tertiary amino compound
1966196658.0low010000
puromycin aminonucleoside3'-deoxyribonucleoside;
adenosines
200820198.7low000120
adenosine diphosphateadenosine 5'-phosphate;
purine ribonucleoside 5'-diphosphate
fundamental metabolite;
human metabolite
1972202140.9low0191321
2,3,4,6-tetrachlorophenoltetrachlorophenolxenobiotic metabolite2007201710.2low000130
uridineuridinesdrug metabolite;
fundamental metabolite;
human metabolite
1973201128.8low020110
uridine diphosphatepyrimidine ribonucleoside 5'-diphosphate;
uridine 5'-phosphate
Escherichia coli metabolite;
mouse metabolite
202220222.0low000001
kanamycin akanamycinsbacterial metabolite2003200321.0low000100
bromodeoxyuridinepyrimidine 2'-deoxyribonucleosideantimetabolite;
antineoplastic agent
1996201117.6low001310
galactoseD-galactose;
galactopyranose
Escherichia coli metabolite;
mouse metabolite
201920195.0low000020
carbostyrilmonohydroxyquinoline;
quinolone
bacterial xenobiotic metabolite2000201912.8low001030
phenylephrinephenols;
phenylethanolamines;
secondary amino compound
alpha-adrenergic agonist;
cardiotonic drug;
mydriatic agent;
nasal decongestant;
protective agent;
sympathomimetic agent;
vasoconstrictor agent
2002201017.7low000300
edetic acidethylenediamine derivative;
polyamino carboxylic acid;
tetracarboxylic acid
anticoagulant;
antidote;
chelator;
copper chelator;
geroprotector
1979201622.2low011220
p-dimethylaminoazobenzeneazobenzenes1970197949.5low020000
tyrosineamino acid zwitterion;
erythrose 4-phosphate/phosphoenolpyruvate family amino acid;
L-alpha-amino acid;
proteinogenic amino acid;
tyrosine
EC 1.3.1.43 (arogenate dehydrogenase) inhibitor;
fundamental metabolite;
micronutrient;
nutraceutical
1993202218.1low002511
adenosine monophosphateadenosine 5'-phosphate;
purine ribonucleoside 5'-monophosphate
adenosine A1 receptor agonist;
cofactor;
EC 3.1.3.1 (alkaline phosphatase) inhibitor;
EC 3.1.3.11 (fructose-bisphosphatase) inhibitor;
fundamental metabolite;
micronutrient;
nutraceutical
1972202135.6low040201
methicillinpenicillin allergen;
penicillin
antibacterial drug1974201629.0low010010
methylene blueorganic chloride saltacid-base indicator;
antidepressant;
antimalarial;
antimicrobial agent;
antioxidant;
cardioprotective agent;
EC 1.4.3.4 (monoamine oxidase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
EC 4.6.1.2 (guanylate cyclase) inhibitor;
fluorochrome;
histological dye;
neuroprotective agent;
physical tracer
1975202220.0low010011
zoxazolaminebenzoxazole1966197155.5low020000
leucineamino acid zwitterion;
L-alpha-amino acid;
leucine;
proteinogenic amino acid;
pyruvate family amino acid
algal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
1966200839.4low091400
anilineanilines;
primary arylamine
2011201113.0low000010
2-aminoisobutyric acid2,2-dialkylglycine zwitterion;
2,2-dialkylglycine
2006200618.0low000100
dimethylnitrosaminenitrosaminegeroprotector;
mutagen
2011201113.0low000010
androstenedione17-oxo steroid;
3-oxo-Delta(4) steroid;
androstanoid
androgen;
Daphnia magna metabolite;
human metabolite;
mouse metabolite
2011201113.0low000010
methionineaspartate family amino acid;
L-alpha-amino acid;
methionine zwitterion;
methionine;
proteinogenic amino acid
antidote to paracetamol poisoning;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical
1969201440.8low051110
1,2-dipalmitoylphosphatidylcholine1997201419.1low002320
phenylalanineamino acid zwitterion;
erythrose 4-phosphate/phosphoenolpyruvate family amino acid;
L-alpha-amino acid;
phenylalanine;
proteinogenic amino acid
algal metabolite;
EC 3.1.3.1 (alkaline phosphatase) inhibitor;
Escherichia coli metabolite;
human xenobiotic metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
1970202024.6low041250
colchicinealkaloid;
colchicine
anti-inflammatory agent;
gout suppressant;
mutagen
1968197254.0low020000
cytidinecytidinesEscherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
1973197351.0low010000
1-naphthaldehydenaphthaldehydemouse metabolite2010201014.0low000100
cycloheximideantibiotic fungicide;
cyclic ketone;
dicarboximide;
piperidine antibiotic;
piperidones;
secondary alcohol
anticoronaviral agent;
bacterial metabolite;
ferroptosis inhibitor;
neuroprotective agent;
protein synthesis inhibitor
1974201828.0low025210
2-naphthaldehydenaphthaldehydemouse metabolite1965196559.0low010000
egtazic aciddiether;
tertiary amino compound;
tetracarboxylic acid
chelator1993201119.5low001210
chloroformchloromethanes;
one-carbon compound
carcinogenic agent;
central nervous system drug;
inhalation anaesthetic;
non-polar solvent;
refrigerant
1968202229.7low022201
sodium citrate, anhydrousorganic sodium saltanticoagulant;
flavouring agent
2014201410.0low000010
dimethylformamideformamides;
volatile organic compound
geroprotector;
hepatotoxic agent;
polar aprotic solvent
1970202228.0low010001
norethindrone17beta-hydroxy steroid;
3-oxo-Delta(4) steroid;
terminal acetylenic compound;
tertiary alcohol
progestin;
synthetic oral contraceptive
2014201410.0low000010
triaziquone1,4-benzoquinones;
aziridines
alkylating agent;
antineoplastic agent
1969196955.0low010000
17-alpha-hydroxyprogesterone17alpha-hydroxy-C21-steroid;
17alpha-hydroxy steroid;
tertiary alpha-hydroxy ketone
human metabolite;
metabolite;
mouse metabolite;
progestin
2011201113.0low000010
ampicillinbeta-lactam antibiotic;
penicillin allergen;
penicillin
antibacterial drug1974197450.0low010000
mannitolmannitolallergen;
antiglaucoma drug;
compatible osmolytes;
Escherichia coli metabolite;
food anticaking agent;
food bulking agent;
food humectant;
food stabiliser;
food thickening agent;
hapten;
metabolite;
osmotic diuretic;
sweetening agent
2008201811.0low000110
cytarabinebeta-D-arabinoside;
monosaccharide derivative;
pyrimidine nucleoside
antimetabolite;
antineoplastic agent;
antiviral agent;
immunosuppressive agent
2008201612.0low000110
dithionitrobenzoic acidnitrobenzoic acid;
organic disulfide
indicator201620168.0low000010
trifluridinenucleoside analogue;
organofluorine compound;
pyrimidine 2'-deoxyribonucleoside
antimetabolite;
antineoplastic agent;
antiviral drug;
EC 2.1.1.45 (thymidylate synthase) inhibitor
202320231.0low000001
ornithinenon-proteinogenic L-alpha-amino acid;
ornithine
algal metabolite;
hepatoprotective agent;
mouse metabolite
2001200123.0low000100
dinitrofluorobenzeneC-nitro compound;
organofluorine compound
agrochemical;
allergen;
chromatographic reagent;
EC 2.7.3.2 (creatine kinase) inhibitor;
protein-sequencing agent;
spectrophotometric reagent
2001201217.5low000110
asparagineamino acid zwitterion;
asparagine;
aspartate family amino acid;
L-alpha-amino acid;
proteinogenic amino acid
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
2005200519.0low000100
histidineamino acid zwitterion;
histidine;
L-alpha-amino acid;
polar amino acid zwitterion;
proteinogenic amino acid
algal metabolite;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite
1970197252.7low030000
n-pentanolpentanol;
short-chain primary fatty alcohol
human metabolite;
plant metabolite
2012201212.0low000010
1,1,1-trichloroethanechloroethanespolar solvent2013201311.0low000010
valineL-alpha-amino acid zwitterion;
L-alpha-amino acid;
proteinogenic amino acid;
pyruvate family amino acid;
valine
algal metabolite;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite
1969201028.3low010200
threonineamino acid zwitterion;
aspartate family amino acid;
L-alpha-amino acid;
proteinogenic amino acid;
threonine
algal metabolite;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
201920195.0low000010
dichlorodiphenyldichloroethanechlorophenylethane;
monochlorobenzenes;
organochlorine insecticide
xenobiotic metabolite2000200621.0low001100
tryptophanerythrose 4-phosphate/phosphoenolpyruvate family amino acid;
L-alpha-amino acid zwitterion;
L-alpha-amino acid;
proteinogenic amino acid;
tryptophan zwitterion;
tryptophan
antidepressant;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
2001202213.1low000421
argininearginine;
glutamine family amino acid;
L-alpha-amino acid;
proteinogenic amino acid
biomarker;
Escherichia coli metabolite;
micronutrient;
mouse metabolite;
nutraceutical
1966201640.4low0113020
ethylenealkene;
gas molecular entity
plant hormone;
refrigerant
2007202011.7low000210
acetylenealkyne;
gas molecular entity;
terminal acetylenic compound
1992201021.1low002500
boranesboranes;
mononuclear parent hydride
201820186.0low000020
acetonitrilealiphatic nitrile;
volatile organic compound
EC 3.5.1.4 (amidase) inhibitor;
NMR chemical shift reference compound;
polar aprotic solvent
1990201220.6low002410
methylene chloridechloromethanes;
volatile organic compound
carcinogenic agent;
polar aprotic solvent;
refrigerant
2002202213.0low000211
carbon disulfideone-carbon compound;
organosulfur compound
1968196856.0low010000
boron trifluorideboron fluorideNMR chemical shift reference compound201820186.0low000010
vinylidene chloridechloroethenescarcinogenic agent;
mouse metabolite;
mutagen
201620168.0low000010
trichloroacetic acidmonocarboxylic acid;
organochlorine compound
carcinogenic agent;
metabolite;
mouse metabolite
1967201737.3low020010
trifluoroacetic acidfluoroalkanoic acidhuman xenobiotic metabolite;
NMR chemical shift reference compound;
reagent
2011201113.0low000010
pinacolglycol201820186.0low000010
fluoxymesterone11beta-hydroxy steroid;
17beta-hydroxy steroid;
3-oxo-Delta(4) steroid;
anabolic androgenic steroid;
fluorinated steroid
anabolic agent;
antineoplastic agent
1968196856.0low010000
phencyclidinebenzenes;
piperidines
anaesthetic;
neurotoxin;
NMDA receptor antagonist;
psychotropic drug
1964202224.1low022331
tromethamineprimary amino compound;
triol
buffer2013201311.0low000010
quinic acid2002200222.0low000100
isoprenealkadiene;
hemiterpene;
volatile organic compound
plant metabolite2011201113.0low000010
trichloroethylenechloroethenesinhalation anaesthetic;
mouse metabolite
201620196.5low000020
acrylic acidalpha,beta-unsaturated monocarboxylic acidmetabolite1998199826.0low001000
tetrabromobisphenol abrominated flame retardant;
bromobisphenol
201720177.0low000010
bisphenol abisphenolendocrine disruptor;
environmental contaminant;
xenobiotic;
xenoestrogen
2000202010.9low001180
benzanthronephenanthrenes1999199925.0low001000
acenaphtheneacenaphthenes1993202216.2high005381
rotenoneorganic heteropentacyclic compound;
rotenones
antineoplastic agent;
metabolite;
mitochondrial NADH:ubiquinone reductase inhibitor;
phytogenic insecticide;
piscicide;
toxin
1968200642.6low050200
9,10-phenanthrenequinonephenanthrenes1977202217.3high082137466
phanquinoneorthoquinones1958195866.0low010000
9,10-anthraquinoneanthraquinone2007201911.0low000110
benzo(f)quinoline1988200131.3medium020100
1-hydroxy-2-naphthoic acidhydroxy monocarboxylic acid;
naphthoic acid;
naphthols
bacterial xenobiotic metabolite;
fungal xenobiotic metabolite
1965202014.9high011590
1-naphthoic acidnaphthoic acidbacterial xenobiotic metabolite;
fungal xenobiotic metabolite
2010201014.0low000100
1-nitronaphthalenemononitronaphthaleneenvironmental contaminant;
mouse metabolite
1985199235.5low011000
fluoreneortho-fused polycyclic arene;
ortho-fused tricyclic hydrocarbon
1953202315.1medium041025387
carbazolecarbazole2009201810.5low000110
1,2,3-trichlorobenzenetrichlorobenzene2007200717.0low000100
2,4,6-trichlorophenoltrichlorophenolcarcinogenic agent201720177.0low000010
n-vinyl-2-pyrrolidinonepyrrolidin-2-ones2007201611.5low000130
2-nitrotoluenemononitrotoluenecarcinogenic agent;
environmental contaminant
2001200123.0low000100
1-methylnaphthalenemethylnaphthalenecarcinogenic agent;
plant metabolite
2010201014.0low000100
1-chloronaphthalene2003200321.0low000100
1-naphtholnaphtholgenotoxin;
human xenobiotic metabolite
1965201616.8low011280
2-phenylphenolhydroxybiphenylsantifungal agrochemical;
environmental food contaminant
2005201016.0low000300
anthroneanthracenoneradical scavenger201620196.5low000020
quinoxalinesmancude organic heterobicyclic parent;
naphthyridine;
ortho-fused heteroarene
1972201629.4low020210
quinolineazaarene;
mancude organic heterobicyclic parent;
ortho-fused heteroarene;
quinolines
1999201118.0low001210
2-methylnaphthalenemethylnaphthalene1962196262.0low010000
2-chloronaphthalene2003200321.0medium000100
2-naphthylaminenaphthylaminecarcinogenic agent1979198542.0low020000
naphthaceneacene;
tetracenes
2010201014.0low000100
diphenylaromatic fungicide;
benzenes;
biphenyls
antifungal agrochemical;
antimicrobial food preservative
1953202119.7low024791
3-hydroxy-2-naphthoic acidnaphthoic acid1965196559.0low010000
xanthenesxanthene1968202022.8low011310
phenothiazinephenothiazineferroptosis inhibitor;
plant metabolite;
radical scavenger
2013201311.0low000010
benzidinebiphenyls;
substituted aniline
carcinogenic agent1985198539.0low010000
propylparabenbenzoate ester;
paraben;
phenols
antifungal agent;
antimicrobial agent
1999200323.0low001100
benzoyl peroxidecarbonyl compound2011201113.0low000010
2-xylenexylene201720177.0low000010
2-dichlorobenzenedichlorobenzenehepatotoxic agent;
metabolite
2005200519.0low000100
1,2,4,5-tetrachlorobenzenetetrachlorobenzene2007200717.0low000100
styrene oxideepoxidehuman xenobiotic metabolite1987200030.5low011000
4-butyrolactonebutan-4-olidemetabolite;
neurotoxin
1986199434.2low022000
ethyl lactateethyl ester;
lactate ester;
secondary alcohol
metabolite201620168.0low000010
ethylene dimethacrylateenoate esterallergen;
cross-linking reagent;
polymerisation monomer
2008200816.0low000100
nitrobenzenenitroarene;
nitrobenzenes
2013201410.5low000020
3-nitrotoluenemononitrotoluene2006200618.0low000100
trehalosetrehaloseEscherichia coli metabolite;
geroprotector;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
2004202011.7low000120
sym-trinitrobenzenetrinitrobenzeneexplosive2004200420.0low000100
carvonebotanical anti-fungal agent;
carvones
allergen2012201212.0low000010
3-dinitrobenzenedinitrobenzeneneurotoxin201720177.0low000010
4-bromophenacyl bromide1988199830.5low013000
4-cymenemonoterpene;
toluenes
human urinary metabolite;
plant metabolite;
volatile oil component
201520159.0low000010
4-nitrotoluenemononitrotoluene201620168.0low000010
4-nitroanisole4-nitroanisoles1996199628.0low001000
styrenestyrenes;
vinylarene;
volatile organic compound
mouse metabolite;
mutagen;
plant metabolite
202220222.0low000001
benzylaminearalkylamine;
primary amine
allergen;
EC 3.5.5.1 (nitrilase) inhibitor;
plant metabolite
2011201710.0low000020
benzonitrilebenzenes;
nitrile
201720177.0low000010
diphenylmethanediarylmethane201820186.0low000010
phenyl etheraromatic etherplant metabolite2014201410.0low000010
boric acidboric acidsastringent202320231.0low000001
1,2-dihydrostilbenediphenylethane1983198341.0low010000
3-phenylpropanalaldehyde;
benzenes
flavouring agent;
plant metabolite
201620168.0low000010
caprolactamcaprolactamshuman blood serum metabolite2007200717.0low000100
4-phenylenediaminephenylenediamineallergen;
dye;
hapten;
reagent
202320231.0low000001
4-vinyl-1-cyclohexene dioxideepoxidecarcinogenic agent201320179.0low000020
epichlorohydrinepoxide;
organochlorine compound
1989198935.0low010000
glycidyl methacrylateenoate ester;
epoxide
2008200816.0low000100
1,3-butadienebutadienecarcinogenic agent;
mutagen
2007200717.0low000100
allyl chlorideorganochlorine compound2008200816.0low000100
propargyl alcoholpropynol;
terminal acetylenic compound;
volatile organic compound
antifungal agent;
Saccharomyces cerevisiae metabolite
2014201410.0low000010
glyoxaldialdehydeagrochemical;
allergen;
pesticide;
plant growth regulator
1962196262.0low040000
2-methylpentanealkane2005201615.0low000530
3-hydroxybutanal2008200816.0low000100
vinyl acetateacetate ester2007200717.0low000100
maleic anhydridecyclic dicarboxylic anhydride;
furans
allergen201820186.0low000010
3-phenylenediaminephenylenediamine202320231.0low000001
mesitylenetrimethylbenzene2011201113.0low000010
1,3,5-trichlorobenzenetrichlorobenzene2004200420.0low000100
melaminetriamino-1,3,5-triazinexenobiotic metabolite202220222.0low000001
chlorobenzenemonochlorobenzenessolvent2006200618.0low000100
pyrrolespyrrole;
secondary amine
1968201328.3low031420
furanfurans;
mancude organic heteromonocyclic parent;
monocyclic heteroarene
carcinogenic agent;
hepatotoxic agent;
Maillard reaction product
2011201113.0low000010
thiophenesmancude organic heteromonocyclic parent;
monocyclic heteroarene;
thiophenes;
volatile organic compound
non-polar solvent1990202016.4low0036100
isopropyl myristatefatty acid ester2005200718.0low000200
n-hexanealkane;
volatile organic compound
neurotoxin;
non-polar solvent
2009201611.5low000110
2-ethoxyethanolglycol ether;
primary alcohol
protic solvent;
teratogenic agent
2014201410.0low000010
cyclohexanecycloalkane;
volatile organic compound
non-polar solvent2008200816.0low000100
cyclohexenecycloalkene2001201217.5low000110
dodecyltrimethylammoniumquaternary ammonium ion2000200024.0low001000
n-decyl alcoholdecanol;
primary alcohol
metabolite;
pheromone;
protic solvent
2009200915.0low000100
n-dodecanealkaneplant metabolite2005201812.5low000110
eicosanelong-chain alkaneplant metabolite2004202014.0low000210
dimethyl etherether202220222.0low000001
triphenyl phosphatearyl phosphateflame retardant;
plasticiser
1983198341.0low010000
diethylhexyl phthalatediester;
phthalate ester
androstane receptor agonist;
apoptosis inhibitor;
plasticiser
1995201021.5low001100
hexachlorobenzenearomatic fungicide;
chlorobenzenes
antifungal agrochemical;
carcinogenic agent;
persistent organic pollutant
2009200915.0low000100
trinitrotoluenetrinitrotolueneexplosive1964196460.0low010000
framycetinaminoglycosideallergen;
antibacterial drug;
Escherichia coli metabolite
1974201727.3low011010
tetralinortho-fused bicyclic hydrocarbon;
tetralins
2011201113.0low000010
isoquinolineazaarene;
isoquinolines;
mancude organic heterobicyclic parent;
ortho-fused heteroarene
2006201314.5low000110
anthraceneacene;
anthracenes;
ortho-fused tricyclic hydrocarbon
1946202318.1medium0122045523
2,4-dichlorophenoldichlorophenol201620168.0low000010
2,4-dinitrotoluenedinitrotoluene2014201410.0low000010
1,4-naphthoquinone1,4-naphthoquinones2011201113.0low000010
1-naphthylaminenaphthylaminehuman xenobiotic metabolite1985201324.7low011010
2-naphtholnaphtholantinematodal drug;
genotoxin;
human urinary metabolite;
human xenobiotic metabolite;
mouse metabolite;
radical scavenger
1955202316.4low04516242
2-naphtholnaphtholantinematodal drug;
genotoxin;
human urinary metabolite;
human xenobiotic metabolite;
mouse metabolite;
radical scavenger
1955202017.0low04516240
2-aminothiophenolaryl thiol;
substituted aniline
plant metabolite2010201014.0low000100
protocatechualdehydedihydroxybenzaldehyde1985201623.3low042720
dodecyl sulfatealkyl sulfate2014201410.0low000010
sterogenolbromide salt;
pyridinium salt
antiseptic drug;
EC 2.7.11.18 (myosin-light-chain kinase) inhibitor;
surfactant
2012201212.0low000010
citronellolmonoterpenoidplant metabolite2007200717.0low000100
ethyl acetateacetate ester;
ethyl ester;
volatile organic compound
EC 3.4.19.3 (pyroglutamyl-peptidase I) inhibitor;
metabolite;
polar aprotic solvent;
Saccharomyces cerevisiae metabolite
1986200925.0low012200
hexanoic acidmedium-chain fatty acid;
straight-chain saturated fatty acid
human metabolite;
plant metabolite
202020204.0low000010
n-heptanealkane;
volatile organic compound
non-polar solvent;
plant metabolite
2006201115.5low000110
sodium cyanidecyanide salt;
one-carbon compound;
sodium salt
EC 1.15.1.1 (superoxide dismutase) inhibitor2000200024.0low001000
pregnenolone20-oxo steroid;
3beta-hydroxy-Delta(5)-steroid;
C21-steroid
human metabolite;
mouse metabolite
201920195.0low000010
diphenhydramine hydrochloridehydrochloride;
organoammonium salt
anti-allergic agent;
antiemetic;
antiparkinson drug;
antipruritic drug;
H1-receptor antagonist;
local anaesthetic;
muscarinic antagonist;
sedative
1955196962.0low040000
ditiocarbdithiocarbamic acidschelator;
copper chelator
2005200519.0low000100
1,2-dihydroxybenzene-3,5-disulfonic acid disodium saltorganic molecular entity2007200717.0low000100
aziridineazacycloalkane;
aziridines;
saturated organic heteromonocyclic parent
alkylating agent2008201015.0low000200
sulfalenepyrazines;
sulfonamide antibiotic;
sulfonamide
1976199538.5low111000
cycloguaniltriazinesantifolate;
antiinfective agent;
antimalarial;
antiparasitic agent;
antiprotozoal drug;
EC 1.5.1.3 (dihydrofolate reductase) inhibitor
1994199629.3low003000
catechincatechinantioxidant;
plant metabolite
1995202210.0low001161
homoargininehomoarginine;
L-lysine derivative;
non-proteinogenic L-alpha-amino acid
biomarker;
EC 3.1.3.1 (alkaline phosphatase) inhibitor;
human metabolite;
rat metabolite;
xenobiotic metabolite
1991199133.0low001000
coroneneortho- and peri-fused polycyclic arene1988201917.6low011030
1,12-benzoperyleneortho- and peri-fused polycyclic arene2001200918.3medium000300
anthanthreneortho- and peri-fused polycyclic arene2012201212.0medium000010
dibenzo(a,l)pyreneortho- and peri-fused polycyclic arenehuman metabolite;
mutagen
1998199826.0low001000
benzo(e)pyreneortho- and peri-fused polycyclic arenecarcinogenic agent;
mutagen
1984201427.0low021110
indeno(1,2,3-cd)pyrenepyrenes2012201610.0low000020
benzo(c)phenanthrenebenzenoid aromatic compound;
ortho-fused polycyclic arene
1958201729.3high013131710
benzo(g)chrysene1998200124.5high001100
peryleneortho- and peri-fused polycyclic arene;
perylenes
1979202225.7low152611
benzo(j)fluoranthenenaphthalenes2000200024.0low001000
benzo(b)fluorantheneortho- and peri-fused polycyclic arenemutagen200120228.4medium000262
fluorantheneortho- and peri-fused polycyclic arene1981202314.0high0215525710
benzo(k)fluoranthenenaphthalenes2001202316.5low000301
acenaphthyleneacenaphthylenes;
ortho- and peri-fused polycyclic arene;
ortho- and peri-fused tricyclic hydrocarbon
1994202313.4medium003213
piceneortho-fused polycyclic arene1988198836.0medium010000
benzotriphenylenecarbopolycyclic compound1974199538.3medium021000
dibenzacridine1987198737.0low010000
triphenyleneortho-fused polycyclic arene1980201033.1medium050200
chryseneortho-fused polycyclic areneplant metabolite1949202325.9high024216123
benzo(c)cinnoline1945201526.3high012220
benzo(h)quinoline2001200123.0low000100
benzo(b)naphtho(2,1-d)thiopheneorganic heterotricyclic compound;
organosulfur heterocyclic compound
1990199034.0medium001000
cinnolineazaarene;
cinnolines;
mancude organic heterobicyclic parent;
ortho-fused heteroarene
1945201135.0low010020
quinazolinesazaarene;
mancude organic heterobicyclic parent;
ortho-fused heteroarene;
quinazolines
1945201631.6low141320
acridinesacridines;
mancude organic heterotricyclic parent;
polycyclic heteroarene
genotoxin1953201841.6low0153330
dibenzo(1,4)dioxindibenzodioxine;
heteranthrene;
mancude organic heterotricyclic parent;
oxacycle;
polycyclic heteroarene
2003200321.0low000100
phenoxathiin1999199925.0low001000
indazolesindazole2011201710.0low000030
azuleneazulenes;
mancude carbobicyclic parent;
ortho-fused bicyclic arene
plant metabolite;
volatile oil component
2012201212.0low000010
adamantaneadamantanes;
polycyclic alkane
2013201311.0low000010
cyclopentanecycloalkane;
cyclopentanes;
volatile organic compound
non-polar solvent1955202033.3low0120370
isoxazolesisoxazoles;
mancude organic heteromonocyclic parent;
monocyclic heteroarene
1976201520.8low010320
oxazoles1,3-oxazoles;
mancude organic heteromonocyclic parent;
monocyclic heteroarene
1970202128.8low020011
thiazoles1,3-thiazoles;
mancude organic heteromonocyclic parent;
monocyclic heteroarene
2002202015.7low000930
pyrimidinediazine;
pyrimidines
Daphnia magna metabolite202020204.0low000010
pyrazinesdiazine;
pyrazines
Daphnia magna metabolite1974201321.8low011220
hydrazineazane;
hydrazines
EC 4.3.1.10 (serine-sulfate ammonia-lyase) inhibitor1967200442.7low020100
thiocyanatepseudohalide anion;
sulfur molecular entity
human metabolite1990199034.0low001000
evans blueorganic sodium saltfluorochrome;
histological dye;
sodium channel blocker;
teratogenic agent
2010201014.0low000100
monocrotalinepyrrolizidine alkaloid2000201417.8low001210
azacitidineN-glycosyl-1,3,5-triazine;
nucleoside analogue
antineoplastic agent2009200915.0low000100
perfluorooctanoic acidfluoroalkanoic acidcarcinogenic agent;
endocrine disruptor;
environmental contaminant;
surfactant;
xenobiotic
201720177.0low000010
citrullineamino acid zwitterion;
citrulline
Daphnia magna metabolite;
EC 1.14.13.39 (nitric oxide synthase) inhibitor;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
protective agent;
Saccharomyces cerevisiae metabolite
2001200123.0low000100
perfluorobutyric acidfluoroalkanoic acidchromatographic reagent;
environmental contaminant;
xenobiotic
201720177.0low000010
silicon carbideorganosilicon compound2011201113.0low000010
lithocholic acidbile acid;
C24-steroid;
monohydroxy-5beta-cholanic acid
geroprotector;
human metabolite;
mouse metabolite
202020204.0low000010
nandrolone17beta-hydroxy steroid;
3-oxo-Delta(4) steroid;
anabolic androgenic steroid
human metabolite1968200941.3low020100
hydantoinsimidazolidine-2,4-dione1978200433.0low010100
fluorobenzenesmonofluorobenzenesNMR chemical shift reference compound1975201122.5low010120
homocystineamino acid zwitterion;
homocystines
human metabolite2007200717.0low000100
propadieneallenes2008200915.5low000200
dextropropoxyphene1-benzyl-3-(dimethylamino)-2-methyl-1-phenylpropyl propanoatemu-opioid receptor agonist;
opioid analgesic
1971197153.0low010000
methylguanidineguanidinesEC 1.14.13.39 (nitric oxide synthase) inhibitor;
metabolite;
uremic toxin
1979197945.0low010000
limestonecalcium salt;
carbonate salt;
inorganic calcium salt;
one-carbon compound
antacid;
fertilizer;
food colouring;
food firming agent
1994202317.0low001101
hopaneterpenoid fundamental parent;
triterpene
2005201414.5low000110
pinanecarbobicyclic compound;
monoterpene;
terpenoid fundamental parent
plant metabolite1989198935.0low010000
chenodeoxycholic acidbile acid;
C24-steroid;
dihydroxy-5beta-cholanic acid
human metabolite;
mouse metabolite
1980198044.0low010000
isocorydineaporphine alkaloid1996199628.0low001000
nuciferine1978197846.0low010000
fusarium1972201426.0low010210
boldineaporphine alkaloid1997200522.0low001200
rheindihydroxyanthraquinone2007200717.0low000100
plumbaginhydroxy-1,4-naphthoquinone;
phenols
anticoagulant;
antineoplastic agent;
immunological adjuvant;
metabolite
2006202210.0low000101
diphenic aciddicarboxylic acid1992201418.4medium002030
phosphoadenosine phosphosulfateacyl sulfate;
adenosine bisphosphate;
purine ribonucleoside bisphosphate
Escherichia coli metabolite;
mouse metabolite
1986198837.0low020000
emetineisoquinoline alkaloid;
pyridoisoquinoline
antiamoebic agent;
anticoronaviral agent;
antiinfective agent;
antimalarial;
antineoplastic agent;
antiprotozoal drug;
antiviral agent;
autophagy inhibitor;
emetic;
expectorant;
plant metabolite;
protein synthesis inhibitor
1977200335.0low020100
retene1946202215.1high12020224
9-phenanthrolphenanthrolTRPM4 channel inhibitor1965202310.1high0126427
lophine2000200024.0low001000
9-fluorenonefluoren-9-onesfungal xenobiotic metabolite1988202317.2low011021
flavanoneflavanones2006200618.0low000100
kainic aciddicarboxylic acid;
L-proline derivative;
non-proteinogenic L-alpha-amino acid;
pyrrolidinecarboxylic acid
antinematodal drug;
excitatory amino acid agonist
1998201814.2low001040
indolineindoles2001200123.0low000100
dithiol2013201311.0low000010
sodium carbonatecarbonate salt;
organic sodium salt
2012201212.0low000010
phloretic acidhydroxy monocarboxylic acidplant metabolite201620168.0low000010
alpha-aminopyridine201720177.0low000010
cyanogen bromide1996199628.0low001000
oleanolic acidhydroxy monocarboxylic acid;
pentacyclic triterpenoid
plant metabolite1991201518.2low001220
methadyl acetatediarylmethane2001200123.0low000100
abietic acidabietane diterpenoid;
monocarboxylic acid
plant metabolite1980201626.9high014343410
hematoxylinorganic heterotetracyclic compound;
oxacycle;
polyphenol;
tertiary alcohol
histological dye;
plant metabolite
202220222.0low000001
podophyllotoxinfuronaphthodioxole;
lignan;
organic heterotetracyclic compound
antimitotic;
antineoplastic agent;
keratolytic drug;
microtubule-destabilising agent;
plant metabolite;
tubulin modulator
2010201412.0low000110
dihydrotestosterone17beta-hydroxy steroid;
17beta-hydroxyandrostan-3-one;
3-oxo-5alpha-steroid
androgen;
Daphnia magna metabolite;
human metabolite;
mouse metabolite
1974201226.0low010110
physcionedihydroxyanthraquinoneanti-inflammatory agent;
antibacterial agent;
antifungal agent;
antineoplastic agent;
apoptosis inducer;
hepatoprotective agent;
metabolite
2003200321.0low000100
1,2-naphthoquinone1,2-naphthoquinonesaryl hydrocarbon receptor agonist;
carcinogenic agent
1999201713.4low001130
flavoneflavonesmetabolite;
nematicide
2007200717.0low000100
2,3,4,5,6-pentachloroaniline2012201212.0low000010
azomycinC-nitro compound;
imidazoles
antitubercular agent1994199430.0low001000
tropolonealpha-hydroxy ketone;
cyclic ketone;
enol
bacterial metabolite;
fungicide;
toxin
1953201540.0low010010
phenylacetylenebenzenes2001200919.0low000200
tricaprylinoctanoate ester;
triglyceride
anticonvulsant;
plant metabolite
2007200717.0low000100
tropone201520159.0low000010
3-aminobutyric acidamino acid zwitterion;
beta-amino acid;
monocarboxylic acid
metabolite2005200519.0low000100
malondialdehydedialdehydebiomarker1991202312.5low00217205
n-hexadecanelong-chain alkanenon-polar solvent;
plant metabolite;
volatile oil component
1990202215.5low0021181
magnesium carbonatecarbonate salt;
magnesium salt;
one-carbon compound;
organic magnesium salt
antacid;
fertilizer
1998199826.0low001000
trinitrobenzenesulfonic acidarenesulfonic acid;
C-nitro compound
epitope;
explosive;
reagent
2008201512.5low000110
eosine yellowish-(ys)organic sodium salt;
organobromine compound
fluorochrome;
histological dye
202220222.0low000001
paeonolmethoxybenzenes;
phenols
metabolite2006200618.0low000100
neutral redhydrochlorideacid-base indicator;
dye;
two-colour indicator
1996201416.7low001020
glycerylphosphorylcholineglycerophosphocholine1991199133.0low001000
1,4-dimethylnaphthalenedimethylnaphthalene1981198143.0low010000
1,2-dihydroxynaphthalenenaphthalenediolmouse metabolite1965196559.0low010000
3-hydroxyflavoneflavonols;
monohydroxyflavone
1991202020.3low002010
2,6-dimethylnaphthalenedimethylnaphthaleneenvironmental contaminant1986198638.0low010000
allyl sulfideorganic sulfide1993199331.0low001000
octadecanelong-chain alkanebacterial metabolite;
plant metabolite
2001201712.8low000240
9-nitroanthraceneanthracenes1982198242.0low010000
pentafluorobenzoic acidperfluorinated compound2005200519.0low000100
triphenylphosphinebenzenes;
tertiary phosphine
NMR chemical shift reference compound;
reducing agent
202120213.0low000001
1,1'-binaphthyl2013201311.0low000010
alpha-naphthoflavoneextended flavonoid;
naphtho-gamma-pyrone;
organic heterotricyclic compound
aryl hydrocarbon receptor agonist;
aryl hydrocarbon receptor antagonist;
EC 1.14.14.14 (aromatase) inhibitor
1985201621.9low012310
dansyl chlorideaminonaphthalene;
sulfonic acid derivative
2000200024.0low001000
2,6-dinitrotoluenedinitrotoluenegenotoxin2007200717.0low000100
2-nitrofluorenenitroarenecarcinogenic agent;
mutagen
1999199925.0low001000
pentachlorobenzenepentachlorobenzenespersistent organic pollutant2007200717.0low000100
1-methylanthracene2002200222.0medium000100
2-methylanthracene202120213.0medium000001
2-anthramineanthracenamine1976200934.2low030100
acetylcysteineacetylcysteine;
L-cysteine derivative;
N-acetyl-L-amino acid
antidote to paracetamol poisoning;
antiinfective agent;
antioxidant;
antiviral drug;
ferroptosis inhibitor;
geroprotector;
human metabolite;
mucolytic;
radical scavenger;
vulnerary
1962201819.6low120570
diazoacetic ester1946194678.0low010000
1,3-dicyanobenzenenitrile201920195.0medium000010
3,5-dichloroanilinedichloroaniline2012201212.0low000010
n-tetradecanelong-chain alkaneplant metabolite;
volatile oil component
2012201410.8low000040
phytanediterpene2010201611.3medium000120
glycochenodeoxycholic acidbile acid glycine conjugatehuman metabolite2007200717.0low000100
erythromycincyclic ketone;
erythromycin
1974201125.4low010310
tetracosanelong-chain alkaneplant metabolite;
volatile oil component
2014201410.0low000010
nitrosoguanidines1972197451.0low020000
methylnitrosoureaN-nitrosoureasalkylating agent;
carcinogenic agent;
mutagen;
teratogenic agent
1982198242.0low010000
acetylenedicarboxylic acid dimethyl ester2008200816.0low000100
2,3-dimethylmaleic anhydridebutenolide201820186.0low000010
chloracizine1993199430.5medium002000
4-nitrophenyl acetateC-nitro compound;
phenyl acetates
1984198440.0low010000
1-methylphenanthrenephenanthrenesmutagen1983201717.1high012250
n-hydroxy-4-acetylaminostilbene1996199628.0medium001000
3-nitrofluoranthenenitronaphthalene1999202313.0low001001
hexafluoroisopropanolorganofluorine compound;
secondary alcohol
drug metabolite2008200816.0low000100
9-aminophenanthrenephenanthrenamine1984200626.5high011200
deoxycytidinepyrimidine 2'-deoxyribonucleosideEscherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
201220188.7low000030
2'-deoxyadenosinepurine 2'-deoxyribonucleoside;
purines 2'-deoxy-D-ribonucleoside
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
2000200024.0low001000
testolactone3-oxo-Delta(1),Delta(4)-steroid;
seco-androstane
1963197155.0low290000
undecanealkane2010201014.0low000100
3-vinylpyridine2010201014.0low000100
tetramethylpyrazinealkaloid;
pyrazines
antineoplastic agent;
apoptosis inhibitor;
bacterial metabolite;
neuroprotective agent;
platelet aggregation inhibitor;
vasodilator agent
1999200721.0low001100
decabromobiphenyl etherpolybromodiphenyl etherneurotoxin201520159.0low000010
calcium peroxidecalcium oxides201920195.0low000010
durapatite1984199335.5low011000
sodium hydroxidealkali metal hydroxide2005202312.7low000201
zinc oxidezinc molecular entity1990202219.6low004121
arsenic trioxide200920228.9low000241
hydrofluoric acidhydrogen halide;
mononuclear parent hydride
NMR chemical shift reference compound2005200519.0low000100
glycyrrhizic acidenone;
glucosiduronic acid;
pentacyclic triterpenoid;
tricarboxylic acid;
triterpenoid saponin
EC 3.4.21.5 (thrombin) inhibitor;
plant metabolite
2007201414.2low000320
d-alpha tocopherolalpha-tocopherolalgal metabolite;
antiatherogenic agent;
anticoagulant;
antioxidant;
antiviral agent;
EC 2.7.11.13 (protein kinase C) inhibitor;
immunomodulator;
micronutrient;
nutraceutical;
plant metabolite
1966202124.0low013311
tocopherols201520159.0low000010
methyl tert-butyl etheretherfuel additive;
metabolite;
non-polar solvent
1997199727.0low001000
6-methylchrysenecarbopolycyclic compound1985198737.7high030000
stearylamineprimary aliphatic aminefilm-forming compound201620168.0low000010
paraquatorganic cationgeroprotector;
herbicide
1974201829.7low011010
pristanelong-chain alkane;
norterpene
biomarker;
immunological adjuvant
2010201014.0low000100
tetrabutylammoniumquaternary ammonium ion2006201712.3low000120
6h-dibenzo-(b,d)-pyran-6-onebenzochromenoneplant metabolite1992201715.3high001140
amiloridearomatic amine;
guanidines;
organochlorine compound;
pyrazines
diuretic;
sodium channel blocker
2013201311.0low000010
5,6-chrysenequinone2009200915.0medium000100
3-chlorobiphenylmonochlorobiphenyl2005200519.0low000100
4-chlorobiphenylmonochlorobiphenyl2009200915.0low000100
fluorenone oxime1986198638.0medium010000
1-methoxynaphthalene2001200123.0low000100
glaucineaporphine alkaloid;
organic heterotetracyclic compound;
polyether;
tertiary amino compound
antibacterial agent;
antineoplastic agent;
antitussive;
muscle relaxant;
NF-kappaB inhibitor;
plant metabolite;
platelet aggregation inhibitor;
rat metabolite
1995199529.0low001000
fluorescein2-benzofurans;
gamma-lactone;
organic heteropentacyclic compound;
oxaspiro compound;
polyphenol;
xanthene dye
fluorescent dye;
radioopaque medium
2004200420.0low000100
sulfadoxinepyrimidines;
sulfonamide
antibacterial drug;
antimalarial
1991201225.7low3012310
2-methylphenanthrene1962200829.3high013200
uridine diphosphate glucuronic acidUDP-D-glucuronic acidEscherichia coli metabolite;
human metabolite;
mouse metabolite
2008200816.0low000100
6-chrysenaminecarbopolycyclic compound1984198937.4high080000
n-octadecyl mercaptan2006200618.0low000100
trichloroepoxypropane1988198836.0low010000
fluorescein-5-isothiocyanatefluorescein isothiocyanate2005201315.0low000110
sabinenethujeneplant metabolite2000200223.0low101100
mannoseD-aldohexose;
D-mannose;
mannopyranose
metabolite201920195.0low000010
dithiothreitol1,4-dimercaptobutane-2,3-diol;
butanediols;
dithiol;
glycol;
thiol
chelator;
human metabolite;
reducing agent
1973202127.8low021101
palmatineberberine alkaloid;
organic heterotetracyclic compound
plant metabolite2013201311.0low000010
cyclazocine1967197055.4low150000
5-methylchrysenecarbopolycyclic compound1978199040.4high0201000
5,6-dimethylchrysene1984199335.0high012000
streptomycinantibiotic antifungal drug;
antibiotic fungicide;
streptomycins
antibacterial drug;
antifungal agrochemical;
antimicrobial agent;
antimicrobial drug;
bacterial metabolite;
protein synthesis inhibitor
1974200431.0low010200
carbonatescarbon oxoanion1994201218.5low001210
2-acetamidophenanthrene1957199739.8high063000
cladribineorganochlorine compound;
purine 2'-deoxyribonucleoside
antineoplastic agent;
immunosuppressive agent
2011201113.0low000010
n-hydroxy-4-acetylaminobiphenylhydroxamic acid1984198440.0low010000
1,3-dithiolanedithiolane2010201014.0medium000100
dehydroemetinearomatic ether;
isoquinolines;
pyridoisoquinoline
antileishmanial agent;
antimalarial;
antiprotozoal drug
2003200321.0low000100
buthionine sulfoximinediastereoisomeric mixture;
homocysteines;
non-proteinogenic alpha-amino acid;
sulfoximide
EC 6.3.2.2 (glutamate--cysteine ligase) inhibitor;
ferroptosis inducer
2014201410.0low000010
1-hydroxypyrenepyrenes1994202015.4low00610160
1-nitropyrenenitroarenecarcinogenic agent1982201434.3low071010
vidarabinebeta-D-arabinoside;
purine nucleoside
antineoplastic agent;
bacterial metabolite;
nucleoside antibiotic
1999199925.0low001000
chlorpyrifos-methylchloropyridine;
organic thiophosphate
acaricide;
agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
environmental contaminant;
insecticide;
xenobiotic
201720177.0low000010
iodinated glyceroldioxolane1967201848.1low2140020
laurolitsineaporphine alkaloid;
aromatic ether;
phenols
HIV-1 integrase inhibitor;
metabolite
1997199727.0medium001000
acetoxyacetylaminofluorene2-acetamidofluorenescarcinogenic agent;
mutagen
1980198044.0low010000
1-indanolaromatic alcohol;
indanes;
secondary alcohol
xenobiotic2010201014.0low000100
n-methylaspartateamino dicarboxylic acid;
D-alpha-amino acid;
D-aspartic acid derivative;
secondary amino compound
neurotransmitter agent2006201215.0low000210
helenalincyclic ketone;
gamma-lactone;
organic heterotricyclic compound;
secondary alcohol;
sesquiterpene lactone
anti-inflammatory agent;
antineoplastic agent;
metabolite;
plant metabolite
1981198143.0low010000
dysprosiumf-block element atom;
lanthanoid atom
201520159.0low000010
iridiumcobalt group element atom;
platinum group metal atom
2001200123.0low000100
manganeseelemental manganese;
manganese group element atom
Escherichia coli metabolite;
micronutrient
2004201615.0low000220
mercuryelemental mercury;
zinc group element atom
neurotoxin2007201810.0low000160
molybdenumchromium group element atommicronutrient1972202219.0low010021
neonmonoatomic neon;
noble gas atom;
p-block element atom
1994200725.3low002100
niobiumvanadium group element atom201520159.0low000010
osmiumiron group element atom;
platinum group metal atom
1969201233.5low010010
palladiummetal allergen;
nickel group element atom;
platinum group metal atom
2003201513.3low00012150
platinumelemental platinum;
nickel group element atom;
platinum group metal atom
201820205.0low000020
praseodymiumf-block element atom;
lanthanoid atom
201520159.0low000010
rhodiumcobalt group element atom1991201225.0low006110
rutheniumiron group element atom;
platinum group metal atom
1990201912.6low0023140
silvercopper group element atom;
elemental silver
Escherichia coli metabolite1972201721.0low010220
terbiumf-block element atom;
lanthanoid atom
2008200816.0low000100
titaniumtitanium group element atom2002202010.8low0005150
argonmonoatomic argon;
noble gas atom;
p-block element atom
food packaging gas;
neuroprotective agent
1994199529.5low002000
cadmiumcadmium molecular entity;
zinc group element atom
2002202310.4low00014315
ceriumf-block element atom;
lanthanoid atom
2009201511.0low000120
chromiumchromium group element atom;
metal allergen
micronutrient1955202119.4low011351
europiumf-block element atom;
lanthanoid atom
2009201313.0low000110
gadoliniumf-block element atom;
lanthanoid atom
1997201714.3low001020
goldcopper group element atom;
elemental gold
1969202313.0low010162
heliummonoatomic helium;
noble gas atom;
s-block element atom
food packaging gas2007200717.0low000100
vanadiumelemental vanadium;
vanadium group element atom
micronutrient2011201113.0low000020
zirconiumtitanium group element atom2000200024.0low001000
aluminum chloridealuminium coordination entityLewis acid1997200622.5low001100
cupric chloridecopper molecular entity;
inorganic chloride
EC 5.3.3.5 (cholestenol Delta-isomerase) inhibitor2007200717.0low000100
magnesium sulfatemagnesium salt;
metal sulfate;
organic magnesium salt
anaesthetic;
analgesic;
anti-arrhythmia drug;
anticonvulsant;
calcium channel blocker;
cardiovascular drug;
fertilizer;
tocolytic agent
201520159.0low000010
6-nitrochrysenecarbopolycyclic compound1982201434.9high0161010
acetylglucosamineN-acetyl-D-glucosamineepitope2013201311.0low000010
galactosamineD-galactosamine;
primary amino compound
toxin2012201411.0low000020
phosphoric acid, trisodium saltsodium phosphate2006200618.0low000100
hypochlorous acidchlorine oxoacid;
reactive oxygen species
EC 2.5.1.18 (glutathione transferase) inhibitor;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
human metabolite
1992199232.0low001000
camptothecindelta-lactone;
pyranoindolizinoquinoline;
quinoline alkaloid;
tertiary alcohol
antineoplastic agent;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
genotoxin;
plant metabolite
1976202212.9low010272
ferric chlorideiron coordination entityastringent;
Lewis acid
201620168.0low000010
nickel chloridenickel coordination entitycalcium channel blocker;
hapten
2003200321.0low000100
ferrous sulfateiron molecular entity;
metal sulfate
reducing agent2001200720.0low000200
sodium pyrophosphateinorganic sodium saltchelator;
food emulsifier;
food thickening agent
2012201212.0low000010
brominediatomic bromine1971202217.8low010031
potassium nitrateinorganic nitrate salt;
potassium salt
fertilizer2001200123.0low000100
sodium sulfateinorganic sodium salt2001200819.5low000200
magnesium phosphate (2:3)inorganic magnesium salt2011201113.0low000010
tricalcium phosphatecalcium phosphate201120189.5low000020
chromateschromium oxoanion;
divalent inorganic anion
oxidising agent1969196955.0low010000
copper sulfatemetal sulfateemetic;
fertilizer;
sensitiser
2009200915.0low000100
calcium sulfatecalcium salt;
inorganic calcium salt
2006200618.0low000100
potassium dichromatepotassium saltallergen;
oxidising agent;
sensitiser
2008200816.0low000100
deuteriumdihydrogen1971200242.3low020100
fluorinediatomic fluorine;
gas molecular entity
NMR chemical shift reference compound1971202219.9low040852
chlorinediatomic chlorine;
gas molecular entity
bleaching agent1970201636.0low040210
cupric bromide2011201113.0low000010
poloxaleneepoxide1996200921.0low001200
ozoneelemental molecule;
gas molecular entity;
reactive oxygen species;
triatomic oxygen
antiseptic drug;
disinfectant;
electrophilic reagent;
greenhouse gas;
mutagen;
oxidising agent;
tracer
1985201923.8low040520
cadmium chloridecadmium coordination entity2001201615.5low000110
cadmium sulfatecadmium salt2012201212.0low000010
n,n-dimethylphenylethylamineprimary amine201920195.0low000010
trolamine salicylate1964202126.6low020311
rhamnoseL-rhamnose2001200123.0low000100
carbendazimbenzimidazole fungicide;
benzimidazoles;
benzimidazolylcarbamate fungicide;
carbamate ester
antifungal agrochemical;
antinematodal drug;
metabolite;
microtubule-destabilising agent
2012201212.0low000010
chrysotile1986198638.0low010000
ancymidolpyrimidines;
tertiary alcohol
cellulose synthesis inhibitor;
gibberellin biosynthesis inhibitor;
plant growth retardant
1999199925.0low001000
ethionineS-ethylhomocysteineantimetabolite;
carcinogenic agent
2007200717.0low000100
3-hydroxybenzo(a)pyreneortho- and peri-fused polycyclic arene2005200519.0low000100
titanium dioxidetitanium oxidesfood colouring2002202011.2low0005120
dechlorane plus201920195.0low000010
tris(1,3-dichloro-2-propyl)phosphatetrialkyl phosphate201720177.0low000010
tiletamine hydrochloride1993201919.8low003020
myrmicacin3-hydroxy fatty acid;
medium-chain fatty acid
antimitotic;
Escherichia coli metabolite
202020204.0low000010
4-benzoylpyridinearomatic ketone2004200519.5low000200
menoctone1992199232.0low001000
n'-nitrosonornicotinepyridines;
pyrrolidines
2014201410.0low000010
tetradecanoylphorbol acetateacetate ester;
diester;
phorbol ester;
tertiary alpha-hydroxy ketone;
tetradecanoate ester
antineoplastic agent;
apoptosis inducer;
carcinogenic agent;
mitogen;
plant metabolite;
protein kinase C agonist;
reactive oxygen species generator
1978201227.9low046510
ethephonphosphonic acidsplant growth regulator201720177.0low000010
fluorideshalide anion;
monoatomic fluorine
2008201711.0low000120
danazol17beta-hydroxy steroid;
terminal acetylenic compound
anti-estrogen;
estrogen antagonist;
geroprotector
2004201714.5low000220
lisuridemonocarboxylic acid amideantidyskinesia agent;
antiparkinson drug;
dopamine agonist;
serotonergic agonist
1985199136.0low011000
chromiumchromium cation;
monoatomic hexacation
201620168.0low000020
7-oxodehydroabietic acid1995200823.4high005300
1-deoxynojirimycin2-(hydroxymethyl)piperidine-3,4,5-triol;
piperidine alkaloid
anti-HIV agent;
anti-obesity agent;
bacterial metabolite;
EC 3.2.1.20 (alpha-glucosidase) inhibitor;
hepatoprotective agent;
hypoglycemic agent;
plant metabolite
202020204.0low000010
iodinehalide anion;
monoatomic iodine
human metabolite1952202328.7low010011
daunorubicinaminoglycoside antibiotic;
anthracycline;
p-quinones;
tetracenequinones
antineoplastic agent;
bacterial metabolite
1995202115.3low001101
phosphotyrosineL-tyrosine derivative;
non-proteinogenic L-alpha-amino acid;
O(4)-phosphotyrosine
Escherichia coli metabolite;
immunogen
2013201311.0low000010
phenyl acetatebenzenes;
phenyl acetates
1948202029.3low01251070
cetylpyridinium chloride anhydrouschloride salt;
organic chloride salt
antiseptic drug;
surfactant
2008200816.0low000100
1,4-dioxanedioxane;
volatile organic compound
carcinogenic agent;
metabolite;
NMR chemical shift reference compound;
non-polar solvent
201120189.5low000020
ursodeoxycholic acidbile acid;
C24-steroid;
dihydroxy-5beta-cholanic acid
human metabolite;
mouse metabolite
2003200321.0low000100
pyreneortho- and peri-fused polycyclic arenefluorescent probe;
persistent organic pollutant
1964202313.7medium062313614721
isothiuronium2009200915.0low000100
4-methoxyamphetamine2002200222.0low000100
wr 300901993199331.0medium001000
8-bromo cyclic adenosine monophosphate3',5'-cyclic purine nucleotide;
adenyl ribonucleotide;
organobromine compound
antidepressant;
protein kinase agonist
2012201212.0low000010
alkenes1965202225.3low072562
glutamic acidglutamic acid;
glutamine family amino acid;
L-alpha-amino acid;
proteinogenic amino acid
Escherichia coli metabolite;
ferroptosis inducer;
micronutrient;
mouse metabolite;
neurotransmitter;
nutraceutical
2003201214.6low000520
adenylyl imidodiphosphateadenosine 5'-phosphate2001200123.0low000100
azoxymethane202020204.0low000010
sodium azideinorganic sodium saltantibacterial agent;
explosive;
mitochondrial respiratory-chain inhibitor;
mutagen
2007201413.5low000110
azidespseudohalide anionmitochondrial respiratory-chain inhibitor1974201330.5low010010
adenosine diphosphate riboseADP-sugarEscherichia coli metabolite;
mouse metabolite
200920219.0low000101
penfluridoldiarylmethane1999199925.0low001000
tramadol2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanoladrenergic uptake inhibitor;
antitussive;
capsaicin receptor antagonist;
delta-opioid receptor agonist;
kappa-opioid receptor agonist;
metabolite;
mu-opioid receptor agonist;
muscarinic antagonist;
nicotinic antagonist;
NMDA receptor antagonist;
opioid analgesic;
serotonergic antagonist;
serotonin uptake inhibitor
1987198737.0low010000
cyclopenta(c,d)pyrenepyrenes1988200030.0low011000
4,5-dihydroxy-4,5-dihydrobenzo(a)pyrene1983198341.0low010000
4-ethynylbiphenyl201520159.0medium000010
octachlorostyreneorganochlorine compound1986198638.0low010000
paclitaxeltaxane diterpenoid;
tetracyclic diterpenoid
antineoplastic agent;
human metabolite;
metabolite;
microtubule-stabilising agent
200320229.7low000282
paclitaxeltaxane diterpenoid;
tetracyclic diterpenoid
antineoplastic agent;
human metabolite;
metabolite;
microtubule-stabilising agent
200320229.9low000292
etoposidebeta-D-glucoside;
furonaphthodioxole;
organic heterotetracyclic compound
antineoplastic agent;
DNA synthesis inhibitor
1976202018.7low011130
substance ppeptideneurokinin-1 receptor agonist;
neurotransmitter;
vasodilator agent
1997201417.0low001110
2,5-dichlorobiphenyldichlorobenzene;
dichlorobiphenyl
2007200717.0low000100
2,4,5,2',4',5'-hexachlorobiphenylhexachlorobiphenyl2008201512.5low000110
2,5,2',5'-tetrachlorobiphenyldichlorobenzene;
tetrachlorobiphenyl
2008201612.0low000110
halofantrinephenanthrenes1982202225.7high6033240102332
ribavirin1-ribosyltriazole;
aromatic amide;
monocarboxylic acid amide;
primary carboxamide
anticoronaviral agent;
antiinfective agent;
antimetabolite;
antiviral agent;
EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor
2012201610.0low000020
6-hydroxychrysenehydroxychrysenexenobiotic metabolite2008200816.0medium000100
phorbol 12,13-dibutyratebutyrate ester;
phorbol ester;
tertiary alpha-hydroxy ketone
1993199331.0low001000
fluorescamine201620168.0low000010
tocainidemonocarboxylic acid amideanti-arrhythmia drug;
local anaesthetic;
sodium channel blocker
1987198737.0low010000
tricyclazoletriazolobenzothiazoleantifungal agrochemical;
melanin synthesis inhibitor
2008200816.0low000100
1,6-dinitropyrenepyrenes1987198737.0low010000
1-methyl-4-phenylpyridiniumpyridinium ionapoptosis inducer;
herbicide;
human xenobiotic metabolite;
neurotoxin
1998202217.3low001401
lonidaminedichlorobenzene;
indazoles;
monocarboxylic acid
antineoplastic agent;
antispermatogenic agent;
EC 2.7.1.1 (hexokinase) inhibitor;
geroprotector
2014201410.0low000010
2,3,7,8-tetrachlorodibenzofuranpolychlorinated dibenzofuran1994199430.0low001000
fagaroninebenzophenanthridine alkaloidmutagen1989198935.0low010000
permethrincyclopropanecarboxylate ester;
cyclopropanes
agrochemical;
ectoparasiticide;
pyrethroid ester acaricide;
pyrethroid ester insecticide;
scabicide
2006201016.0low000200
chlorodiphenyl (54% chlorine)1985200830.0low021100
quisqualic acidnon-proteinogenic alpha-amino acid1998199826.0low001000
decamethrinaromatic ether;
cyclopropanecarboxylate ester;
nitrile;
organobromine compound
agrochemical;
antifeedant;
calcium channel agonist;
EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor;
pyrethroid ester insecticide
202020204.0low000010
6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acidchromanol;
monocarboxylic acid;
phenols
antioxidant;
ferroptosis inhibitor;
neuroprotective agent;
radical scavenger;
Wnt signalling inhibitor
1991200826.7low002100
pinaveriummonoterpenoid1987198737.0low010000
7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxideepoxideintercalator1983199533.8low023000
idarubicinanthracycline antibiotic;
deoxy hexoside;
monosaccharide derivative
1999202113.8low001111
piperacillinpenicillin allergen;
penicillin
antibacterial drug2013201311.0low000010
6-nitrobenzo(a)pyreneortho- and peri-fused polycyclic arene1982198839.2medium040000
4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanonenitrosamine;
pyridines
2011201411.0low000030
nicorandilnitrate ester;
pyridinecarboxamide
potassium channel opener;
vasodilator agent
2000200024.0low001000
12,14-dichlorodehydroabietic acid1999200621.5high001100
colforsinacetate ester;
cyclic ketone;
labdane diterpenoid;
organic heterotricyclic compound;
tertiary alpha-hydroxy ketone;
triol
adenylate cyclase agonist;
anti-HIV agent;
antihypertensive agent;
plant metabolite;
platelet aggregation inhibitor;
protein kinase A agonist
1993200325.3low002100
1,2-dihydro-1,2-dihydroxy-5-methylchrysene1978198741.4high050000
5-hydroxymethylchrysene1981198938.0high050000
amonafideisoquinolines2000200024.0low001000
fomesafenaromatic ether;
C-nitro compound;
monochlorobenzenes;
N-sulfonylcarboxamide;
organofluorine compound;
phenols
agrochemical;
EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor;
herbicide
1967201241.3low020010
quinpirolepyrazoloquinolinedopamine agonist1991199133.0low001000
pravastatin3-hydroxy carboxylic acid;
carbobicyclic compound;
carboxylic ester;
hydroxy monocarboxylic acid;
secondary alcohol;
statin (semi-synthetic)
anticholesteremic drug;
environmental contaminant;
metabolite;
xenobiotic
202120213.0low000001
itraconazolearomatic ether;
conazole antifungal drug;
cyclic ketal;
dichlorobenzene;
dioxolane;
N-arylpiperazine;
triazole antifungal drug;
triazoles
EC 3.6.3.44 (xenobiotic-transporting ATPase) inhibitor;
Hedgehog signaling pathway inhibitor;
P450 inhibitor
1988198836.0low010000
benzo(c)phenanthrene 3,4-dihydrodiol1980200835.2high060200
fura-22000200422.0low001100
crisnatol1988198935.5medium020000
1,2-dihydroxy-epoxy-1,2,3,4-tetrahydro-5-methylchrysene1983199038.1high091000
imiquimodimidazoquinolineantineoplastic agent;
interferon inducer
201720186.5low000020
sdz 208-9121991199332.0medium002000
clopidogrelmethyl ester;
monochlorobenzenes;
thienopyridine
anticoagulant;
P2Y12 receptor antagonist;
platelet aggregation inhibitor
201820186.0low000010
topotecanpyranoindolizinoquinolineantineoplastic agent;
EC 5.99.1.2 (DNA topoisomerase) inhibitor
2013201311.0low000010
gemcitabineorganofluorine compound;
pyrimidine 2'-deoxyribonucleoside
antimetabolite;
antineoplastic agent;
antiviral drug;
DNA synthesis inhibitor;
EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor;
environmental contaminant;
immunosuppressive agent;
photosensitizing agent;
prodrug;
radiosensitizing agent;
xenobiotic
201220188.7low000030
atorvastatinaromatic amide;
dihydroxy monocarboxylic acid;
monofluorobenzenes;
pyrroles;
statin (synthetic)
environmental contaminant;
xenobiotic
200920218.0low000111
irinotecancarbamate ester;
delta-lactone;
N-acylpiperidine;
pyranoindolizinoquinoline;
ring assembly;
tertiary alcohol;
tertiary amino compound
antineoplastic agent;
apoptosis inducer;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
prodrug
200320219.0low000141
valsartanbiphenylyltetrazole;
monocarboxylic acid amide;
monocarboxylic acid
angiotensin receptor antagonist;
antihypertensive agent;
environmental contaminant;
xenobiotic
2008201015.0low000200
adenosineadenosines;
purines D-ribonucleoside
analgesic;
anti-arrhythmia drug;
fundamental metabolite;
human metabolite;
vasodilator agent
1983200630.3low011100
3-n-butylphthalidebenzofurans2004200420.0low000100
vanadatestrivalent inorganic anion;
vanadium oxoanion
EC 3.1.3.1 (alkaline phosphatase) inhibitor;
EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor;
EC 3.1.3.41 (4-nitrophenylphosphatase) inhibitor;
EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor
2005202010.7low000120
florisil1963196361.0low010000
dimethylhydrazines1994200922.5low001100
acridine orangeaminoacridines;
aromatic amine;
tertiary amino compound
fluorochrome;
histological dye
2004200519.5low000200
benzylaminopurine6-aminopurinescytokinin;
plant metabolite
2003200321.0low000100
trifluoromethanesulfonic acidone-carbon compound;
perfluoroalkanesulfonic acid
2008200816.0low000100
sodium persulfate2014201410.0low000010
3-nitroperylenephenanthrenes1982198242.0medium010000
trazodone hydrochloridehydrochlorideadrenergic antagonist;
antidepressant;
H1-receptor antagonist;
sedative;
serotonin uptake inhibitor
200120228.7low00010307
glucose, (beta-d)-isomerD-glucopyranoseepitope;
mouse metabolite
1982202018.5low115890
ursolic acidhydroxy monocarboxylic acid;
pentacyclic triterpenoid
geroprotector;
plant metabolite
1994200824.2low002200
thiazolyl blueorganic bromide saltcolorimetric reagent;
dye
2005202015.1low000520
plerixaforazacycloalkane;
azamacrocycle;
benzenes;
crown amine;
secondary amino compound;
tertiary amino compound
anti-HIV agent;
antineoplastic agent;
C-X-C chemokine receptor type 4 antagonist;
immunological adjuvant
201720205.3low000030
5-methylcytosinemethylcytosine;
pyrimidines
human metabolite1984201325.5low010010
epigallocatechin gallateflavans;
gallate ester;
polyphenol
antineoplastic agent;
antioxidant;
apoptosis inducer;
geroprotector;
Hsp90 inhibitor;
neuroprotective agent;
plant metabolite
1995201811.6low001150
2'-deoxycytidine 5'-triphosphate2'-deoxycytidine phosphate;
pyrimidine 2'-deoxyribonucleoside 5'-triphosphate
Escherichia coli metabolite;
human metabolite;
mouse metabolite
1993199331.0low001000
25-hydroxycholesterol25-hydroxy steroid;
oxysterol
human metabolite2012201212.0low000010
salvinabietane diterpenoid;
carbotricyclic compound;
catechols;
monocarboxylic acid
angiogenesis modulating agent;
anti-inflammatory agent;
antineoplastic agent;
antioxidant;
apoptosis inducer;
food preservative;
HIV protease inhibitor;
plant metabolite
1989200823.0low0171500
1,2-distearoyllecithin2006200618.0low000100
bathocuproine2007200717.0low000100
neocuproinephenanthrolineschelator;
copper chelator
2007200717.0low000100
o-(6)-methylguaninemethylguaninemutagen1996199628.0low001000
n,n-bis(trimethylsilyl)-2,2,2-trifluoroacetamide1998199826.0low001000
pyrrolidine dithiocarbamatedithiocarbamic acids;
pyrrolidines
anticonvulsant;
antineoplastic agent;
geroprotector;
neuroprotective agent;
NF-kappaB inhibitor;
radical scavenger
202020204.0low000010
peroxynitric acidnitrogen oxoacid1998200025.0low002000
glutathione disulfideglutathione derivative;
organic disulfide
Escherichia coli metabolite;
mouse metabolite
2001200123.0low000100
simalikalactone d1980198143.5medium020000
fanasil, pyrimethamine drug combination1995201223.8low206210
triptonidebutenolide;
cyclic ketone;
diterpene triepoxide;
organic heteroheptacyclic compound
anti-inflammatory agent;
antineoplastic agent;
immunosuppressive agent
2000202314.6medium001431
quassintriterpenoid1975198840.1high080000
naphthalimides2000202111.0low002031
benzeneboronic acidboronic acids201720177.0low000010
laurosept2009201312.7medium000120
4,7-phenanthrolinephenanthroline1959195965.0low010000
1,7-phenanthrolinephenanthroline1951202127.3low0231620262
triazoles1,2,3-triazole1951202021.1low021350
pinocembrin(2S)-flavan-4-one;
dihydroxyflavanone
antineoplastic agent;
antioxidant;
metabolite;
neuroprotective agent;
vasodilator agent
2012201212.0low000010
isocoumarinsisocoumarins201720177.0low000010
dimidium1952195272.0low010000
delphinidinanthocyanidin chloride1974200534.5low010100
4-aminoquinoline1992199331.5low002000
floxacrine1992199232.0medium001000
artemisininorganic peroxide;
sesquiterpene lactone
antimalarial;
plant metabolite
1988201224.6low0113710
artemetherartemisinin derivative;
cyclic acetal;
organic peroxide;
semisynthetic derivative;
sesquiterpenoid
antimalarial1993201124.5low006110
1,4-anthraquinone201620168.0low000010
perfluorooctanesulfonamideperfluorinated compound;
sulfonamide
persistent organic pollutant201520159.0low000010
allyltrimethylsilane201920195.0medium000010
dibenzocycloheptadiene1964196460.0medium010000
9-nitrophenanthrene1984202323.5high022011
5-hydroxymethylcytosineaminopyrimidine;
aromatic primary alcohol;
nucleobase analogue;
pyrimidone
human metabolite;
mouse metabolite
2013201311.0low000010
cromakalim1993199331.0low001000
masoprocolnordihydroguaiaretic acidantineoplastic agent;
hypoglycemic agent;
lipoxygenase inhibitor;
metabolite
1991199729.4low005000
bufuralolbenzofurans1995199727.7low003000
efaroxan1-benzofurans1998199826.0low001000
7-hydroxystaurosporine2007200717.0low000100
magnololbiphenyls2007200717.0low000100
betulindiol;
pentacyclic triterpenoid
analgesic;
anti-inflammatory agent;
antineoplastic agent;
antiviral agent;
metabolite
2013201311.0low000010
tubulosinebeta-carbolines;
isoquinoline alkaloid;
isoquinolines;
phenols;
secondary amino compound;
tertiary amino compound
1977197747.0low010000
narciclasinephenanthridinesmetabolite201820186.0low000010
juncusol1977202220.2high040151
lycoricidinephenanthridines2007200717.0low000100
tetrandrinebisbenzylisoquinoline alkaloid;
isoquinolines
1994200920.3low001200
chaparrinonetriterpenoid1980198542.0high030000
brusatoltriterpenoid1981198441.8low040000
taxodionediterpenoid2012201212.0low000010
ceric oxidecerium molecular entity;
metal oxide
2009201512.0low000110
fluoren-9-olhydroxyfluorenes;
secondary alcohol
animal metabolite202020204.0low000010
perfluorooctane sulfonic acidperfluoroalkanesulfonic acidantilipemic drug;
persistent organic pollutant
201520159.0low000010
2,5-bis(hydroxymethyl)furandiol;
furans
202020204.0low000010
atovaquonehydroxy-1,2-naphthoquinone1999202017.0low101110
2-hydroxyfluorenefluorenes2010201213.0low000110
1-hydroxybenzotriazolebenzotriazoles1998200423.0low001100
c.i. direct red 80organic sodium saltfluorochrome;
histological dye
2013201311.0low000010
4,4'-dipyridyl disulfideorganic disulfide;
pyridines
2000200024.0low001000
rosiglitazoneaminopyridine;
thiazolidinediones
EC 6.2.1.3 (long-chain-fatty-acid--CoA ligase) inhibitor;
ferroptosis inhibitor;
insulin-sensitizing drug
2005200519.0low000100
2-n-nonyl-1,3-dioxolane2007200717.0medium000100
n-hydroxysuccinimide202020204.0low000010
2-bromobenzaldehyde201520159.0medium000010
4-hydroxyphenanthrenephenanthrol1994201911.6high001060
dichlorquinazine1985198539.0high020000
benzoylmetronidazolebenzoate esterantibacterial drug;
antimicrobial agent;
antiparasitic agent;
antitrichomonal drug;
prodrug
2001200123.0low000100
coenzyme aadenosine 3',5'-bisphosphatecoenzyme;
Escherichia coli metabolite;
mouse metabolite
1969199947.3low061000
fenozan1997199727.0low001000
dihydroisotanshinone i1984202112.5high010142
nicotine3-(1-methylpyrrolidin-2-yl)pyridineanxiolytic drug;
biomarker;
immunomodulator;
mitogen;
neurotoxin;
nicotinic acetylcholine receptor agonist;
peripheral nervous system drug;
phytogenic insecticide;
plant metabolite;
psychotropic drug;
teratogenic agent;
xenobiotic
1968202223.8low134441
fibrinogeniditolfungal metabolite2009201512.0low100120
aucubinorganic molecular entitymetabolite201920195.0low000010
5-bromouridineuridinesmutagen2008200816.0low000100
goethite200920208.0low000120
inerminmaackiain1986198638.0low010000
acid green 502009200915.0low000100
homocysteineamino acid zwitterion;
homocysteine;
serine family amino acid
fundamental metabolite;
mouse metabolite
2004201216.3low000210
n-acetoxy-4-acetylaminobiphenyl1980198044.0medium010000
tylophorineorganic heteropentacyclic compound;
organonitrogen heterocyclic compound
1979202114.7high03223271
maleopimaric acid1992199232.0low001000
elemololefinic compound;
sesquiterpenoid;
tertiary alcohol
fragrance;
plant metabolite
1986198638.0low010000
4-cyano-4'-pentylbiphenyl2002200222.0low000100
cryptopleurinealkaloid antibiotic;
alkaloid;
aromatic ether;
organic heteropentacyclic compound
antineoplastic agent;
antiviral agent;
protein synthesis inhibitor
1974201528.0high040140
totarolditerpenoidmetabolite2012201212.0low000010
dextromoramidemorpholines;
N-acylpyrrolidine
opioid analgesic1968196856.0low010000
podocarpic acidabietane diterpenoid1984200825.1high015300
glycidyl nitrate1989200429.7low011100
dehydroabietic acidabietane diterpenoid;
carbotricyclic compound;
monocarboxylic acid
allergen;
metabolite
1963202321.5medium02111742
glucuronic acidD-glucuronic acidalgal metabolite1995201517.2low001210
2,2',4,4'-tetrabromodiphenyl etheraromatic ether;
organobromine compound
2013201311.0low000010
ro 2-72391960196163.5high020000
9,10-phenanthrenequinone monoxime1984198440.0medium010000
allenolic acidnaphthols1997199727.0low001000
aristolactam i1999199925.0low001000
atherosperminealkaloid1993201320.7high001110
10-hydroxycamptothecinpyranoindolizinoquinoline201920195.0low000010
3-methoxybenzamide1995199529.0low001000
1-hydroxyphenanthrenephenanthrolmouse metabolite1994202011.2high0011100
allocryptopinearomatic ether;
cyclic acetal;
cyclic ketone;
dibenzazecine alkaloid;
organic heterotetracyclic compound;
tertiary amino compound
202020204.0low000010
1,4-phenanthrenequinone1997201716.1high002240
diosgenin3beta-sterol;
hexacyclic triterpenoid;
sapogenin;
spiroketal
antineoplastic agent;
antiviral agent;
apoptosis inducer;
metabolite
2006201613.0low000110
9,10-dihydroxy-9,10-dihydrophenanthrenedihydrophenanthrenediol1983201724.0high010010
syringaresinolaromatic ether;
furofuran;
lignan;
polyether;
polyphenol
plant metabolite201620168.0low000010
arctiinglycoside;
lignan
202020204.0low000020
effusol201820224.2high000041
n-(3,5-dinitrobenzoyl)leucine1986198638.0medium010000
l-phenylalanine ethylester201620168.0low000010
cobaltcobalt group element atom;
metal allergen
micronutrient1987201920.0low011220
p-methoxy-n-methylphenethylaminearomatic ether;
secondary amino compound
metabolite1982199436.0low011000
1,2-bis(2-aminophenoxy)ethane-n,n,n',n'-tetraacetic acidpolyamino carboxylic acid;
tetracarboxylic acid
chelator2011201113.0low000010
tert-butylbicyclophosphorothionateorganic thiophosphate1992199331.5low002000
u 73122aromatic ether;
aza-steroid;
maleimides
EC 3.1.4.11 (phosphoinositide phospholipase C) inhibitor1996200026.0low002000
plicatic acidlignan1989198935.0low010000
4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-olnitrosamine;
pyridines;
secondary alcohol
biomarker;
carcinogenic agent;
human urinary metabolite
2006201413.2low000230
2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridinehydroxylamine;
imidazopyridine
carcinogenic agent;
genotoxin;
human xenobiotic metabolite;
mouse metabolite;
mutagen;
neurotoxin;
rat metabolite
2006200618.0low000100
1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1h-imidazoleether;
imidazoles;
monomethoxybenzene
TRP channel blocker2013201311.0low000010
9,10-epoxy-9,10-dihydrophenanthrenephenanthrene oxide1965201830.2high043120
benz(j)aceanthrylenephenanthrenes1984198440.0low010000
paxillinediterpene alkaloid;
enone;
organic heterohexacyclic compound;
terpenoid indole alkaloid;
tertiary alcohol
anticonvulsant;
Aspergillus metabolite;
EC 3.6.3.8 (Ca(2+)-transporting ATPase) inhibitor;
genotoxin;
geroprotector;
mycotoxin;
Penicillium metabolite;
potassium channel blocker
2009201114.0low000110
paxillinediterpene alkaloid;
enone;
organic heterohexacyclic compound;
terpenoid indole alkaloid;
tertiary alcohol
anticonvulsant;
Aspergillus metabolite;
EC 3.6.3.8 (Ca(2+)-transporting ATPase) inhibitor;
genotoxin;
geroprotector;
mycotoxin;
Penicillium metabolite;
potassium channel blocker
2011201113.0low000010
benzo(a)pyrene-7,8-dioneorthoquinones;
pyrenes
genotoxin;
xenobiotic metabolite
1999199925.0low001000
artesunic acid1993201322.1low103310
cyanates2014201410.0low000010
4-hydroxydebrisoquincarboxamidine;
isoquinolines;
secondary alcohol
metabolite1998199826.0low101000
15,16-dihydrocyclopenta(a)phenanthren-17-one1976199538.5high011000
pyronaridineaminoquinoline1990199928.2low105000
aceanthryleneortho- and peri-fused polycyclic arene2000200024.0medium001000
epicatechin gallatecatechin;
gallate ester;
polyphenol
EC 3.2.1.1 (alpha-amylase) inhibitor;
EC 3.2.1.20 (alpha-glucosidase) inhibitor;
metabolite
201720177.0low000010
phosphitesphosphite ion;
trivalent inorganic anion
2012201212.0low000010
hydroxycotinineN-alkylpyrrolidine;
pyridines;
pyrrolidin-2-ones;
pyrrolidine alkaloid
2010201014.0low000100
fingolimod hydrochloridehydrochlorideimmunosuppressive agent;
prodrug;
sphingosine-1-phosphate receptor agonist
201120208.5low000020
triptolidediterpenoid;
epoxide;
gamma-lactam;
organic heteroheptacyclic compound
antispermatogenic agent;
plant metabolite
1972202310.8high6731275624116
3,5-dihydroxyphenylglycinealpha-amino acid2012201212.0low000010
nopalineamino acid opine;
D-glutamic acid derivative;
guanidines;
L-arginine derivative;
secondary amino compound;
tricarboxylic acid
1995199529.0low001000
tesmilifenediarylmethane201820186.0low000010
schizandrin b2014201410.0low000010
1-hexadecyl-2-acetyl-glycero-3-phosphocholine2-acetyl-1-alkyl-sn-glycero-3-phosphocholineantihypertensive agent;
beta-adrenergic antagonist;
bronchoconstrictor agent;
hematologic agent;
vasodilator agent
1989200525.5low013200
aristolochic acid iiaristolochic acids;
aromatic ether;
C-nitro compound;
cyclic acetal;
monocarboxylic acid;
organic heterotetracyclic compound
carcinogenic agent;
metabolite;
mutagen;
nephrotoxin;
toxin
1984200035.1high074000
1,2-epoxy-3,4-dihydroxy-1,2,3,4-tetrahydrobenzo(c)phenanthrene1980200628.2high0122500
deoxyglucose1985198539.0low010000
chrysene,2-diol-3,4-epoxide-11982199537.6high092000
territrem b2013201410.5low000020
trans-1,2-dihydro-1,2-naphthalenedioltrans-1,2-dihydronaphthalene-1,2-diol202020204.0low000010
1,5(10)-estradiene-3,4,17-trione17-oxo steroid;
3-oxo-Delta(1) steroid;
orthoquinones
human metabolite1996199628.0low001000
dodecyl-beta-d-maltosidedisaccharide derivative;
glycoside
detergent2000200024.0low001000
aporphineaporphine alkaloid;
isoquinoline alkaloid fundamental parent;
tertiary amino compound
1996202117.5low002211
tanshinoneabietane diterpenoidanticoronaviral agent1980202317.3high11635313657
mefloquine-sulfadoxine-pyrimethamine1995199529.0low001000
benzyloxyresorufin1996199628.0low001000
2-ethynylnaphthalene1992200028.0medium003000
perloline1945199252.8high041000
gastrodinglycoside201420169.0low000020
1,3-dichloro-6-trifluoromethyl-9-phenanthryl-3-(n-butyl)aminopropanol1984200926.8high4222800
benzo(g)chrysene-11,12-dihydrodiol-13,14-epoxide1995199828.0high003000
brassinolide22-hydroxy steroid;
23-hydroxy steroid;
2alpha-hydroxy steroid;
3alpha-hydroxy steroid;
brassinosteroid
plant growth stimulator;
plant hormone
2012201311.5low000020
3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphatepurine ribonucleoside triphosphate202020204.0low000010
1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane1999199925.0low001000
benzoperylene1994199430.0low001000
culmorin2006200618.0low000100
tafenoquine(trifluoromethyl)benzenes;
aminoquinoline;
aromatic ether;
primary amino compound;
secondary amino compound
1991200029.0low104000
glyceraldehyde 3-phosphate dehydrogenase (304-313)2013201311.0low000010
s-(3-hydroxypropyl)cysteine n-acetateN-acyl-L-amino acid201820186.0low100010
lithospermate b2007200717.0low000100
3,4-dihydroxyphenylacetaldehydealpha-CH2-containing aldehyde;
catechols;
phenylacetaldehydes
Escherichia coli metabolite;
human metabolite;
mouse metabolite
2001200123.0low000100
dioscinhexacyclic triterpenoid;
spiroketal;
spirostanyl glycoside;
trisaccharide derivative
anti-inflammatory agent;
antifungal agent;
antineoplastic agent;
antiviral agent;
apoptosis inducer;
EC 1.14.18.1 (tyrosinase) inhibitor;
hepatoprotective agent;
metabolite
201620168.0low000010
bw 245cimidazolidine-2,4-dione;
monocarboxylic acid;
secondary alcohol
2004200420.0low000100
caprylatesfatty acid anion 8:0;
straight-chain saturated fatty acid anion
human metabolite;
Saccharomyces cerevisiae metabolite
2007201712.0low000110
aristolic acid1982199338.2high031000
dibenz(a,h)anthracene-3,4-diol 1,2-oxide1995199529.0medium001000
pramipexolebenzothiazoles;
diamine
antidyskinesia agent;
antiparkinson drug;
dopamine agonist;
radical scavenger
2002200222.0low000100
1,2-dihydroxy-5,6-dimethyl-3,4-epoxy-1,2,3,4-tetrahydrochrysene1993199331.0medium001000
wr 992101984199734.3low021000
desethylamodiaquine2010201014.0low000100
tenax2004201415.2low000320
muristerone a1998199826.0low001000
piperaquineaminoquinoline;
N-arylpiperazine;
organochlorine compound
antimalarial1985202022.8low020020
aj 76secondary amino compound;
tetralins
dopaminergic antagonist1986198638.0low010000
celastrolmonocarboxylic acid;
pentacyclic triterpenoid
anti-inflammatory drug;
antineoplastic agent;
antioxidant;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
Hsp90 inhibitor;
metabolite
200220239.4low0005112
bruceine d1981198143.0low010000
benzynearyne;
benzyne
2014201410.0low000020
carbenecarbene;
methanediyl
2002201416.5low000220
peroxynitrous acidnitrogen oxoacid2002201018.2low000500
diethylaminosulfur trifluoride2008200816.0low000100
fullerene c60fullerenegeroprotector1997201514.2low001350
imatinib mesylatemethanesulfonate saltanticoronaviral agent;
antineoplastic agent;
apoptosis inducer;
tyrosine kinase inhibitor
2009202110.4low000351
gefitinibaromatic ether;
monochlorobenzenes;
monofluorobenzenes;
morpholines;
quinazolines;
secondary amino compound;
tertiary amino compound
antineoplastic agent;
epidermal growth factor receptor antagonist
201520215.2low000031
5-hydroxy-1-methyl-2--(di-n-propylamino)tetralin methyl ether1986198638.0low010000
n,n-dimethylargininedimethylarginine;
guanidines;
L-arginine derivative;
non-proteinogenic L-alpha-amino acid
EC 1.14.13.39 (nitric oxide synthase) inhibitor2011201113.0low000010
dodecyloctaethyleneglycol monoetherhydroxypolyether2000200024.0low001000
peroxyoxalate2009200915.0low000100
e 64dicarboxylic acid monoamide;
epoxy monocarboxylic acid;
guanidines;
L-leucine derivative;
zwitterion
antimalarial;
antiparasitic agent;
protease inhibitor
1998199826.0low001000
8,9-dihydro-8,9-dihydroxybenzanthracene 10,11-oxide1980198044.0medium010000
1,1,2-triphenylbut-1-ene1987198737.0medium010000
hw 1651985199336.4high062000
3-(4-(4-phenyl-1,2,3,6-tetrahydropyridyl-1)-butyl)indole1993199331.0low001000
n-(3,5-dinitrobenzoyl)phenylglycine1986198638.0medium010000
methotrexatedicarboxylic acid;
monocarboxylic acid amide;
pteridines
abortifacient;
antimetabolite;
antineoplastic agent;
antirheumatic drug;
dermatologic drug;
DNA synthesis inhibitor;
EC 1.5.1.3 (dihydrofolate reductase) inhibitor;
immunosuppressive agent
200620218.4low100131
1,2-dihydroxy-3,4-epoxy-1,2,3,4-tetrahydro-6-methylchrysene1986199036.0high021000
clausenamide2004200420.0low000100
wr 1949651988199135.0high021000
7-ethoxy-4-trifluoromethylcoumarin1995199529.0low001000
sauristolactam1997201019.5high001300
purpactin a2007200717.0low000100
haloquinone1981202123.0high020002
metakelfin1995199529.0low101000
wr 2425111992199232.0low001000
alpha-ergocryptineergot alkaloid1992199232.0low001000
xyloseD-xylose201820186.0low000010
ethynylpyridine2013201311.0low000010
prolineamino acid zwitterion;
glutamine family amino acid;
L-alpha-amino acid;
proline;
proteinogenic amino acid
algal metabolite;
compatible osmolytes;
Escherichia coli metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite
2008201911.0low000230
cucurbitaceae2007200717.0low000100
tris-(1,10-phenanthroline)ruthenium201920195.0low000010
bis(phenanthroline)(phenanthrenequinone diimine)rhodium(iii)1992199928.5high008000
docetaxel anhydroussecondary alpha-hydroxy ketone;
tetracyclic diterpenoid
antimalarial;
antineoplastic agent;
photosensitizing agent
202220222.0low000001
tariquidarbenzamides2013201510.0low000020
n-(2,6-dimethylergoline-8-yl)-2,2-dimethylpropanamide1993199331.0low001000
levofloxacin9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid;
fluoroquinolone antibiotic;
quinolone antibiotic
antibacterial drug;
DNA synthesis inhibitor;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
topoisomerase IV inhibitor
202020204.0low000010
tanshinone vi1994201020.6high001400
molybdenum chloride2012201411.0medium000020
3,4-dihydroxy-1,2-epoxy-1,2,3,4-tetrahydrobenz(a)anthracene1980199138.3medium021000
moxifloxacinaromatic ether;
cyclopropanes;
fluoroquinolone antibiotic;
pyrrolidinopiperidine;
quinolinemonocarboxylic acid;
quinolone antibiotic;
quinolone
antibacterial drug202020204.0low000010
1-ethynylpyrene2000200024.0low001000
naproxenmethoxynaphthalene;
monocarboxylic acid
antipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
drug allergen;
environmental contaminant;
gout suppressant;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic
2010201014.0low000100
hydroxyl radicaloxygen hydride;
oxygen radical;
reactive oxygen species
2003202214.0low000631
wilforlide a201520159.0low000010
tripchlorolide1990202221.1high00171461
sodium percarbonate202220222.0low000001
singlet oxygenchalcogen;
monoatomic oxygen;
nonmetal atom
macronutrient2009201114.0low000110
bruceine aquassinoid1980198541.5medium020000
miltironeabietane diterpenoid1991202210.9high0023182
aloesinchromones2003200321.0low000100
cryptotanshinoneabietane diterpenoidanticoronaviral agent1983202310.4high0667919240
fenton's reagent2004201414.5low000530
coclaurinecoclaurine2013201311.0low000010
cyclocolorenone1986198638.0medium010000
testololactone3-oxo-Delta(4) steroid;
seco-androstane;
steroid lactone
1963196361.0low010000
prostaglandins b1985199235.5low011000
stephenanthrinecyclic acetal;
organic heterotetracyclic compound;
tertiary amino compound
1986200329.5high010100
bruceine btriterpenoid1980198044.0medium010000
ampelopsindihydromyricetin;
secondary alpha-hydroxy ketone
antineoplastic agent;
antioxidant;
metabolite
202020204.0low000010
corydalmine2013201311.0low000010
tylophorinidine2001201217.5high000110
aristololactam bii2008200816.0low000100
15-hydroperoxyabietic acid1988198836.0medium010000
4-(2'-pyridyldithio)benzyldiazoacetate2004200420.0low000100
tetraphenylphosphoniumheteroorganic entity;
phosphorus molecular entity;
polyatomic cation
2004200420.0low000100
aristolochic acid caristolochic acids;
aromatic ether;
C-nitro compound;
cyclic acetal;
monocarboxylic acid;
organic heterotetracyclic compound
carcinogenic agent;
metabolite;
mutagen;
nephrotoxin;
toxin
1994199430.0medium001000
desosamineamino sugar2007200717.0low000100
1,2-diphytanoylphosphatidylcholine202020204.0low000010
biotinbiotins;
vitamin B7
coenzyme;
cofactor;
Escherichia coli metabolite;
fundamental metabolite;
human metabolite;
mouse metabolite;
nutraceutical;
prosthetic group;
Saccharomyces cerevisiae metabolite
2001201812.2low000130
angiotensin iiamino acid zwitterion;
angiotensin II
human metabolite2002201913.8low0001460
methyl abietate1980200233.0high011100
triptophenolideoxo steroid2000201617.0medium001110
wr 1848061988199831.0high012000
atropine1970197054.0low010000
ruthenium-tris-1,4,5,8-tetraazaphenanthrene1992201916.9high002330
cypripedinphenanthrol202020204.0medium000010
lignin1991202217.8low004541
ropivacainepiperidinecarboxamide;
ropivacaine
local anaesthetic201720177.0low000010
dendrophenol1994202016.0low001110
sb 203580imidazoles;
monofluorobenzenes;
pyridines;
sulfoxide
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor;
geroprotector;
Hsp90 inhibitor;
neuroprotective agent
2004201214.8low000220
sb 216763indoles;
maleimides
202020204.0low000010
organophosphonatesdivalent inorganic anion;
phosphite ion
2000200024.0low002000
9-ethynylphenanthrene1995201521.7high004020
6-acetonyldihydrochelerythrine2003202012.4high000230
aflatoxin b1aflatoxin;
aromatic ether;
aromatic ketone
carcinogenic agent;
human metabolite
1984201320.2low011220
methyl-1alpha, 7alpha-dihydroxy-3-oxopregn-4-en-21-oate1962196262.0low010000
beauverolides2007200717.0low000100
annetocin2012201212.0low000010
hydrastineisoquinolinesmetabolite201520159.0low000010
lapatinibfurans;
organochlorine compound;
organofluorine compound;
quinazolines
antineoplastic agent;
tyrosine kinase inhibitor
202020204.0low000010
sorafenib(trifluoromethyl)benzenes;
aromatic ether;
monochlorobenzenes;
phenylureas;
pyridinecarboxamide
angiogenesis inhibitor;
anticoronaviral agent;
antineoplastic agent;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
ferroptosis inducer;
tyrosine kinase inhibitor
201420216.2low000041
pimaric acidditerpenoid1999201617.2medium001320
cholic acid12alpha-hydroxy steroid;
3alpha-hydroxy steroid;
7alpha-hydroxy steroid;
bile acid;
C24-steroid;
trihydroxy-5beta-cholanic acid
human metabolite;
mouse metabolite
2006201414.0low000110
sandaracopimaric acidmonocarboxylic acid;
pimarane diterpenoid;
tricyclic diterpenoid
plant metabolite2006201612.3medium000120
erythritolbutane-1,2,3,4-tetrolantioxidant;
human metabolite;
plant metabolite
202020204.0low000010
deoxycholic acidbile acid;
C24-steroid;
dihydroxy-5beta-cholanic acid
human blood serum metabolite1974201335.0low020010
delrin2005200519.0low000100
cortisone11-oxo steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
C21-steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone
human metabolite;
mouse metabolite
1965196559.0low010000
adrenosterone11-oxo steroid;
17-oxo steroid;
3-oxo-Delta(4) steroid;
androstanoid
androgen;
EC 1.1.1.146 (11beta-hydroxysteroid dehydrogenase) inhibitor;
human urinary metabolite;
marine metabolite
2013201311.0low000010
1-keto-1,2,3,4-tetrahydrophenanthrene2000201119.0high001610
1,4-phenylenebis(boronic acid)2011201113.0high000020
3-nitrotyrosine2-nitrophenols;
C-nitro compound;
nitrotyrosine;
non-proteinogenic alpha-amino acid
2002200520.5low000200
sodium sulfide201920195.0low000010
propargylamine201520159.0low000010
lanosterol14alpha-methyl steroid;
3beta-sterol;
tetracyclic triterpenoid
bacterial metabolite;
human metabolite;
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
202220222.0low000001
2-hydroxyestradiol17beta-hydroxy steroid;
2-hydroxy steroid
carcinogenic agent;
human metabolite;
metabolite;
mouse metabolite;
prodrug
1995199529.0low001000
nogalamycin2004200420.0low000100
anisomycinmonohydroxypyrrolidine;
organonitrogen heterocyclic antibiotic
anticoronaviral agent;
antimicrobial agent;
antineoplastic agent;
antiparasitic agent;
bacterial metabolite;
DNA synthesis inhibitor;
protein synthesis inhibitor
1977197747.0low010000
benzofurans1994202114.8low00320131
potassium bromidepotassium salt2009200915.0low000100
calendula201820186.0low000010
metribolone17beta-hydroxy steroid;
3-oxo steroid;
anabolic androgenic steroid
androgen1984198440.0low010000
noscapinearomatic ether;
benzylisoquinoline alkaloid;
cyclic acetal;
isobenzofuranone;
organic heterobicyclic compound;
organic heterotricyclic compound;
tertiary amino compound
antineoplastic agent;
antitussive;
apoptosis inducer;
plant metabolite
201420159.5low000020
glaucarubinone1980198741.3high030000
homoharringtoninealkaloid ester;
enol ether;
organic heteropentacyclic compound;
tertiary alcohol
anticoronaviral agent;
antineoplastic agent;
apoptosis inducer;
protein synthesis inhibitor
201820186.0low000010
tripdiolideoxacycle1972201423.2high022420
wortmanninacetate ester;
cyclic ketone;
delta-lactone;
organic heteropentacyclic compound
anticoronaviral agent;
antineoplastic agent;
autophagy inhibitor;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor;
geroprotector;
Penicillium metabolite;
radiosensitizing agent
1996201018.0low001400
2-oxindolegamma-lactam;
indolinone
2011201113.0low000010
lariciresinolaromatic ether;
lignan;
oxolanes;
phenols;
primary alcohol
antifungal agent;
plant metabolite
2005200519.0low000100
anthricinfuronaphthodioxole;
gamma-lactone;
lignan;
methoxybenzenes
antineoplastic agent;
apoptosis inducer;
plant metabolite
2014201410.0low000010
trimethoprim, sulfamethoxazole drug combination1995199529.0low001000
sampanginealkaloid;
organic heterotetracyclic compound
antifungal agent;
plant metabolite
2011201113.0low000010
bortezomibamino acid amide;
L-phenylalanine derivative;
pyrazines
antineoplastic agent;
antiprotozoal drug;
protease inhibitor;
proteasome inhibitor
2008201313.0low000120
ritonavir1,3-thiazoles;
carbamate ester;
carboxamide;
L-valine derivative;
ureas
antiviral drug;
environmental contaminant;
HIV protease inhibitor;
xenobiotic
201320188.5low000020
bardoxolone methylcyclohexenones2012201212.0low000010
dihydropyridines2000200024.0low001000
permanganatemanganese oxoacid201820186.0low000010
leupeptins201120208.0low000030
carboplatin2008201611.3low000120
nsc 259,9681982198242.0low010000
lithium chlorideinorganic chloride;
lithium salt
antimanic drug;
geroprotector
201820186.0low000010
glycogen201620196.5low000020
arabinoseL-arabinoseEscherichia coli metabolite;
mouse metabolite
1994199430.0low001000
fibrinpeptide1998201517.5low001010
bradykininoligopeptidehuman blood serum metabolite;
vasodilator agent
1999199925.0low001000
canavanineamino acid zwitterion;
non-proteinogenic L-alpha-amino acid
phytogenic insecticide;
plant metabolite
1984200828.0low010100
hexacyanoferrate iii1992201719.5low001010
glucosamineD-glucosamineEscherichia coli metabolite;
geroprotector;
mouse metabolite
201520159.0low000010
carnosineamino acid zwitterion;
dipeptide
anticonvulsant;
antineoplastic agent;
antioxidant;
Daphnia magna metabolite;
geroprotector;
human metabolite;
mouse metabolite;
neuroprotective agent
1992201325.0low002010
mevalonic acid3,5-dihydroxy-3-methylpentanoic acid1968197154.7low030000
raffinoseraffinose family oligosaccharide;
trisaccharide
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
2006200618.0low000100
naringenin(2S)-flavan-4-one;
naringenin
expectorant;
plant metabolite
200620227.7low000102
oxytocinheterodetic cyclic peptide;
peptide hormone
oxytocic;
vasodilator agent
1971200931.2low012100
3,4-dihydroxyphenyllactic acid2-hydroxy monocarboxylic acid;
catechols
1990201617.9low0021020
inositol 1,4,5-trisphosphatemyo-inositol trisphosphatemouse metabolite1997199926.0low002000
cysteinylglycinedipeptide zwitterion;
dipeptide
Escherichia coli metabolite;
human metabolite;
Saccharomyces cerevisiae metabolite
2014201410.0low000010
ouabain11alpha-hydroxy steroid;
14beta-hydroxy steroid;
5beta-hydroxy steroid;
alpha-L-rhamnoside;
cardenolide glycoside;
steroid hormone
anti-arrhythmia drug;
cardiotonic drug;
EC 2.3.3.1 [citrate (Si)-synthase] inhibitor;
EC 3.1.3.41 (4-nitrophenylphosphatase) inhibitor;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor;
EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor;
ion transport inhibitor;
plant metabolite
1967202039.2low041010
salicinaromatic primary alcohol;
aryl beta-D-glucoside;
benzyl alcohols
antipyretic;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
metabolite;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
prodrug
2001200222.5low000200
puromycinpuromycinsantiinfective agent;
antimicrobial agent;
antineoplastic agent;
EC 3.4.11.14 (cytosol alanyl aminopeptidase) inhibitor;
EC 3.4.14.2 (dipeptidyl-peptidase II) inhibitor;
nucleoside antibiotic;
protein synthesis inhibitor
1996199628.0low001000
tartaric acidtartaric acidEscherichia coli metabolite2013201311.0low000010
nicotinamide-beta-ribosideN-glycosylnicotinamide;
pyridine nucleoside
geroprotector;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
2014201410.0low000010
adenosine 5'-o-(3-thiotriphosphate)nucleoside triphosphate analogue2001200123.0low000100
cortodoxonedeoxycortisol;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone
human metabolite;
mouse metabolite
1999200620.5low001300
pr toxinoxacycle1982198242.0low010000
strychninemonoterpenoid indole alkaloid;
organic heteroheptacyclic compound
avicide;
cholinergic antagonist;
glycine receptor antagonist;
neurotransmitter agent;
rodenticide
201720177.0low000010
quinidinecinchona alkaloidalpha-adrenergic antagonist;
anti-arrhythmia drug;
antimalarial;
drug allergen;
EC 1.14.13.181 (13-deoxydaunorubicin hydroxylase) inhibitor;
EC 3.6.3.44 (xenobiotic-transporting ATPase) inhibitor;
muscarinic antagonist;
P450 inhibitor;
potassium channel blocker;
sodium channel blocker
1971201027.9low033500
griseofulvin1-benzofurans;
antibiotic antifungal drug;
benzofuran antifungal drug;
organochlorine compound;
oxaspiro compound
antibacterial agent;
Penicillium metabolite
2004201814.0low000220
monensincyclic hemiketal;
monocarboxylic acid;
polyether antibiotic;
spiroketal
antifungal agent;
coccidiostat;
ionophore
1979197945.0low010000
pentazocinebenzazocine1968197154.5low040000
terconazole1-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)-4-isopropylpiperazine1951195173.0low010000
pancratistatincitraconoyl group2002201316.5low000110
chaparrintriterpenoid1986198638.0medium010000
glaucarubolonetriterpenoid1980198541.5high020000
ginsenoside rg112beta-hydroxy steroid;
3beta-hydroxy-4,4-dimethylsteroid;
beta-D-glucoside;
ginsenoside;
tetracyclic triterpenoid
neuroprotective agent;
pro-angiogenic agent
2008201015.0low000300
notoginsenoside r112beta-hydroxy steroid;
3beta-hydroxy-4,4-dimethylsteroid;
3beta-hydroxy steroid;
beta-D-glucoside;
disaccharide derivative;
ginsenoside;
tetracyclic triterpenoid
antioxidant;
apoptosis inducer;
neuroprotective agent;
phytoestrogen;
plant metabolite
2010201014.0low000100
carnosolditerpenoid1991201623.0high00162710
isopimaric acidcarbotricyclic compound;
diterpenoid;
monocarboxylic acid
1996202115.2high00312101
cephaelinpyridoisoquinoline1977197747.0low010000
amantadine hydrochlorideisoquinoline alkaloid1963201126.8high010210
lubiminvetispirane sesquiterpenoidantifungal agent;
phytoalexin
1986198638.0medium010000
pulegonep-menth-4(8)-en-3-one2001200123.0low000100
ochratoxin aisochromanes;
monocarboxylic acid amide;
N-acyl-L-phenylalanine;
organochlorine compound;
phenylalanine derivative
Aspergillus metabolite;
calcium channel blocker;
carcinogenic agent;
mycotoxin;
nephrotoxin;
Penicillium metabolite;
teratogenic agent
2000200123.5low001100
juliflorinecitraconoyl group2005200519.0medium000100
lusianthridindihydrophenanthrene200520235.3high000165
lignans1989201619.1low011430
2-c-methylerythritol 4-phosphatetetritol phosphateEscherichia coli metabolite202020204.0low000010
n-formylmethionine leucyl-phenylalaninetripeptide1992201122.0low001110
abieta-7(8),13(14)-dieneabietadiene1996200026.0high002000
sodium arsenitearsenic molecular entity;
inorganic sodium salt
antibacterial agent;
antifungal agent;
antineoplastic agent;
carcinogenic agent;
herbicide;
insecticide;
rodenticide
2012201212.0low000010
trispheridinephenanthridines2013201311.0medium000010
7-deoxypancratistatinphenanthridines2010201014.0low000100
daunorubicinol13-dihydrodaunorubicin1995199529.0low001000
ergonovineergot alkaloid;
monocarboxylic acid amide;
organic heterotetracyclic compound;
primary alcohol;
secondary amino compound;
tertiary amino compound
diagnostic agent;
fungal metabolite;
oxytocic;
toxin
1992199232.0low001000
dironylorganic molecular entity1985199136.0low011000
erythromycin ethylsuccinatecyclic ketone;
erythromycin derivative;
ethyl ester;
succinate ester
1974197450.0low010000
betadexcyclodextrin1992202215.5low0012191
acetyl coenzyme aacyl-CoAacyl donor;
coenzyme;
effector;
fundamental metabolite
1973201928.0low010010
e-z cinnamic acidcinnamic acidplant metabolite1985202218.0low010201
trichostatin aantibiotic antifungal agent;
hydroxamic acid;
trichostatin
bacterial metabolite;
EC 3.5.1.98 (histone deacetylase) inhibitor;
geroprotector
2009201412.5low000110
tretinoinretinoic acid;
vitamin A
anti-inflammatory agent;
antineoplastic agent;
antioxidant;
AP-1 antagonist;
human metabolite;
keratolytic drug;
retinoic acid receptor agonist;
retinoid X receptor agonist;
signalling molecule
1994201717.5low002830
arachidonic acidicosa-5,8,11,14-tetraenoic acid;
long-chain fatty acid;
omega-6 fatty acid
Daphnia galeata metabolite;
EC 3.1.1.1 (carboxylesterase) inhibitor;
human metabolite;
mouse metabolite
1989200826.9low0120700
alpha-cyclodextrincyclodextrin2013201311.0low000010
fumaric acidbutenedioic acidfood acidity regulator;
fundamental metabolite;
geroprotector
2011201113.0low000010
prostaglandin h2olefinic compound;
oxylipin;
prostaglandins H;
secondary alcohol
mouse metabolite1985198539.0low010000
3-hydroxy-3-methylglutaryl-coenzyme a3-hydroxy-3-methylglutaryl-CoA;
3-hydroxy fatty acyl-CoA
human metabolite;
mouse metabolite
2011201113.0low000010
resveratrolresveratrolantioxidant;
phytoalexin;
plant metabolite;
quorum sensing inhibitor;
radical scavenger
201220218.5low000091
retinolretinol;
vitamin A
human metabolite;
mouse metabolite;
plant metabolite
1968200639.2low030200
cyanoginosin lrmicrocystinbacterial metabolite;
EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor;
environmental contaminant;
xenobiotic
201920214.3low000021
oleic acidoctadec-9-enoic acidantioxidant;
Daphnia galeata metabolite;
EC 3.1.1.1 (carboxylesterase) inhibitor;
Escherichia coli metabolite;
mouse metabolite;
plant metabolite;
solvent
2001201816.0low000530
tacrolimusmacrolide lactambacterial metabolite;
immunosuppressive agent
1999201618.6low001610
ferric hydroxide2012201311.5low000020
ferulic acidferulic acidsanti-inflammatory agent;
antioxidant;
apoptosis inhibitor;
cardioprotective agent;
MALDI matrix material;
plant metabolite
2004201815.7low000510
1,5-dihydro-fadflavin adenine dinucleotideEscherichia coli metabolite;
mouse metabolite
201520159.0low000010
cocainebenzoate ester;
methyl ester;
tertiary amino compound;
tropane alkaloid
adrenergic uptake inhibitor;
central nervous system stimulant;
dopamine uptake inhibitor;
environmental contaminant;
local anaesthetic;
mouse metabolite;
plant metabolite;
serotonin uptake inhibitor;
sodium channel blocker;
sympathomimetic agent;
vasoconstrictor agent;
xenobiotic
1993202218.7low003321
cocainebenzoate ester;
methyl ester;
tertiary amino compound;
tropane alkaloid
adrenergic uptake inhibitor;
central nervous system stimulant;
dopamine uptake inhibitor;
environmental contaminant;
local anaesthetic;
mouse metabolite;
plant metabolite;
serotonin uptake inhibitor;
sodium channel blocker;
sympathomimetic agent;
vasoconstrictor agent;
xenobiotic
1993202218.2low103621
eicosapentaenoic acidicosapentaenoic acid;
omega-3 fatty acid
anticholesteremic drug;
antidepressant;
antineoplastic agent;
Daphnia galeata metabolite;
fungal metabolite;
micronutrient;
mouse metabolite;
nutraceutical
201720177.0low000010
thapsigarginbutyrate ester;
organic heterotricyclic compound;
sesquiterpene lactone
calcium channel blocker;
EC 3.6.3.8 (Ca(2+)-transporting ATPase) inhibitor
1999201418.6low002120
mycophenolic acid2-benzofurans;
gamma-lactone;
monocarboxylic acid;
phenols
anticoronaviral agent;
antimicrobial agent;
antineoplastic agent;
EC 1.1.1.205 (IMP dehydrogenase) inhibitor;
environmental contaminant;
immunosuppressive agent;
mycotoxin;
Penicillium metabolite;
xenobiotic
2008201015.0low000200
clindamycin1994199430.0low101000
zithromaxmacrolide antibioticantibacterial drug;
environmental contaminant;
xenobiotic
1995199529.0low001000
geranylgeranyl pyrophosphategeranylgeranyl diphosphatemouse metabolite1994201522.3low002010
isofagominepiperidines202020204.0low000010
y 27632aromatic amide201620168.0low000010
prostaglandin d2prostaglandins Dhuman metabolite;
mouse metabolite
1985201122.4low010310
diethylstilbestrololefinic compound;
polyphenol
antifungal agent;
antineoplastic agent;
autophagy inducer;
calcium channel blocker;
carcinogenic agent;
EC 1.1.1.146 (11beta-hydroxysteroid dehydrogenase) inhibitor;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor;
endocrine disruptor;
xenoestrogen
1962197655.5low080000
h 89N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide2000200024.0low001000
afimoxifenephenols;
tertiary amino compound
antineoplastic agent;
estrogen receptor antagonist;
metabolite
2000200024.0low001000
decitabine2'-deoxyribonucleoside2009200915.0low000100
steviolbridged compound;
ent-kaurane diterpenoid;
monocarboxylic acid;
tertiary allylic alcohol;
tetracyclic diterpenoid
antineoplastic agent202120213.0low000001
dactinomycinactinomycinmutagen1994202121.8low003001
gamma-sitosterol3beta-hydroxy-Delta(5)-steroid;
3beta-sterol;
phytosterols
marine metabolite;
plant metabolite
1996202016.9low001430
aphidicolintetracyclic diterpenoidantimicrobial agent;
antimitotic;
antineoplastic agent;
antiviral drug;
apoptosis inducer;
Aspergillus metabolite;
DNA synthesis inhibitor;
EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor;
fungal metabolite
1993199331.0low001000
melphalanL-phenylalanine derivative;
nitrogen mustard;
non-proteinogenic L-alpha-amino acid;
organochlorine compound
alkylating agent;
antineoplastic agent;
carcinogenic agent;
drug allergen;
immunosuppressive agent
201520159.0low000010
benzyloxycarbonylleucyl-leucyl-leucine aldehydeamino aldehyde;
carbamate ester;
tripeptide
proteasome inhibitor201120208.0low000030
schizandrin1991201421.5low001010
shikoninhydroxy-1,4-naphthoquinone2010201014.0low000100
dihydrochelerythrinebenzophenanthridine alkaloid2007200717.0low000100
riboflavinflavin;
vitamin B2
anti-inflammatory agent;
antioxidant;
cofactor;
Escherichia coli metabolite;
food colouring;
fundamental metabolite;
human urinary metabolite;
mouse metabolite;
photosensitizing agent;
plant metabolite
201520235.0low000011
o,o-diacetyl tartaric acid anhydride1995199529.0medium001000
potassium permanganate2008200915.3low000300
sodium bicarbonateone-carbon compound;
organic sodium salt
antacid;
food anticaking agent
2001200123.0low000100
sodium acetate, anhydrousorganic sodium saltNMR chemical shift reference compound2002200222.0low000100
ammonium acetateacetate salt;
ammonium salt
buffer;
food acidity regulator
2006201115.5low000110
11-mercaptoundecanoic acid2012201212.0low000010
wr 2432511992199232.0medium001000
diphenylbutadiene2004200420.0low000100
tolfenamic acidaminobenzoic acid;
organochlorine compound;
secondary amino compound
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
EC 2.7.1.33 (pantothenate kinase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
2012201212.0low000010
methyl triclosan2013201311.0low000010
7-hydroxy-2-methoxy-1,4-phenanthrenedione2001201816.0high000210
trans-4-coumaric acid4-coumaric acidfood component;
mouse metabolite;
plant metabolite
2008200816.0low000100
glycosides1968201942.8low0340170
benzylideneacetonebenzylideneacetonebacterial metabolite;
EC 3.1.1.4 (phospholipase A2) inhibitor;
flavouring agent;
fragrance
1994199430.0low001000
chalconechalconeEC 3.2.1.1 (alpha-amylase) inhibitor2002200222.0low000100
isomethyleugenolisomethyleugenol1949201533.2low0112730
retinaldehyderetinal;
vitamin A
gap junctional intercellular communication inhibitor;
human metabolite;
mouse metabolite
2005200618.5low000200
squalenetriterpenehuman metabolite;
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
1968197154.5low020000
stilbenesstilbene1947202127.6low019614171
isoliquiritigeninchalconesantineoplastic agent;
biological pigment;
EC 1.14.18.1 (tyrosinase) inhibitor;
GABA modulator;
geroprotector;
metabolite;
NMDA receptor antagonist
201620168.0low000010
coumestancoumestans;
delta-lactone
phytoestrogen;
plant metabolite
2006200618.0low000100
phenyl-n-tert-butylnitrone2007200717.0low000100
antofinealkaloid antibiotic;
alkaloid;
aromatic ether;
organic heteropentacyclic compound
angiogenesis inhibitor;
anti-inflammatory agent;
antimicrobial agent;
antineoplastic agent;
antiviral agent;
phytotoxin;
plant metabolite
2006202110.6medium000271
prolinol201620168.0low000010
cardamoninchalcones202120213.0low000001
flavin-adenine dinucleotideflavin adenine dinucleotide;
vitamin B2
cofactor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
prosthetic group
2013201510.0low000020
cannabidiololefinic compound;
phytocannabinoid;
resorcinols
antimicrobial agent;
plant metabolite
201920223.5low000011
pyrophosphatediphosphate ion2012201212.0low000010
polidocanolhydroxypolyetherhepatotoxic agent;
nonionic surfactant;
sclerotherapy agent
1986201617.4low010640
fludarabinepurine nucleoside1999199925.0low001000
dithizone2001200123.0low000100
sesquiterpenes1974201825.6low35221320
vasicine201620168.0low000010
ag-2131999199925.0low001000
armepavine2004200420.0low000100
thiobenzamidebenzenes2013201311.0low000010
caffeic acidcaffeic acidgeroprotector;
mouse metabolite
2003202015.0low000320
lolineloline alkaloid;
secondary amino compound
1992199232.0low001000
4-acetylaminostilbene1993199729.0medium004000
cotinineN-alkylpyrrolidine;
pyridines;
pyrrolidin-2-ones;
pyrrolidine alkaloid
antidepressant;
biomarker;
human xenobiotic metabolite;
plant metabolite
1990202218.4low003321
phenanthraquinone monothiosemicarbazone1987200225.4high010400
curcuminaromatic ether;
beta-diketone;
diarylheptanoid;
enone;
polyphenol
anti-inflammatory agent;
antifungal agent;
antineoplastic agent;
biological pigment;
contraceptive drug;
dye;
EC 1.1.1.205 (IMP dehydrogenase) inhibitor;
EC 1.1.1.21 (aldehyde reductase) inhibitor;
EC 1.1.1.25 (shikimate dehydrogenase) inhibitor;
EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor;
EC 1.8.1.9 (thioredoxin reductase) inhibitor;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor;
EC 3.5.1.98 (histone deacetylase) inhibitor;
flavouring agent;
food colouring;
geroprotector;
hepatoprotective agent;
immunomodulator;
iron chelator;
ligand;
lipoxygenase inhibitor;
metabolite;
neuroprotective agent;
nutraceutical;
radical scavenger
1995202115.0low001421
nootkatonecarbobicyclic compound;
enone;
sesquiterpenoid
fragrance;
insect repellent;
plant metabolite
1986198638.0low010000
methimazole1,3-dihydroimidazole-2-thionesantithyroid drug1972197252.0low010000
cinnarizinediarylmethane;
N-alkylpiperazine;
olefinic compound
anti-allergic agent;
antiemetic;
calcium channel blocker;
geroprotector;
H1-receptor antagonist;
histamine antagonist;
muscarinic antagonist
2004201714.5low000220
capsaicincapsaicinoidnon-narcotic analgesic;
TRPV1 agonist;
voltage-gated sodium channel blocker
2007200717.0low000100
enclomiphene1974198644.0low020000
chlorogenic acidcinnamate ester;
tannin
food component;
plant metabolite
200720238.0low000111
longifolenelongifolene1986198638.0low010000
thioguanine anhydrous2-aminopurinesanticoronaviral agent;
antimetabolite;
antineoplastic agent
1985201420.3low010020
thioureaone-carbon compound;
thioureas;
ureas
antioxidant;
chromophore
1969198348.0low020000
indigo carmine2000201218.7low001110
digoxincardenolide glycoside;
steroid saponin
anti-arrhythmia drug;
cardiotonic drug;
EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor;
epitope
1974202016.6low010240
1,6-anhydro-beta-glucopyranoseanhydrohexoseArabidopsis thaliana metabolite;
biomarker;
human metabolite
2006201912.3low000210
tamoxifenstilbenoid;
tertiary amino compound
angiogenesis inhibitor;
antineoplastic agent;
bone density conservation agent;
EC 1.2.3.1 (aldehyde oxidase) inhibitor;
EC 2.7.11.13 (protein kinase C) inhibitor;
estrogen antagonist;
estrogen receptor antagonist;
estrogen receptor modulator
1993200822.2low002200
nadp1974202125.7low0311441
1,1-diphenyl-2-picrylhydrazyl2001201816.6low000620
horminone1994199430.0low001000
methyl-thiohydantoin-tryptophanorganonitrogen compound;
organooxygen compound
201020199.2low000140
fusidic acid11alpha-hydroxy steroid;
3alpha-hydroxy steroid;
alpha,beta-unsaturated monocarboxylic acid;
steroid acid;
steroid antibiotic;
sterol ester
EC 2.7.1.33 (pantothenate kinase) inhibitor;
Escherichia coli metabolite;
protein synthesis inhibitor
2010201014.0low000100
artemotilartemisinin derivative1993199331.0low001000
u 0126aryl sulfide;
dinitrile;
enamine;
substituted aniline
antineoplastic agent;
antioxidant;
apoptosis inducer;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor;
osteogenesis regulator;
vasoconstrictor agent
2007202212.6low000431
laccase199820239.9low0023103
cobaltous chloridecobalt salt;
inorganic chloride
allergen;
calcium channel blocker;
sensitiser;
two-colour indicator
2006201414.0low000110
nitrogen dioxidenitrogen oxide1980198740.5low020000
enpiroline1985199833.3high034000
orlistatbeta-lactone;
carboxylic ester;
formamides;
L-leucine derivative
anti-obesity agent;
bacterial metabolite;
EC 2.3.1.85 (fatty acid synthase) inhibitor;
EC 3.1.1.3 (triacylglycerol lipase) inhibitor
201620168.0low000010
quininecinchona alkaloidantimalarial;
muscle relaxant;
non-narcotic analgesic
1973201330.0low218511620
kaurenoic acid201620168.0low000010
1,2-bis(2-aminophenoxy)ethane n,n,n',n'-tetraacetic acid acetoxymethyl ester2005200519.0low000100
2,2-dimethyl-5-hydroxy-1-pyrrolidinyloxy2007200717.0low000100
11,12-dihydroxy-13,14-epoxy-11,12,13,14-tetrahydrodibenzo(a,l)pyrene1995199529.0low001000
7-benzyloxyquinoline2002200222.0low000100
dasatinib1,3-thiazoles;
aminopyrimidine;
monocarboxylic acid amide;
N-(2-hydroxyethyl)piperazine;
N-arylpiperazine;
organochlorine compound;
secondary amino compound;
tertiary amino compound
anticoronaviral agent;
antineoplastic agent;
tyrosine kinase inhibitor
201920195.0low000010
piperolactam aalkaloid2008200816.0low000100
dipyrromethenedipyrrins2008200816.0low000200
cytellin1981202019.8low011430
gigantol200620208.5medium000130
ginsenosides2008201911.4low000320
ovalbumin1997202015.2low001130
tert-butanesulfinamide2014201410.0low000010
sodium dodecyl sulfateorganic sodium saltdetergent;
protein denaturant
1974201516.5low011980
sto 609naphthoic acid202020204.0low000010
mtt formazan2008200816.0low000100
l 663536aryl sulfide;
indoles;
monocarboxylic acid;
monochlorobenzenes
antineoplastic agent;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
leukotriene antagonist
1997199727.0low001000
alizarin red sorganic sodium salt;
organosulfonate salt
histological dye202320231.0low000001
alpha-chymotrypsin1967197453.5low020000
17-ketosteroids1969197453.0low030000
naphthoquinones1967202221.0low2351062
jhw 015indolecarboxamide2010201213.0low000110
am 630N-acylindole2012201212.0low000010
osteoprotegerinlong-chain fatty acid2004200619.0low000200
myelin basic protein2004200420.0low000100
imd 0354benzamides201720177.0low000010
2-mercaptoacetatemonocarboxylic acid anion2004200420.0low000100
sphingosinesphing-4-eninehuman metabolite;
mouse metabolite
1992202014.8low001030
quercetin7-hydroxyflavonol;
pentahydroxyflavone
antibacterial agent;
antineoplastic agent;
antioxidant;
Aurora kinase inhibitor;
chelator;
EC 1.10.99.2 [ribosyldihydronicotinamide dehydrogenase (quinone)] inhibitor;
geroprotector;
phytoestrogen;
plant metabolite;
protein kinase inhibitor;
radical scavenger
1991202313.9low002853
bilirubinbiladienes;
dicarboxylic acid
antioxidant;
human metabolite;
mouse metabolite
1974201928.0low121110
dinoprostoneprostaglandins Ehuman metabolite;
mouse metabolite;
oxytocic
1985201819.4low0181570
dinoprostmonocarboxylic acid;
prostaglandins Falpha
human metabolite;
mouse metabolite
1985200328.4low017200
formononetin4'-methoxyisoflavones;
7-hydroxyisoflavones
phytoestrogen;
plant metabolite
201320198.0low000020
prostaglandin b1prostaglandins Bhuman metabolite1985199235.5low011000
arachidonyltrifluoromethanefatty acid derivative;
ketone;
olefinic compound;
organofluorine compound
EC 3.1.1.4 (phospholipase A2) inhibitor1998200124.2low002200
apigenintrihydroxyflavoneantineoplastic agent;
metabolite
2006201713.0low000210
luteolin3'-hydroxyflavonoid;
tetrahydroxyflavone
angiogenesis inhibitor;
anti-inflammatory agent;
antineoplastic agent;
apoptosis inducer;
c-Jun N-terminal kinase inhibitor;
EC 2.3.1.85 (fatty acid synthase) inhibitor;
immunomodulator;
nephroprotective agent;
plant metabolite;
radical scavenger;
vascular endothelial growth factor receptor antagonist
201920195.0low000010
7,3'-dihydroxy-4'-methoxyisoflavone4'-methoxyisoflavones;
7-hydroxyisoflavones
antioxidant;
metabolite
201920195.0low000010
linoleic acidoctadecadienoic acid;
omega-6 fatty acid
algal metabolite;
Daphnia galeata metabolite;
plant metabolite
1998200223.3low001200
calcitriolD3 vitamins;
hydroxycalciol;
triol
antineoplastic agent;
antipsoriatic;
bone density conservation agent;
calcium channel agonist;
calcium channel modulator;
hormone;
human metabolite;
immunomodulator;
metabolite;
mouse metabolite;
nutraceutical
2001200123.0low000100
pinosylvinpinosylvin1986198638.0low010000
vitamin k semiquinone radical1990199629.8low004000
beta carotenecarotenoid beta-end derivative;
cyclic carotene
antioxidant;
biological pigment;
cofactor;
ferroptosis inhibitor;
human metabolite;
mouse metabolite;
plant metabolite;
provitamin A
2004200420.0low000100
leukotriene b4dihydroxy monocarboxylic acid;
hydroxy polyunsaturated fatty acid;
leukotriene;
long-chain fatty acid
human metabolite;
mouse metabolite;
plant metabolite;
vasoconstrictor agent
1989200726.0low010100
leukotriene c4leukotrienebronchoconstrictor agent;
human metabolite;
mouse metabolite
2011201113.0low000010
maleylpyruvate4,6-dioxohept-2-enedioic acid;
beta-diketone
201520159.0low000010
thromboxane a2epoxy monocarboxylic acid;
thromboxanes A
mouse metabolite2006200618.0low000100
feruloyltyraminetyraminesmetabolite201620168.0low000010
8,11,14-eicosatrienoic acidfatty acid 20:3;
long-chain fatty acid
fungal metabolite;
human metabolite;
nutraceutical
1999199925.0low001000
rosin1952202230.2low0819321
alprostadilprostaglandins Eanticoagulant;
human metabolite;
platelet aggregation inhibitor;
vasodilator agent
2001200123.0low000100
5-hydroxy-6,8,11,14-eicosatetraenoic acidHETEhuman metabolite;
mouse metabolite
1997199727.0low001000
vitamin d 2hydroxy seco-steroid;
seco-ergostane;
vitamin D
bone density conservation agent;
nutraceutical;
plant metabolite;
rodenticide
1963200739.0low010100
stigmasterol3beta-hydroxy-Delta(5)-steroid;
3beta-sterol;
phytosterols;
stigmastane sterol
plant metabolite202020204.0low000010
rutindisaccharide derivative;
quercetin O-glucoside;
rutinoside;
tetrahydroxyflavone
antioxidant;
metabolite
2004202312.7low000201
kaempferol7-hydroxyflavonol;
flavonols;
tetrahydroxyflavone
antibacterial agent;
geroprotector;
human blood serum metabolite;
human urinary metabolite;
human xenobiotic metabolite;
plant metabolite
2006202011.0low000110
6-ketoprostaglandin f1 alphaprostaglandins Falphahuman metabolite;
mouse metabolite
1996201620.0low002010
arachidonic acid omega-9 hydroperoxideHPETEmouse metabolite1999199925.0low001000
alpha-linolenic acidlinolenic acid;
omega-3 fatty acid
micronutrient;
mouse metabolite;
nutraceutical
2001200123.0low000100
genistein7-hydroxyisoflavonesantineoplastic agent;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
geroprotector;
human urinary metabolite;
phytoestrogen;
plant metabolite;
tyrosine kinase inhibitor
2006200618.0low000100
amphotericin bantibiotic antifungal drug;
macrolide antibiotic;
polyene antibiotic
antiamoebic agent;
antiprotozoal drug;
bacterial metabolite
1999199925.0low001000
pulmicort11beta-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
cyclic acetal;
glucocorticoid;
primary alpha-hydroxy ketone
anti-inflammatory drug;
bronchodilator agent;
drug allergen
201620168.0low000010
cassaineenoate ester;
organic hydroxy compound;
tertiary amino compound;
tricyclic diterpenoid
antihypertensive agent;
cardiotonic drug;
EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor;
local anaesthetic;
plant metabolite;
poison
1976197648.0low020000
bruceantintriterpenoid1978198841.5high0120000
mezereinditerpenoid2010201014.0low000100
humulenealpha-humulene200920228.5low000101
zearalenonemacrolide;
resorcinols
fungal metabolite;
mycoestrogen
2006200618.0low000100
baicaleintrihydroxyflavoneangiogenesis inhibitor;
anti-inflammatory agent;
antibacterial agent;
anticoronaviral agent;
antifungal agent;
antineoplastic agent;
antioxidant;
apoptosis inducer;
EC 1.13.11.31 (arachidonate 12-lipoxygenase) inhibitor;
EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor;
EC 4.1.1.17 (ornithine decarboxylase) inhibitor;
ferroptosis inhibitor;
geroprotector;
hormone antagonist;
plant metabolite;
prostaglandin antagonist;
radical scavenger
2011201113.0low000010
diosmetin3'-hydroxyflavonoid;
monomethoxyflavone;
trihydroxyflavone
angiogenesis inhibitor;
anti-inflammatory agent;
antineoplastic agent;
antioxidant;
apoptosis inducer;
bone density conservation agent;
cardioprotective agent;
plant metabolite;
tropomyosin-related kinase B receptor agonist;
vasodilator agent
202020204.0low000010
fisetin3'-hydroxyflavonoid;
7-hydroxyflavonol;
tetrahydroxyflavone
anti-inflammatory agent;
antioxidant;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
geroprotector;
metabolite;
plant metabolite
1991200028.5low002000
hyperosidebeta-D-galactoside;
monosaccharide derivative;
quercetin O-glycoside;
tetrahydroxyflavone
hepatoprotective agent;
plant metabolite
202220222.0low000001
mangostinaromatic ether;
phenols;
xanthones
antimicrobial agent;
antineoplastic agent;
antioxidant;
plant metabolite
202020204.0low000010
myricetin7-hydroxyflavonol;
hexahydroxyflavone
antineoplastic agent;
antioxidant;
cyclooxygenase 1 inhibitor;
food component;
geroprotector;
hypoglycemic agent;
plant metabolite
1991200625.5low001100
wogonindihydroxyflavone;
monomethoxyflavone
angiogenesis inhibitor;
antineoplastic agent;
cyclooxygenase 2 inhibitor;
plant metabolite
201620168.0low000010
daidzein7-hydroxyisoflavonesantineoplastic agent;
EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor;
EC 3.2.1.20 (alpha-glucosidase) inhibitor;
phytoestrogen;
plant metabolite
2006200618.0low000100
rosmarinic acidrosmarinic acidgeroprotector;
plant metabolite
1998202112.4low001561
salvianolic acid astilbenoid2007201414.3low000420
maytansinealpha-amino acid ester;
carbamate ester;
epoxide;
maytansinoid;
organic heterotetracyclic compound;
organochlorine compound
antimicrobial agent;
antimitotic;
antineoplastic agent;
plant metabolite;
tubulin modulator
1976197648.0low010000
rottlerinaromatic ketone;
benzenetriol;
chromenol;
enone;
methyl ketone
anti-allergic agent;
antihypertensive agent;
antineoplastic agent;
apoptosis inducer;
K-ATP channel agonist;
metabolite
2010201014.0low000100
prostaglandin a1prostaglandins A1985198539.0low010000
coenzyme q10ubiquinonesantioxidant;
ferroptosis inhibitor;
human metabolite
201720177.0low000010
copalyl diphosphatecopalyl diphosphate2000200024.0low001000
4-hydroxyestradiol4-hydroxy steroidmetabolite1995199529.0low001000
thromboxane b2thromboxanes Bhuman metabolite;
mouse metabolite
1997201617.0low001110
4-hydroxy-2-nonenal4-hydroxynon-2-enal;
4-hydroxynonenal
201820186.0low000010
sphingosine 1-phosphatesphingoid 1-phosphatemouse metabolite;
signalling molecule;
sphingosine-1-phosphate receptor agonist;
T-cell proliferation inhibitor;
vasodilator agent
201420207.0low000020
codeinemorphinane alkaloid;
organic heteropentacyclic compound
antitussive;
drug allergen;
environmental contaminant;
opioid analgesic;
opioid receptor agonist;
prodrug;
xenobiotic
1966198051.4low050000
phenylephrine hydrochloridehydrochloride2007200717.0low000100
3-amino-1,4-dimethyl-5h-pyrido(4,3-b)indolepyridoindole1992199232.0low001000
nalorphinemorphinane alkaloid1967197154.7low270000
methylestrenolonesteroidestrogen2009200915.0low000100
sirolimusantibiotic antifungal drug;
cyclic acetal;
cyclic ketone;
ether;
macrolide lactam;
organic heterotricyclic compound;
secondary alcohol
antibacterial drug;
anticoronaviral agent;
antineoplastic agent;
bacterial metabolite;
geroprotector;
immunosuppressive agent;
mTOR inhibitor
2008202110.5low000211
gamma-cyclodextrincyclodextrin2013201311.0low000010
alvocidibdihydroxyflavone;
hydroxypiperidine;
monochlorobenzenes;
tertiary amino compound
antineoplastic agent;
antirheumatic drug;
apoptosis inducer;
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
201420188.0low000020
morphinemorphinane alkaloid;
organic heteropentacyclic compound;
tertiary amino compound
anaesthetic;
drug allergen;
environmental contaminant;
geroprotector;
mu-opioid receptor agonist;
opioid analgesic;
plant metabolite;
vasodilator agent;
xenobiotic
1947200653.2low1190200
pactamycin1977197747.0low010000
su 54022011201113.0low000010
benzphetamineamphetamines;
tertiary amine
adrenergic uptake inhibitor;
appetite depressant;
dopamine uptake inhibitor;
sympathomimetic agent
1995199529.0low001000
istradefyllineoxopurine2008200816.0low000100
preclamol1985199137.2low041000
lacidipinecinnamate ester;
tert-butyl ester
2000200024.0low001000
lysophosphatidylcholines1-O-acyl-sn-glycero-3-phosphocholine1996200026.0low002000
cytochalasin bcytochalasin;
lactam;
lactone;
organic heterotricyclic compound
actin polymerisation inhibitor;
metabolite;
mycotoxin;
platelet aggregation inhibitor
2014201410.0low000010
7,7-dimethyl-5,8-eicosadienoic acidlong-chain fatty acid1997200125.0low002100
1,2-oleoylphosphatidylcholinephosphatidylcholine(1+)2003201415.5low000110
biliverdine2006200916.5low000200
chrysotoxine202020204.0medium000010
n-cinnamoyltyraminecinnamamides;
phenols;
secondary carboxamide
allelochemical;
antimicrobial agent;
phytoalexin;
platelet aggregation inhibitor
201620168.0medium000010
tylophorine b2000200620.3high001200
dehydroeffusol201120208.5high000080
icariinflavonols;
glycosyloxyflavone
antioxidant;
bone density conservation agent;
EC 3.1.4.35 (3',5'-cyclic-GMP phosphodiesterase) inhibitor;
phytoestrogen
2007200717.0low000100
marchantin c2002200222.0low000100
caryophyllene1986198638.0low010000
thebainemorphinane alkaloid;
organic heteropentacyclic compound
1967196757.0low010000
mitoguazoneguanidines;
hydrazone
antineoplastic agent;
apoptosis inducer;
EC 4.1.1.50 (adenosylmethionine decarboxylase) inhibitor
1985198539.0low010000
leadcarbon group element atom;
elemental lead;
metal atom
neurotoxin1969202214.1low010772
4-amylcinnamoylanthranilic acidamidobenzoic acid;
cinnamamides;
secondary carboxamide
EC 3.1.1.4 (phospholipase A2) inhibitor;
TRP channel blocker
202120213.0low000001
bay 11-7082nitrile;
sulfone
apoptosis inducer;
EC 2.7.11.10 (IkappaB kinase) inhibitor;
EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor;
non-steroidal anti-inflammatory drug;
platelet aggregation inhibitor
201320197.3low000030
bay 11-7085benzenes;
nitrile;
sulfone
anti-inflammatory agent;
antibacterial agent;
antineoplastic agent;
apoptosis inducer;
autophagy inducer;
EC 2.7.11.10 (IkappaB kinase) inhibitor;
ferroptosis inducer;
NF-kappaB inhibitor
2008200816.0low000100
15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid1997200623.3low002100
cesiumalkali metal atom1991199133.0low001000
aluminumboron group element atom;
elemental aluminium;
metal atom
1967202318.4low010121
levorphanolmorphinane alkaloid1970197153.5low020000
bismuthmetal atom;
pnictogen
2001200123.0low000100
levallorphanmorphinane alkaloid1967197155.5low240000
arsenicmetalloid atom;
pnictogen
micronutrient1964202115.5low0204121
indiumboron group element atom2013201410.5low000020
dextromethorphan6-methoxy-11-methyl-1,3,4,9,10,10a-hexahydro-2H-10,4a-(epiminoethano)phenanthreneantitussive;
environmental contaminant;
neurotoxin;
NMDA receptor antagonist;
oneirogen;
prodrug;
xenobiotic
1997201319.0low001010
galliumboron group element atom201520159.0low000010
sulfurchalcogen;
nonmetal atom
macronutrient1949201730.8low011210
glyceryl behenate1-monoglyceride;
fatty acid ester
antineoplastic agent;
plant metabolite
2007200717.0low000100
ethyl oleatelong-chain fatty acid ethyl esteracaricide;
plant metabolite
2006200618.0low000100
geldanamycin2014201410.0low000010
methyl oleatefatty acid methyl ester1994199430.0low001000
diphenylhexatrienealkatrienefluorochrome2014201410.0low000010
puerarinC-glycosyl compound;
isoflavonoid
201620196.5low000020
sinomeninemorphinane alkaloid2010201014.0low000100
ecdysterone14alpha-hydroxy steroid;
20-hydroxy steroid;
22-hydroxy steroid;
25-hydroxy steroid;
2beta-hydroxy steroid;
3beta-sterol;
ecdysteroid;
phytoecdysteroid
animal metabolite;
plant metabolite
1998199826.0low001000
deoxyribosedeoxypentosehuman metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
1992199232.0low001000
fumaratesbutenedioate;
C4-dicarboxylate
human metabolite;
metabolite;
Saccharomyces cerevisiae metabolite
2011201113.0low000010
cysteinecysteiniumfundamental metabolite1965202228.4low041231
siliconcarbon group element atom;
metalloid atom;
nonmetal atom
1971197153.0low010000
phosphorusmonoatomic phosphorus;
nonmetal atom;
pnictogen
macronutrient1994202215.1low002341
boronboron group element atom;
metalloid atom;
nonmetal atom
micronutrient2008200816.0low000200
heroinmorphinane alkaloidmu-opioid receptor agonist;
opioid analgesic;
prodrug
1968196955.5low120000
2,2'-azino-di-(3-ethylbenzothiazoline)-6-sulfonic acid2004200619.0low000200
bakuchiol2010201014.0low000100
thiosemicarbazone h1983198341.0medium010000
trioleintriglycerideCaenorhabditis elegans metabolite;
plant metabolite
201520159.0low000010
guanabenzdichlorobenzene1998199826.0low001000
carbocyaninescyanine dye;
organic iodide salt
fluorochrome201820195.5low000020
cinidon-ethylethyl ester;
isoindoles;
monochlorobenzenes
herbicide202220222.0low000001
1,2-dielaidoylphosphatidylethanolamine1997199727.0low001000
6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2h-pyran-2-onenaphthalenes1999200124.0low001100
su 1498enamide;
monocarboxylic acid amide;
nitrile;
phenols;
secondary carboxamide
vascular endothelial growth factor receptor antagonist2008200816.0low000100
4,4'-diisothiocyanostilbene-2,2'-disulfonic acid1999199925.0low002000
proguanilbiguanides;
monochlorobenzenes
antimalarial;
antiprotozoal drug;
EC 1.5.1.3 (dihydrofolate reductase) inhibitor
1972202025.6low115410
tetrodotoxinazatetracycloalkane;
oxatetracycloalkane;
quinazoline alkaloid
animal metabolite;
bacterial metabolite;
marine metabolite;
neurotoxin;
voltage-gated sodium channel blocker
1999199925.0low001000
seleniumchalcogen;
nonmetal atom
micronutrient1964201833.0low010010
oxalates2004202212.8low000301
dizocilpine maleatemaleate salt;
tetracyclic antidepressant
anaesthetic;
anticonvulsant;
neuroprotective agent;
nicotinic antagonist;
NMDA receptor antagonist
2010201014.0low000100
antimycin aamidobenzoic acid1968197451.5low040000
pregnanediol1965196559.0low010000
longiborneolorganic molecular entity2006200618.0medium000100
bongkrekic acidether;
olefinic compound;
tricarboxylic acid
apoptosis inhibitor;
ATP/ADP translocase inhibitor;
bacterial metabolite;
EC 2.5.1.18 (glutathione transferase) inhibitor;
toxin
2002200222.0low000100
1-palmitoyl-2-oleoylphosphatidylcholine2009200915.0low000100
1-oleoyl-2-acetylglycerol1,2-diglyceride1992199232.0low001000
15-hydroperoxy-5,8,11,13-eicosatetraenoic acidHPETEhuman xenobiotic metabolite1999199925.0low001000
manoalidebutenolide;
lactol;
sesterterpenoid
EC 3.1.1.4 (phospholipase A2) inhibitor;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
metabolite
1999199925.0low001000
lumefantrinefluorenes;
monochlorobenzenes;
secondary alcohol;
tertiary amine
antimalarial2003202012.6low000360
isocupressic acid1999199925.0low001000
2-(4-amylcinnamoyl)amino-4-chlorobenzoic acid1993200127.2medium004100
glisoprenin a2007200717.0medium000100
valerenic acidcarbobicyclic compound;
monocarboxylic acid;
sesquiterpenoid
GABA modulator;
plant metabolite;
sedative;
volatile oil component
201820186.0low000010
trk 820phenanthrenes2012201212.0low000010
chlorophyll201920195.0low000010
cgp-566971999201218.8low201210
salvianolic acid B1-benzofurans;
catechols;
dicarboxylic acid;
enoate ester;
polyphenol
anti-inflammatory agent;
antidepressant;
antineoplastic agent;
antioxidant;
apoptosis inducer;
autophagy inhibitor;
cardioprotective agent;
hepatoprotective agent;
hypoglycemic agent;
neuroprotective agent;
osteogenesis regulator;
plant metabolite
2005202112.8low00014111
verlukast2007201712.0low000110
beta-escin1970202220.8low034562
morphinansisoquinoline alkaloid fundamental parent;
morphinane alkaloid
1969201229.6low020210
ergolinediamine;
ergoline alkaloid;
indole alkaloid fundamental parent;
indole alkaloid;
organic heterotetracyclic compound
1991199332.0low003000
sq-23377cyclic ether;
enol;
polyunsaturated fatty acid;
very long-chain fatty acid
calcium ionophore;
metabolite
1993201619.5low001010
fk 866benzamides;
N-acylpiperidine
201420216.5low000011
stepholidine2004200420.0low000100
fluorodeoxyglucose f182002200222.0medium000100
omtriptolide2003202012.0high000130
isoborneolborneol201720186.5low000020
staurosporineammonium ion derivative1993200822.2low002200
bufalin14beta-hydroxy steroid;
3beta-hydroxy steroid
animal metabolite;
anti-inflammatory agent;
antineoplastic agent;
cardiotonic drug
202020204.0low000010
phosphocreatinephosphagen;
phosphoamino acid
human metabolite;
mouse metabolite
2002200222.0low000100
pimaranediterpene;
terpenoid fundamental parent
2002200222.0low000100
formazans2008200816.0low000100
sincalideoligopeptide2014201410.0low000010
mocetinostataminopyrimidine;
benzamides;
pyridines;
secondary amino compound;
secondary carboxamide;
substituted aniline
antineoplastic agent;
apoptosis inducer;
autophagy inducer;
cardioprotective agent;
EC 3.5.1.98 (histone deacetylase) inhibitor;
hepatotoxic agent
2002202013.5low0001090
xestospongin a2014201410.0low000010
gw 4064stilbenoid201520159.0low000010
ginsenoside rb1ginsenoside;
glycoside;
tetracyclic triterpenoid
anti-inflammatory drug;
anti-obesity agent;
apoptosis inhibitor;
neuroprotective agent;
plant metabolite;
radical scavenger
2010201014.0low000100
2-((aminocarbonyl)amino)-5-(4-fluorophenyl)-3-thiophenecarboxamidearomatic amide;
thiophenes
2012201212.0low000010
tivozanibaromatic ether202120213.0low000001
ginsenoside rg3ginsenoside;
glycoside;
tetracyclic triterpenoid
angiogenesis modulating agent;
antineoplastic agent;
apoptosis inducer;
plant metabolite
201920195.0low000010
phenylalanyl-glycyl-leucyl-methioninamidetetrapeptide2008200816.0low000100
zeolites200520249.4low000131
zeolites2005202410.2low000121
3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2h)-isoquinolinone2001201416.2medium000220
azonafide2000200024.0low001000
1-oxomiltirone2001201715.0high000110
andrastin c2013201311.0medium000010
blestriarene c2002201517.3high000210
aluminum oxide1980201022.0low010400
bisdehydrodoisynolic acid1950201026.8high012500
araloside atriterpenoid saponinmetabolite1991199133.0medium001000
phosphoramidite2005200519.0low000100
sepantroniumorganic cation202120213.0low000001
artenimol1998199925.5low002000
anomalin2005200519.0low000100
alpha-synuclein2007201712.0low000110
demethylzeylasteralarenecarbaldehyde;
benzenediols;
carbopolycyclic compound;
cyclic ketone;
enone;
oxo monocarboxylic acid
anti-inflammatory agent;
EC 2.4.1.17 (glucuronosyltransferase) inhibitor;
immunosuppressive agent;
nephroprotective agent;
plant metabolite
201620168.0low000010
artelinic acid1993199331.0low001000
ngr peptide202020204.0low000010
1,6-anhydro-beta-d-mannopyranose201920195.0low000010
erianthridin1997202114.2high001121
denbinobin2001201813.7high00010110
panepophenanthrin2002201018.5high000600
3,7-dihydroxy-2,4-dimethoxyphenanthrene2006200618.0medium000100
oxadiazoles2008201313.5low000110
ly 3414952010201014.0low000100
septicine2012201212.0medium000010
decabromodiphenyl ethane202320231.0low000001
dioscorealide b2006200618.0medium000100
abt-737aromatic amine;
aryl sulfide;
biphenyls;
C-nitro compound;
monochlorobenzenes;
N-arylpiperazine;
N-sulfonylcarboxamide;
secondary amino compound;
tertiary amino compound
anti-allergic agent;
anti-inflammatory agent;
antineoplastic agent;
apoptosis inducer;
B-cell lymphoma 2 inhibitor
2012201212.0low000010
nu 7441dibenzothiophenes201920204.5low000020
cannabidiol hydroxyquinoneprenylquinone201920195.0low000010
Dihydrotanshinone Iabietane diterpenoidanticoronaviral agent199920227.9high002103018
nutlin-3astilbenoid2008200816.0low000100
clematichinenoside ar202220222.0medium000001
dorsomorphinaromatic ether;
piperidines;
pyrazolopyrimidine;
pyridines
bone morphogenetic protein receptor antagonist;
EC 2.7.11.31 {[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase} inhibitor
202020204.0low000010
artemisone2014201410.0low000010
quisinostatindoles202120213.0low000001
chlorophyll bchlorophyllcofactor201920204.5low000020
alpha-(2-piperidyl)-3,6-bis(trifluoromethyl)-9-phenanthrenemethanol1983202129.5high032001
galactosan201920195.0low000010
abexinostatbenzofurans2007200717.0low000100
losartan potassium201920195.0low000010
silvestroldioxanes;
ether;
methyl ester;
organic heterotricyclic compound
antineoplastic agent;
metabolite
202020204.0low000010
4-hydroxy-5-azaphenanthrene1994199430.0medium001000
pyripyropene aorganic heterotetracyclic compound;
sesquiterpenoid
acyl-CoA:cholesterol acyltransferase 2 inhibitor;
metabolite
2007200717.0low000100
7-methoxycryptopleurine2007202011.7high000210
calcimycinbenzoxazole1989202224.7low015001
veliparibbenzimidazolesEC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor201520178.0low000030
sepharose1974201722.7low010020
scopolamine hydrobromide2007201613.0low000210
cinobufaginsteroid lactone1959195965.0low010000
kobusine1962201131.2high012010
pazufloxacin1962201131.9high022120
hexacyclinol2009200915.0low000100
pituitrin1963200943.0low020100
podophyllin1972197252.0low010000
phytosterols2000200820.0low001100
doisynolic acid1997199727.0low001000
ouabagenin1-hydroxy steroid;
11alpha-hydroxy steroid;
14beta-hydroxy steroid;
19-hydroxy steroid;
3beta-hydroxy steroid;
5beta-hydroxy steroid
EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor1993199331.0low001000
ethidium homodimer-11953195371.0low010000
clove1985200232.5low021100
acid phosphatase1970201527.0low031130
mefloquine1982201427.0low912652650
bleomycetin1994199430.0low001000
1,4,5,8,9,12-hexaazatriphenylene2012201212.0medium000010
rosmanol2001200321.8high000500
salvianolic acid cbenzofurans201520197.0low000020
lyoniside1981198143.0low010000
mogrolhydroxy seco-steroid;
tetracyclic triterpenoid
antineoplastic agent202220222.0medium000001
nadorganophosphate oxoanioncofactor;
human metabolite;
hydrogen acceptor;
Saccharomyces cerevisiae metabolite
1965201920.5low0351090
cytochrome c-t2003202313.0low00013101
mf63 compound2007201612.4high000230
melitten1993200028.0low008000
ceruletideoligopeptidediagnostic agent;
gastrointestinal drug
1996202213.2low001111
atrial natriuretic factorpolypeptide2008200816.0low000100
glycoprotein e2, hepatitis c virus201920195.0low000010
gramicidin a1956195668.0low020000
glucagonpeptide hormone2006200618.0low000100
iberiotoxin2008200915.5low000200
tannins2011201113.0low000010
oligonucleotides1994201918.9low005760
glucagon-like peptide 1201720177.0low000010
celluloseglycoside1998201516.9low001420
endothelin-12002200917.6low000500
phosphatidylcholines1,2-diacyl-sn-glycero-3-phosphocholine1987202022.0low023420
atractyloside1973197550.0low020000
chlorophyll achlorophyll;
methyl ester
cofactor1967202012.6low0104140
thimerosalalkylmercury compoundantifungal drug;
antiseptic drug;
disinfectant;
drug allergen
1998200025.0low002000
hoe 333422009200915.0low000100
sphingosine kinase202020204.0low000010
ubiquinone1968201729.3low011010
1,3,4-oxadiazol-2(3h)-one2013201311.0medium000010
calpain201720205.7low000030
miltiradieneabietadiene;
carbotricyclic compound
plant metabolite201520159.0low000010
sapogenins202220222.0low000001
chitosan200220237.7low000132
nnc 55-0396hydrochlorideangiogenesis inhibitor;
antineoplastic agent;
apoptosis inducer;
neuroprotective agent;
potassium channel blocker;
T-type calcium channel blocker
201720177.0low000010
15-deoxyprostaglandin j22004200420.0low000100
cep 89832013201311.0high000020
bucladesine3',5'-cyclic purine nucleotide1974200031.8low013000
tert-butoxide, potassium201620168.0low000010
tanshinone ii a sodium sulfonate1981202311.2high566208515
stearates2004200420.0low000100
sodium glutamatemonosodium glutamateflavouring agent2011201113.0low000010
chiniofon1984198440.0low010000
arginine1976197648.0low010000
olaparibcyclopropanes;
monofluorobenzenes;
N-acylpiperazine;
phthalazines
antineoplastic agent;
apoptosis inducer;
EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor
201720215.5low000031
picrotoxinin1999199925.0low001000
methyl jasmonate2007202010.1low000350
beta-Elemonic acidtriterpenoid202020204.0medium000010
gdc 0449benzamides;
monochlorobenzenes;
pyridines;
sulfone
antineoplastic agent;
Hedgehog signaling pathway inhibitor;
SMO receptor antagonist;
teratogenic agent
202020204.0low000010
picrotoxin1999199925.0low001000
rosettacin2012201212.0medium000010
insulin, isophane2006200916.5low000200
oxymatrine2014201410.0low000010
niraparib2-[4-(piperidin-3-yl)phenyl]-2H-indazole-7-carboxamideantineoplastic agent;
apoptosis inducer;
EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor;
radiosensitizing agent
201720177.0low000010
mk 2206organic heterotricyclic compoundEC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor202020204.0low000010
navitoclaxaryl sulfide;
monochlorobenzenes;
morpholines;
N-sulfonylcarboxamide;
organofluorine compound;
piperazines;
secondary amino compound;
sulfone;
tertiary amino compound
antineoplastic agent;
apoptosis inducer;
B-cell lymphoma 2 inhibitor
2014201410.0low000010
pervanadate2005200519.0low000100
4,4-difluoro-4-bora-3a,4a-diaza-s-indaceneBODIPY compound200820218.7low000111
cardiovascular agents1981202124.7low355612
neurotensinpeptide hormonehuman metabolite;
mitogen;
neurotransmitter;
vulnerary
2011201113.0low000010
mannans2003200321.0low000100
gsk 2126458aromatic ether;
difluorobenzene;
pyridazines;
pyridines;
quinolines;
sulfonamide
anticoronaviral agent;
antineoplastic agent;
autophagy inducer;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor;
mTOR inhibitor;
radiosensitizing agent
202120213.0low000001
ixazomibbenzamides;
boronic acids;
dichlorobenzene;
glycine derivative
antineoplastic agent;
apoptosis inducer;
drug metabolite;
orphan drug;
proteasome inhibitor
202120213.0low000001
kurarinone2014201410.0low000010
peptones2008202310.2low000121
glycolipids2001202211.1low0008172
piperidines1972202129.2low01613101
manassantin a2012201212.0low000010
interleukin-81999202115.2low0021051
sofosbuvirisopropyl ester;
L-alanyl ester;
nucleotide conjugate;
organofluorine compound;
phosphoramidate ester
antiviral drug;
hepatitis C protease inhibitor;
prodrug
201920195.0low000010
bufadienolidebufadienolides2004200420.0low000100
14-o-phosphonooxymethyltriptolide201220238.3high0000262
dinaciclibpyrazolopyrimidine2014201410.0low000010
abt-199aromatic ether;
C-nitro compound;
monochlorobenzenes;
N-alkylpiperazine;
N-arylpiperazine;
N-sulfonylcarboxamide;
oxanes;
pyrrolopyridine
antineoplastic agent;
apoptosis inducer;
B-cell lymphoma 2 inhibitor
202020204.0low000010
methylcellulose1972200730.3low010200
heme1988199930.5low011000
chondroitin1966196658.0low010000
2,3-dihydro-2,5-dihydroxy-4h-benzopyran-4-one2012201212.0medium000010
ascorbic acidascorbic acid;
vitamin C
coenzyme;
cofactor;
flour treatment agent;
food antioxidant;
food colour retention agent;
geroprotector;
plant metabolite;
skin lightening agent
1964202225.1low043451
tetracycline1973200436.0low222100
oxytetracycline, anhydrous1974201728.5low010010
minocycline2010202110.0low000111
salicylatesmonohydroxybenzoateplant metabolite1974202122.2low020611
dicumarolhydroxycoumarinanticoagulant;
EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor;
Hsp90 inhibitor;
vitamin K antagonist
1994201620.2low002310
laquinimodaromatic amide2011201113.0low000010
warfarinbenzenes;
hydroxycoumarin;
methyl ketone
1962202025.6low033540
metastat2014201410.0low000010
teriflunomide(trifluoromethyl)benzenes;
aromatic amide;
enamide;
enol;
nitrile;
secondary carboxamide
drug metabolite;
EC 1.3.98.1 [dihydroorotate oxidase (fumarate)] inhibitor;
hepatotoxic agent;
non-steroidal anti-inflammatory drug;
tyrosine kinase inhibitor
2011201113.0low000010
mna 7152004200420.0low000100
epidermal growth factor2009201114.0low000110
kaolinitealuminosilicate mineral;
mixture
antidiarrhoeal drug;
excipient
2001202313.4low000941
clay1998202214.7low0011882
charybdotoxin2011201511.0low000020
lead radioisotopes2005200519.0low000100
transforming growth factor beta1999202013.7low002270
phytoestrogens2000201814.0low001120
okadaic acidketal202220222.0low000001
pyrethrins202020204.0low000010
stemofoline2011201113.0low000010
agar2006200817.0low000200
cyclin d12005202011.5low000560
contraceptives, postcoital1974197450.0low010000
oligomycins1973197450.4low090000
illite2010201014.0low000100
asbestos, crocidolite1986198638.0low010000
phthalocyaninephthalocyanines;
tetrapyrrole fundamental parent
2011201113.0low000010
benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone2005201912.4low000340
nitrophenols1965202128.8low030111
bassianolidecyclodepsipeptide;
cyclooctadepsipeptide
antineoplastic agent;
fungal metabolite;
insecticide
2002201611.8low000130
glaucarubin1980198940.6high0350000
hyaluronoglucosaminidase1995199529.0low001000
nephrin2008202010.7low000120
carboxyatractyloside1973197351.0low010000
ginkgolide b1997199727.0low001000
oridonin201720177.0low000010
ailanthone1981198143.0low010000
morroniside201820186.0low000010
gibberellins200620199.5low000130
sorbicillinol201920195.0low000010
trichodermin1977197846.5low020000
nifedipine201820186.0low000010
peoniflorin200820199.5low000130
vitamin b 122001201516.0low000110
aconitine201920195.0low000010
s 8932aromatic amine;
C-nucleoside;
carboxylic ester;
nitrile;
phosphoramidate ester;
pyrrolotriazine
anticoronaviral agent;
antiviral drug;
prodrug
202120213.0low000001
transforming growth factor alpha1997200125.0low001100
as 1411201620168.0low000010
wilforgineacetate ester;
dihydroagarofuran sesquiterpenoid;
furans;
macrocyclic lactone;
organic heteropentacyclic compound;
pyridine alkaloid
plant metabolite2008201711.0high000120
cyclosporine1998201420.1low007530
silybin202020204.0low000010
digitonin1974197450.0low020000
catalpol201920204.5low000020
jarosite202020204.0low000010
sparsomycin1977197747.0low010000
phenanthroindolizidine2006201611.2high0002100
phenanthroquinolizidine2006201414.0high000210
orabase201320225.0low000012
thromboplastin2001202113.4low000311
muramidase1969201727.7low020310
amyloid beta-peptides2004201413.8low000130
chondroitin sulfates2000200024.0low001000
nu 1025phenols;
quinazolines
EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor2004200519.5low000200
cyclic gmp3',5'-cyclic purine nucleotide;
guanyl ribonucleotide
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
1993201718.0low001110
deoxyguanosinepurine 2'-deoxyribonucleoside;
purines 2'-deoxy-D-ribonucleoside
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
1987200429.6low037200
deoxyinosinepurine 2'-deoxyribonucleoside;
purines 2'-deoxy-D-ribonucleoside
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
1987198737.0low010000
2'-deoxyguanosine 5'-phosphatedeoxyguanosine phosphate;
guanyl deoxyribonucleotide;
purine 2'-deoxyribonucleoside 5'-monophosphate
Escherichia coli metabolite;
mouse metabolite
1994199430.0low001000
guanosine monophosphateguanosine 5'-phosphate;
purine ribonucleoside 5'-monophosphate
biomarker;
Escherichia coli metabolite;
metabolite;
mouse metabolite
1994201519.5low001010
guanosine triphosphateguanosine 5'-phosphate;
purine ribonucleoside 5'-triphosphate
Escherichia coli metabolite;
mouse metabolite;
uncoupling protein inhibitor
1976201135.7low020010
guanine2-aminopurines;
oxopurine;
purine nucleobase
algal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
1975201924.0low023130
guanosineguanosines;
purines D-ribonucleoside
fundamental metabolite1973199243.4low041000
hypoxanthinenucleobase analogue;
oxopurine;
purine nucleobase
fundamental metabolite2001200123.0low000100
inosineinosines;
purines D-ribonucleoside
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
1977200833.3low020100
folic acidfolic acids;
N-acyl-amino acid
human metabolite;
mouse metabolite;
nutrient
200120228.2low000123
3-methyladenine201320188.0low000030
guanosine 5'-o-(3-thiotriphosphate)nucleoside triphosphate analogue1994199430.0low001000
pheophytin a201420206.0low000040
neopterin1997199727.0low101000
clozapinebenzodiazepine;
N-arylpiperazine;
N-methylpiperazine;
organochlorine compound
adrenergic antagonist;
dopaminergic antagonist;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
environmental contaminant;
GABA antagonist;
histamine antagonist;
muscarinic antagonist;
second generation antipsychotic;
serotonergic antagonist;
xenobiotic
2013201311.0low000010
dacarbazinedacarbazine201420178.5low000020
ganciclovir2-aminopurines;
oxopurine
antiinfective agent;
antiviral drug
2001200421.3low000300
allopurinolnucleobase analogue;
organic heterobicyclic compound
antimetabolite;
EC 1.17.3.2 (xanthine oxidase) inhibitor;
gout suppressant;
radical scavenger
1990200924.3low003400
valganciclovirL-valyl ester;
purines
antiviral drug;
prodrug
2001200123.0low000100
xav939(trifluoromethyl)benzenes;
thiopyranopyrimidine
tankyrase inhibitor201220208.0low000020
trypan blue2009200915.0low000100
methylnitronitrosoguanidinenitroso compoundalkylating agent1977201031.1low040300
8-hydroxy-2'-deoxyguanosineguanosinesbiomarker201920195.0low000010
n-(deoxyguanosin-8-yl)acetylaminofluoreneguanosines1990199034.0low001000
2-naphthol orange201520159.0low000010
remazol black b2014201410.0low000010
prodigiosin1976197648.0low010000
n-(deoxyguanosin-8-yl)-2-aminofluoreneguanosines1990199034.0low001000
bmn 673201720215.0low000011
cyanine dye 3201920195.0low000010
cholestyramine resin2012201212.0low000010
eye1980200730.5low010100
acetylcellulose201520159.0low000010
ferroquine202020204.0low000010
wilforine2008201711.2high000130
pseudolaric acid b2007200717.0low000100
mordenite2012201212.0low000010
concanavalin a1994201020.8low002300
chlorotoxin2014201410.0low000010
nk3142007202012.0high000340
dinitrobenzenes2007201711.3low000120
phosphorus radioisotopes1974200134.9low066200
leptin2009200915.0low000100
pyrimidinones1970197054.0low010000
ConditionIndicatedStudiesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
2019 Novel Coronavirus Disease0202020213.5low000011
A-V Dissociation01993201720.7low002010
Abdominal Migraine0202120213.0low000001
Abnormalities, Autosome01973201936.5low071210
Abnormalities, Cardiovascular02013201311.0low000010
Abnormalities, Drug-Induced01967201328.7low010110
Abscess01966196658.0low010000
Abscess, Amebic01956195966.1low0170000
Abscess, Pulmonary01962196262.0low010000
Absence Seizure01969197452.3low130000
Absence Status02014201410.0low000010
Academic Disorder, Developmental0201620168.0low000010
Ache02001201613.8low000330
Acid Aspiration Syndrome02011201113.0low000010
Acne01980202223.8low030021
Acne Vulgaris01980202223.8low030021
Acquired Immune Deficiency Syndrome0201920195.0low000010
Acquired Immunodeficiency Syndrome0201920195.0low000010
Actinic Reticuloid Syndrome01972197351.5low020000
Acute Brain Injuries02005201612.0low000240
Acute Confusional Senile Dementia0200220229.6low0006174
Acute Coronary Syndrome0201520216.0low100011
Acute Disease01974202225.8low9118441
Acute Edematous Pancreatitis02005202212.8low000311
Acute Hepatic Failure02014201410.0low000010
Acute Hypercapnic Respiratory Failure0201520159.0low000010
Acute Ischemic Stroke0202220222.0low000001
Acute Kidney Failure01999201914.3low002360
Acute Kidney Injury01999201914.3low002360
Acute Kidney Tubular Necrosis01974200231.7low010200
Acute Liver Injury, Drug-Induced0198420238.4low0215409
Acute Lung Injury0200920229.8low000171
Acute Lymphoid Leukemia02004201612.0low000260
Acute Myelogenous Leukemia0200720228.8low000382
Acute Onset Vascular Dementia0201020198.0low000120
Acute Pain02014201410.0low000010
Acute Promyelocytic Leukemia01991201718.5low0031110
Acute Respiratory Distress Syndrome01994202116.5low001001
Addiction, Opioid02001200123.0low000100
Addison Disease01970197054.0low010000
Addison's Disease01970197054.0low010000
Adenocarcinoma01964202114.8low0219161
Adenocarcinoma Of Kidney0201120179.7low000030
Adenocarcinoma of Lung0201220208.3low000060
Adenocarcinoma, Basal Cell01964202114.8low0219161
Adenoma01979201828.2low031110
Adenoma, Basal Cell01979201828.2low031110
Adenoma, Prostatic0201720177.0low000010
Adhesions, Tissue0201220198.3low000030
Adjuvant Arthritis01980202113.5low02112173
Adolescent Gynecomastia01973197351.0low010000
ADPKD02008202110.8low000211
Adrenal Cancer02011201113.0low000010
Adult Fanconi Syndrome01997200223.8low003300
Adult Spinal Muscular Atrophy02012201212.0low000010
Adverse Drug Event01973202310.6low010024
African Lymphoma02001201813.7low000120
African Sleeping Sickness01954195470.0low010000
Age-Related Memory Disorders02007201613.0low000320
Age-Related Osteoporosis0201020208.5low000130
Aggression01967196757.0low010000
Aging02002201811.8low000350
Agnogenic Myeloid Metaplasia0201920195.0low000010
AIDS-Related Opportunistic Infections02001200123.0low000100
Airflow Obstruction, Chronic0201820205.0low000020
Airway Hyper-Responsiveness02005200519.0low000100
Airway Remodeling02007202011.0low000240
Albuminuria0201220189.0low000020
Alcohol Abuse01966196658.0low010000
Alcohol Drinking02006200618.0low000100
Alcoholic Fatty Liver0201720186.5low000020
Alcoholic Liver Diseases02008200816.0low000100
Alcoholism01966196658.0low010000
Aldosteronism01970197054.0low010000
Allergic Contact Dermatitis01993200526.6low007200
Allergic Encephalomyelitis02002201515.9low000720
Allergic Reaction01965202025.7low010110
Allergy, Drug01973200840.6low151100
Allodynia02007202111.4low000331
Alloxan Diabetes01975202313.1low01011132
Alveolar Bone Atrophy02003200321.0low000100
Alveolitis, Fibrosing0199420229.3low001171
Alzheimer Disease0200220229.6low0006174
Amebiasis01956195966.1low0170000
Amebiasis, Intestinal01956196965.4low0160000
Amnesia01994201022.0low001100
Amnesia-Memory Loss01994201022.0low001100
Amyloid Deposits02009200915.0low000100
Amyloidosis02007200717.0low000100
Anaphylactic Reaction01980199735.5low011000
Anaphylaxis01980199735.5low011000
Anaplasia01977197747.0low010000
Anasarca01970202021.3low054880
Androgen-Independent Prostatic Cancer0201420178.5low000020
Androgenization01970197054.0low010000
Anemia01967201925.7low110110
Anesthesia01970199641.0low011000
Angina at Rest0200920237.3low100111
Angina Pectoris01981202316.0low010102
Angina, Unstable0200920237.3low100111
Angiogenesis, Pathologic02000202210.0low0013171
Angioma0202120213.0low000001
Angiospasm, Intracranial0201820186.0low000010
Angor Pectoris01981202316.0low010102
Animal Diseases02001200123.0low000100
Animal Mammary Carcinoma01963196460.5low020000
Ankylosing Spondylarthritis0201820224.3low000021
Anochlesia01978197846.0low010000
Anoxemia01990202214.2low002451
Anoxia-Ischemia, Brain02005200718.0low000200
Anterior Cerebral Circulation Infarction02007200717.0low000100
Anterior Choroidal Artery Infarction02006200916.3low000300
Anterior Circulation Transient Ischemic Attack02006202112.8low000301
Anxiety0201420169.3low000030
Aortic Stenosis0201120218.0low000011
Aortic Valve Stenosis0201120218.0low000011
Apoplexy02001202211.3low100672
Appendicitis01993199430.5low002000
Arachnoidal Cerebellar Sarcoma, Circumscribed0201620187.0low000020
Arrhythmia01963202326.0low046522
Arrhythmias, Cardiac01963202326.0low046522
Arsenic Encephalopathy02003200321.0low000100
Arterial Obstructive Diseases02004200420.0low000100
Arterial Occlusive Diseases02004200420.0low000100
Arteriosclerosis, Coronary01999201716.3low101110
Arthritis01964202126.6low020311
Arthritis, Degenerative0201020217.1low000142
Arthritis, Rheumatoid01969202211.4low616132711
Ascites01960196761.0low030000
Asthma01980202319.0low124861
Asthma, Bronchial01980202319.0low124861
Astrocytoma, Grade IV0200720217.9low000172
Astrocytosis02008201413.3low000210
Asymmetric Diabetic Proximal Motor Neuropathy02004201017.0low000200
Asystole02005200519.0low000100
At-V10202220222.0low000002
Ataxia01993199331.0low001000
Ataxia Telangiectasia02011201113.0low000010
Ataxia Telangiectasia Syndrome02011201113.0low000010
Atherogenesis02005202210.7low000491
Atheroma02011201113.0low000010
Atherosclerosis02005202210.7low000491
Atherosclerotic Parkinsonism0201920195.0low000010
ATLL01999201517.0low001010
Atrial Fibrillation0201820234.3low000021
Atrioventricular Block0201720177.0low000010
Atrioventricular Conduction Block0201720177.0low000010
Atrioventricular Nodal Re-Entrant Tachycardia01994200126.5low001100
Atrophy01967200239.5low010100
Atrophy, Muscle0201720205.0low000030
Atypical Lipomatous Tumor0202120213.0low000001
Atypical Mycobacterial Infection, Disseminated02011201113.0low000010
Aura01991201816.3low001020
Auricular Fibrillation0201820234.3low000021
Autism0202120213.0low000001
Autistic Disorder0202120213.0low000001
Autoimmune Diabetes02003201316.3low000210
Autoimmune Disease02003202111.2low000131
Autoimmune Diseases02003202111.2low000131
Autosomal Dominant Juvenile Parkinson Disease02006201215.3low000210
Autosomal Hemophilia A01959195965.0low010000
Avian Diseases01981198143.0low010000
B-Cell Chronic Lymphocytic Leukemia0201520159.0low000010
B-Cell Lymphoma02006201515.0low000210
B16 Melanoma02003201614.0low000230
Bacterial Disease01990200228.0low001100
Bacterial Endocarditides01966196658.0low010000
Bacterial Infections01990200228.0low001100
Bacterial Meningitides02003200321.0low000100
Bacterial Pneumonia02005200519.0low000100
Balkan Endemic Nephropathy01999200622.0low001300
Bed Sores01964196460.0low010000
Behavior Disorders02007201613.2low000220
Benign Cerebellar Neoplasms0201620187.0low000020
Benign Neoplasms01946202319.4low119121478
Benign Neoplasms, Brain0200720209.2low0002100
Berger Disease0201520225.8low000031
Besnier-Boeck Disease01970197054.0low010000
Bilateral Headache01973197351.0low010000
Bilateral Wilms Tumor0201920195.0low000010
Bile Duct Cancer01998201718.2low001310
Bile Duct Neoplasms01998201718.2low001310
Bile Duct Obstruction0202120213.0low000001
Bilharziasis02013201410.5low000020
Black Water Fever01992200227.0low003100
Bladder Cancer01972202118.1low011231
Bladder Neck Obstruction0201520159.0low000010
Blast Crisis02009202010.3low000120
Blast Phase02009202010.3low000120
Bleeding0201320188.5low000020
Blood Clot01984201820.3low010110
Blood Coagulation Disorders01994199430.0low001000
Blood Poisoning02003202010.4low000270
Blood Pressure, High0201220226.4low000041
Blood Pressure, Low01982200733.7low020100
Body Weight01961202319.2low33517121
Body Weight, Fetal0202320231.0low000001
Bone Cancer0198520229.1low010072
Bone Diseases02008200816.0low000100
Bone Loss, Osteoclastic02004202011.5low000560
Bone Loss, Perimenopausal02008201512.5low000110
Bone Neoplasms0198520229.1low010072
Bovine Diseases01952195272.0low020000
Bowel Diseases, Inflammatory0201720214.7low000021
Bradyarrhythmia01993201318.6low001220
Bradycardia01993201318.6low001220
Brain Diseases02005200519.0low000100
Brain Disorders02005200519.0low000100
Brain Edema02007201512.7low000120
Brain Hemorrhage, Cerebral02008201811.0low000110
Brain Infarction02007200717.0low000100
Brain Inflammation02008201712.3low000210
Brain Injuries02005201612.0low000240
Brain Injuries, Traumatic0201720177.0low000010
Brain Ischemia02001202212.4low10012112
Brain Neoplasms0200720209.2low0002100
Brain Swelling02007201512.7low000120
Brain Vascular Disorders01964201623.5low010120
Breast Cancer01958202214.9low26417454
Breast Neoplasms01958202214.9low26417454
Bronchial Diseases01955196265.5low020000
Bronchial Hyperreactivity0202020204.0low000010
Bronchial Neoplasms01968196856.0low010000
Bronchial Spasm01955195569.0low010000
Bronchitis01998199826.0low001000
Bronchospasm01955195569.0low010000
Burkitt Lymphoma02001201813.7low000120
Burns02012201212.0low000010
Cachexia0202020204.0low000010
Calcification, Pathologic02007202110.0low000101
Calcinosis02007202110.0low000101
Calcinosis-Raynaud Phenomenon-Sclerodactyly-Telangiectasia02001200123.0low000100
Cancer of Cervix01995201915.4low001540
Cancer of Colon01991202110.9low00112204
Cancer of Endometrium02010201511.0low000120
Cancer of Esophagus01987201921.0low010010
Cancer of Gallbladder02014201410.0low000010
Cancer of Gastrointestinal Tract0201620168.0low000010
Cancer of Head0200220227.8low000123
Cancer of Intestines01966196658.0low010000
Cancer of Kidney01966201725.9low022230
Cancer of Larynx01991201322.0low001010
Cancer of Liver01963202317.7low110512247
Cancer of Lung01963202213.8low3133116610
Cancer of Mouth01970202121.9low030231
Cancer of Nasopharynx01974202119.9low030151
Cancer of Ovary0200820227.1low0002184
Cancer of Pancreas0200620228.9low000124510
Cancer of Pelvis02002200222.0low000100
Cancer of Pituitary02000201812.3low001020
Cancer of Prostate02007202110.2low0003241
Cancer of Skin01963202238.1low0392461
Cancer of Stomach01983202316.3low014673
Cancer of the Thyroid0200920218.3low000223
Cancer of the Tongue0201420178.5low000020
Cancer of the Ureter01999200124.0low001100
Cancer of the Urinary Tract02000200223.5low004200
Cancer of the Uterus01995199529.0low001000
Cancer Pain0201720177.0low000010
Cancer-Associated Pain0201720177.0low000010
Carbon Tetrachloride Poisoning02001201119.5low000310
Carcinogenesis01953202220.4low030063
Carcinoma01970201627.3low063550
Carcinoma 256, Walker01969201437.7low020010
Carcinoma in Situ01999199925.0low001000
Carcinoma, Anaplastic01970201627.3low063550
Carcinoma, Bronchial01971197153.0low010000
Carcinoma, Bronchogenic01971197153.0low010000
Carcinoma, Ductal, Breast02014201410.0low000010
Carcinoma, Ductal, Pancreatic0201220208.8low000080
Carcinoma, Ehrlich Tumor01960201749.0low060010
Carcinoma, Epidermoid01966201925.6low061470
Carcinoma, Hepatocellular01963202314.0low13213177
Carcinoma, Intraepithelial01999199925.0low001000
Carcinoma, Lewis Lung0201920195.0low000010
Carcinoma, Non-Small Cell Lung0200820226.5low0001277
Carcinoma, Non-Small-Cell Lung0200820226.5low0001277
Carcinoma, Ovarian Epithelial0201420215.3low000051
Carcinoma, Pancreatic Ductal0201220208.8low000080
Carcinoma, Papillary02002200222.0low000100
Carcinoma, Renal Cell0201120179.7low000030
Carcinoma, Squamous Cell01966201925.6low061470
Carcinoma, Squamous Cell of Head and Neck0201920213.7low000012
Carcinoma, Transitional Cell01966200228.1low012400
Cardiac Arrest, Sudden01994200922.7low001200
Cardiac Death02002200222.0low000100
Cardiac Diseases01993202316.4low005251
Cardiac Edema02011201113.0low000010
Cardiac Failure01970202214.1low010123
Cardiac Hypertrophy02001201618.0low000810
Cardiac Remodeling, Ventricular0200320228.2low100141
Cardiac Rupture, Traumatic0201620168.0low000010
Cardiac Toxicity0201620234.4low000084
Cardiomegaly02001201618.0low000810
Cardiometabolic Syndrome02005201711.7low000120
Cardiomyopathies0201620216.3low000021
Cardiomyopathies, Primary0201620216.3low000021
Cardiomyopathy, Chagas0201820186.0low000010
Cardiomyopathy, Hypertrophic02001200819.5low000200
Cardiomyopathy, Hypertrophic Obstructive02001200819.5low000200
Cardiotoxicity0201620234.4low000084
Cardiovascular Abnormalities02013201311.0low000010
Cardiovascular Diseases02000202110.3low101342
Cardiovascular Stroke01981202216.4low021762
Carditis0201920195.0low000010
Carotid Arteriopathies, Traumatic02004201017.3low000300
Carotid Artery Narrowing02004200619.0low000200
Carotid Stenosis02004200619.0low000200
Celiac Disease0201620168.0low000010
Celiac Sprue0201620168.0low000010
Cell Transformation, Neoplastic01968202227.7low0104571
Cell Transformation, Viral01980200332.5low010100
Central Hypothyroidism0201520159.0low000010
Central Nervous System Disease02013201311.0low000010
Central Nervous System Diseases02013201311.0low000010
Cerebral Hemorrhage02008201811.0low000110
Cerebral Infarction02006200916.3low000300
Cerebral Infarction, Middle Cerebral Artery02001202212.2low000872
Cerebral Ischemia02001202212.4low10012112
Cerebral Malaria01992201423.0low002010
Cerebrovascular Disorders01964201623.5low010120
Chagas Cardiomyopathy0201820186.0low000010
Chemical and Drug Induced Liver Injury0198420238.4low0215409
Chemical Dependence01966196956.5low020000
Cholangiocarcinoma01998201716.8low001320
Cholangiocellular Carcinoma01998201716.8low001320
Cholera01974197450.0low010000
Cholestasis0202120213.0low000001
Choroid Neovascularization0202020204.0low000010
Chromosomal Fragility02013201311.0low000010
Chromosomal Translocation01976200434.0low010100
Chromosome-Defective Micronuclei02002201216.7low000210
Chronic Disease01967201824.7low020520
Chronic Hepatitis C0201920195.0low000020
Chronic Illness01967201824.7low020520
Chronic Kidney Diseases0201020199.5low000110
Chronic Kidney Failure01998200223.8low006300
Chronic Lung Injury0201920214.0low000011
Chronic Pain0201220179.5low000020
Chronic Pancreatitis0202020204.0low000010
Cicatrix0201320226.5low000011
Cicatrix, Hypertrophic0201620168.0low000010
Cicatrization0201320226.5low000011
Circulatory Collapse02002200222.0low000200
Cirrhoses, Experimental Liver02002201117.5low000110
Cirrhosis01996202212.2low1027145
Cirrhosis, Liver0201320226.0low100043
Clinically Isolated CNS Demyelinating Syndrome02008201512.5low000110
Coagulation Disorders, Blood01994199430.0low001000
Coagulation, Disseminated Intravascular0201220179.5low000020
Cocarcinogenesis01979199340.5low051000
Cognition Disorders0201420159.5low000020
Cognitive Decline0201620224.2low000033
Cognitive Dysfunction0201620224.2low000033
Colitis02001202210.8low000763
Colitis Gravis0202020204.0low000010
Colitis-Associated Cancer0202020204.0low000010
Colitis, Granulomatous02010201910.7low100150
Colitis, Mucous0202320231.0low000001
Colitis, Ulcerative0202020204.0low000010
Colonic Diseases, Functional01970197054.0low010000
Colonic Neoplasms01991202110.9low00112204
Colorectal Cancer0200820227.7low0003125
Colorectal Neoplasms0200820227.7low0003125
Communicable Diseases01963196361.0low020000
Community Acquired Infection02003200321.0low000100
Complication, Intraoperative0201520159.0low000010
Complication, Postoperative01999201912.3low001150
Complications of Diabetes Mellitus0202020204.0low000010
Complications, Parasitic Pregnancy01993199828.5low002000
Complications, Pregnancy02012201212.0low000010
Condition, Preneoplastic01975201127.0low012110
Congestive Ophthalmopathy02006200618.0low000100
Connective Tissue Diseases0202220222.0low000001
Contact Dermatitis01970199737.2low0117000
Convulsions, Febrile01992199232.0low001000
Corneal Angiogenesis0201720177.0low000010
Corneal Diseases02008200816.0low000100
Corneal Neovascularization0201720177.0low000010
Coronary Artery Disease01999201716.3low101110
Coronary Disease01984202316.4low120131
Coronary Heart Disease01984202316.4low120131
Coronary Occlusion0201520159.0low000010
Coronary Restenosis02005200718.3low000300
Coronavirus Infections0201020207.2low000130
Cough01957200746.3low020100
Cranial Nerve II Injuries0201720177.0low000010
Crohn Disease02010201910.7low100150
Cross Infection02003200321.0low000100
Cryptogenic Fibrosing Alveolitis0201820186.0low000010
Curling Ulcer01968197353.7low230000
Cystadenocarcinoma, Serous02012201212.0low000010
Cystadenoma01969197253.5low020000
Cystic Echinococcosis01994199430.0low001000
Cystic Fibrosis02014201410.0low000010
Cystic Fibrosis of Pancreas02014201410.0low000010
Cytomegaloviral Retinitis02001200123.0low000100
Cytomegalovirus01979199338.0low011000
Cytomegalovirus Retinitis02001200123.0low000100
Deafness, Transitory02003200321.0low000100
Death, Sudden02001200123.0low000200
Death, Sudden, Cardiac01994200922.7low001200
Deficiency Diseases01987198737.0low010000
Deficiency, Glucosephosphatase01997199727.0low001000
Degenerative Disc Disease0202020213.7low000021
Degenerative Diseases, Central Nervous System0200220227.8low000233
Dehydration01958195866.0low010000
Delayed Effects, Prenatal Exposure0200820237.8low000122
Delayed Hypersensitivity01977201828.3low031120
Dementia Praecox02013201311.0low000010
Dementia, Vascular0201020198.0low000120
Demyelinating Diseases02008201512.5low000110
Depression01979201720.0low110020
Dermatitis0201720177.0low000010
Dermatitis Medicamentosa01977199138.3low121000
Dermatitis, Allergic Contact01993200526.6low007200
Dermatitis, Atopic01981201824.5low010010
Dermatitis, Contact01970199737.2low0117000
Dermatitis, Contact, Phototoxic02011201113.0low000010
Dermatitis, Eczematous01983200029.8low014000
Dermatitis, Irritant01995199529.0low001000
Dermatitis, Occupational01994199728.7low003000
Dermatomycoses01999199925.0low001000
Dermatoses01972200729.0low010200
Developmental Psychomotor Disorders02004200420.0low000100
Di Guglielmo Disease01995201022.7low002100
Diabetes Mellitus0201020224.3low000114
Diabetes Mellitus, Adult-Onset0200620229.2low000141
Diabetes Mellitus, Gestational0202020232.5low000011
Diabetes Mellitus, Type 102003201316.3low000210
Diabetes Mellitus, Type 20200620229.2low000141
Diabetes, Gestational0202020232.5low000011
Diabetic Angiopathies02001200123.0low000100
Diabetic Cardiomyopathies0201320217.8low000031
Diabetic Glomerulosclerosis0200520227.9low100495
Diabetic Nephropathies0200520227.9low100495
Diabetic Neuropathies02004201017.0low000200
Diabetic Retinopathy02004201713.3low000120
Diarrhea01971199441.5low111000
Diarrhea, Infantile01967196757.0low010000
Diathesis02011201312.0low100020
Diffuse Large B-Cell Lymphoma01998200920.5low001100
Diffuse Mixed Small and Large Cell Lymphoma01971201128.0low010110
Diffuse Parenchymal Lung Disease0202220222.0low000001
Disbacteriosis0202120213.0low000001
Disease01955196265.5low020000
Disease Exacerbation01996202112.4low101491
Disease Models, Animal01970202311.8low0556112517
Disease Resistance0201720177.0low000010
Disease, Pulmonary01989201221.8low011210
Diseases, Metabolic0202120213.0low000001
Diseases, Occupational01980200330.7low023100
Disorders, Sex Chromosome01959195965.0low010000
Disseminated Intravascular Coagulation0201220179.5low000020
Dizziness01994199430.0low101000
Dizzyness01994199430.0low101000
Drop Attack01994199430.0low001000
Drug Hypersensitivity01973200840.6low151100
Drug Overdose01992199232.0low001000
Drug Withdrawal Symptoms01967201830.8low220210
Drug-Related Side Effects and Adverse Reactions01973202310.6low010024
Ductus Arteriosus, Patent02011201113.0low000010
Duodenal Diseases01970197054.0low010000
Duodenal Ulcer01968197353.7low230000
Dyslipidemia0201520159.0low000010
Dyslipidemias0201520159.0low000010
Dysmyelopoietic Syndromes02005201614.0low000210
Dysplastic Nevus Syndrome, Hereditary0202220222.0low000001
E coli Infections02002200222.0low000100
Eczema01983200029.8low014000
Eczema, Atopic01981201824.5low010010
Edema01970202021.3low054880
Edema-Proteinuria-Hypertension Gestosis02005201711.8low000140
Edema, Cardiac02011201113.0low000010
Edema, Pulmonary01998201119.5low001010
EHS Tumor01953196963.8low080000
Elaeophoriasis01994199430.0low001000
Electrocardiogram QT Prolonged01993201223.3low4081210
Electrolytes01963201429.0low010110
Electron Transport Chain Deficiencies, Mitochondrial02014201410.0low000010
Emaciation0202220222.0low000001
Embolism0202120213.0low000001
Embolus0202120213.0low000001
Embryopathies02003200321.0low000100
Emergencies01999199925.0low001000
Emesis01975202131.0low121001
Encephalitis02008201712.3low000210
Encephalitis, Polio01962197058.0low020000
Encephalomyopathies, Mitochondrial02014201410.0low000010
Encephalopathy, Hepatic0202120213.0low100001
Encephalopathy, Toxic02003201914.4low000320
Encephalopathy, Traumatic0201720177.0low000010
Endocarditis, Bacterial01966196658.0low010000
Endocarditis, Loeffler02009200915.0low000100
Endometrial Neoplasms02010201511.0low000120
Endometrioma01970202319.0low010111
Endometriosis01970202319.0low010111
Endomyocardial Fibrosis0202020204.0low000010
Endotoxemia02001202114.0low000521
Endotoxin Shock01993202112.8low001112
Enlarged Spleen01963200637.3low011100
ENT Diseases01967196856.5low020000
Enteritis02005200519.0low000100
Envenomation, Snakebite01999199925.0low001000
Epilepsy01991201816.3low001020
Epithelial Neoplasms02008201810.7low000120
Epithelial Ovarian Cancer0201420215.3low000051
ER-Negative PR-Negative HER2-Negative Breast Cancer0201320215.7low000061
Erectile Dysfunction0201720177.0low000010
Erythema02010201014.0low000100
Escherichia coli Infections02002200222.0low000100
Esophageal Neoplasms01987201921.0low010010
Esophageal Squamous Cell Carcinoma0201920195.0low000010
Exertional Heat Illness0201720177.0low000010
Experimental Hepatoma01986202119.9low015231
Experimental Leukemia01959198646.6low090000
Experimental Lung Inflammation0201020209.6low000140
Experimental Mammary Neoplasms01963202134.3low0116331
Experimental Neoplasms01953202042.7low06842100
Extramembranous Glomerulopathy02010201610.3low000120
Extravascular Hemolysis01968202128.3low056131
Eye Burns0201720177.0low000010
Fasting Hypoglycemia01986200921.2low010400
Fatty Liver02011201511.0low000020
Fatty Liver, Nonalcoholic0201720214.8low000032
Female Genital Neoplasms01970197054.0low010000
Fetal Death01982198242.0low010000
Fetal Growth Restriction02012201212.0low000010
Fetal Growth Retardation02012201212.0low000010
Fetal Resorption01982198242.0low010000
Fever01969201637.0low242110
Fibroadenoma01994199430.0low001000
Fibroid01995199529.0low001000
Fibrosarcoma02009201114.0low000110
Fibrosis01996202212.2low1027145
Fibrosis, Radiation0201520159.0low000010
Filariasis01994199430.0low001000
Fish Diseases01984201121.0low010410
Fistula01959195965.0low010000
Flatulence01970197054.0low010000
Flatus01970197054.0low010000
FMR1-Related Primary Ovarian Insufficiency0201520206.5low000020
Foreign-Body Granuloma01994199430.0low001000
Fowl Paralysis0201320169.7low000030
Friedreich Ataxia0201520168.5low000020
Friedreich Disease0201520168.5low000020
Furrow Keratitis01980198044.0low010000
Gallbladder Neoplasms02014201410.0low000010
Gastric Diseases01970197054.0low010000
Gastric Ulcer01969197253.5low120000
Gastritis, Atrophic02010201014.0low000100
Gastroduodenal Ulcer01968201639.7low120010
Gastroenteritis01974197450.0low010000
Gastroenteritis, Transmissible, of Swine02010201014.0low000100
Genital Neoplasms, Female01970197054.0low010000
Genome Instability0201020209.0low000130
Germinoblastoma01963199741.7low042000
Glaucoma02013201510.0low000020
Glial Cell Tumors02002202010.6low0003110
Glioblastoma0200720217.9low000172
Glioma02002202010.6low0003110
Glomerulonephritis, IGA0201520225.8low000031
Glomerulonephritis, Lupus02006200817.0low000200
Glomerulonephritis, Membranous02010201610.3low000120
Glucose Intolerance0202020213.5low000011
Glucose Metabolic Disorder02014201410.0low000010
Glycogen Storage Disease Type I01997199727.0low001000
Glycosuria01974197450.0low010000
Gout0202120213.0low000001
Granulocytic Leukemia01957201330.3low021310
Granulocytic Leukemia, Chronic02004202111.7low000471
Granuloma01969198547.0low020000
Granulomas01969198547.0low020000
Graves Ophthalmopathy02006200618.0low000100
Grippe01962201734.5low010010
Group A Strep Infection02003202112.0low000101
Gynecomastia01973197351.0low010000
Hallucination of Body Sensation01968196856.0low110000
Hallucinations01968196856.0low110000
Hand Dermatoses01992199530.5low002000
Hand Dermatosis01992199530.5low002000
Hay Fever02010201014.0low000100
Head and Neck Neoplasms0200220227.8low000123
Headache01973197351.0low010000
Health Care Associated Infection02003200321.0low000100
Hearing Loss02003200321.0low000100
Heart Arrest02005200519.0low000100
Heart Disease, Ischemic01996201715.8low001520
Heart Diseases01993202316.4low005251
Heart Failure01970202214.1low010123
Heat Stroke02008201711.5low000110
Heatstroke02008201711.5low000110
Heavy Metal Poisoning0201520159.0low000010
Helicobacter Infections02010201014.0low000100
Hemangioma0202120213.0low000001
Hematologic Malignancies02009202311.0low000301
Hematologic Neoplasms02009202311.0low000301
Hematuria02011201113.0low000010
Hemolysis01968202128.3low056131
Hemophilia A01959195965.0low010000
Hemorrhage0201320188.5low000020
Hemorrhage, Subarachnoid0201620168.0low000010
Hemorrhagic Shock0201720234.0low000011
Hemorrhagic Thrombocythemia0201920195.0low000010
Hepatic Encephalopathy0202120213.0low100001
Hepatitis0201520235.0low000011
Hepatitis C0201920195.0low000010
Hepatitis C, Chronic0201920195.0low000020
Hepatitis, Animal02008200816.0low000100
Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted0201920195.0low000010
Hepatocellular Carcinoma01963202314.0low13213177
Herpes Simplex01978202224.0low010001
Herpes Simplex Virus Infection01978202224.0low010001
Histomoniasis02003200321.0low000100
HIV Coinfection01999200323.0low001100
HIV Infections01999200323.0low001100
Hives01975199539.0low011000
Hormone-Dependent Neoplasms02008200816.0low000100
Hospital-Acquired Condition01973199241.5low011000
HPV Infection02014201410.0low000010
Hyperaldosteronism01970197054.0low010000
Hypercoagulability0202120213.0low000001
Hypereosinophilic Syndrome02009200915.0low000100
Hyperglycemia0201920195.0low000010
Hyperglycemia, Postprandial0201920195.0low000010
Hyperlipemia01999201217.6low001510
Hyperlipidemias01999201217.6low001510
Hyperplasia01972201822.8low031630
Hypersensitivity01965202025.7low010110
Hypertension0201220226.4low000041
Hypertension, Pulmonary02000202214.7low002531
Hypertriglyceridemia02011201113.0low000010
Hypertrophy02008201513.7low000210
Hypertrophy, Left Ventricular0201720177.0low000010
Hypertrophy, Right Ventricular02007200717.0low000100
Hypoglycemia01986200921.2low010400
Hypokalemia02002200222.0low000100
Hypopharyngeal Cancer0201920195.0low000010
Hypopharyngeal Neoplasms0201920195.0low000010
Hypospermatogenesis0202120213.0low000001
Hypotension01982200733.7low020100
Hypotension, Orthostatic01972197252.0low010000
Hypotension, Postural01972197252.0low010000
Hypothyroidism0201520159.0low000010
Hypoxia01990202214.2low002451
Hypoxia-Ischemia, Brain02005200718.0low000200
Idiopathic Inflammatory Myopathies0202220222.0low000001
Idiopathic Parkinson Disease02001202213.2low000741
Idiopathic Pulmonary Fibrosis0201820186.0low000010
IgA Vasculitis02011201312.0low100020
Impaired Glucose Tolerance0202020213.5low000011
Impotence0201720177.0low000010
Infantile Diarrhea01967196757.0low010000
Infantile Respiratory Distress Syndrome01998199826.0low001000
Infarction, Middle Cerebral Artery02001202212.2low000872
Infection01956196662.3low030000
Infection, Wound01966199046.0low011000
Infections01956196662.3low030000
Infections, Coronavirus0201020207.2low000130
Infections, Helicobacter02010201014.0low000100
Infections, Orthomyxoviridae01970197054.0low010000
Infections, Plasmodium01946202242.2low1374451331
Infections, Pneumococcal01967196757.0low020000
Infections, Pseudomonas02005200519.0low000100
Infections, Salmonella0201920195.0low000010
Infections, Staphylococcal01970202116.2low010112
Infections, Staphylococcal Skin01999199925.0low001000
Infectious Diseases01963196361.0low020000
Infertility, Male02002201912.8low000220
Inflammation01963202212.6low054215014
Inflammatory Bowel Diseases0201720214.7low000021
Inflammatory Response Syndrome, Systemic02006200618.0low000100
Influenza, Human01962201734.5low010010
Inhalation Injury, Smoke02012201212.0low000010
Injuries, Radiation0202020204.0low000020
Injuries, Spinal Cord02006202210.2low000351
Injuries, Tendon02012201212.0low000010
Injury, Ischemia-Reperfusion02002202112.6low00017142
Injury, Myocardial Reperfusion01996202113.7low001681
Innate Inflammatory Response01963202212.6low054215014
Insect Bites01992199232.0low001000
Insect Bites and Stings01992199232.0low001000
Insulin Resistance0201120217.2low000072
Insulin Sensitivity0201120217.2low000072
Interstitial Nephritis01996200224.2low103500
Intervertebral Disc Degeneration0202020213.7low000021
Intestinal Diseases01970197054.0low010000
Intestinal Neoplasms01966196658.0low010000
Intestinal Polyps02004200420.0low000100
Intraocular Pressure02013201510.0low000020
Invasiveness, Neoplasm0200620209.3low0004270
Irritable Bowel Syndrome0202320231.0low000001
Ischemia02005201912.7low000210
Ischemic Attack, Transient02006202112.8low000301
Ischemic Stroke0202220222.0low000001
Itching01989199134.3low221000
Kahler Disease02005202011.5low0006130
Kaposi Disease01975198046.5low020000
Kaposi Sarcoma02012201610.0low000020
Kidney Calculi0201620168.0low000010
Kidney Diseases01963202020.6low018670
Kidney Failure01996201920.4low101310
Kidney Failure, Chronic01998200223.8low006300
Kidney Neoplasms01966201725.9low022230
Kidney Stones0201620168.0low000010
Kidney Tubular Necrosis, Acute01974200231.7low010200
Kidney, Polycystic02007201811.5low000110
Koch's Disease01955200741.2low020200
Laryngeal Neoplasms01991201322.0low001010
Learning Disabilities0201620168.0low000010
Left Ventricular Hypertrophy0201720177.0low000010
Leiomyoma01995199529.0low001000
Leishmaniasis, American01999201216.7low001020
Leishmaniasis, Cutaneous01999201216.7low001020
Lesion of Sciatic Nerve02004202012.0low000110
Leucocythaemia01957202222.8low051481
Leukemia01957202222.8low051481
Leukemia L 121001964198449.3low030000
Leukemia P38801981201034.4low074200
Leukemia-Lymphoma, Adult T-Cell01999201517.0low001010
Leukemia, Erythroblastic, Acute01995201022.7low002100
Leukemia, Lymphoblastic, Acute, T Cell02013201510.0low000020
Leukemia, Lymphocytic01976200732.5low010100
Leukemia, Lymphocytic, Chronic, B-Cell0201520159.0low000010
Leukemia, Lymphocytic, T Cell02011201411.5low000020
Leukemia, Lymphoid01976200732.5low010100
Leukemia, Myelogenous, Chronic, BCR-ABL Positive02004202111.7low000471
Leukemia, Myeloid01957201330.3low021310
Leukemia, Myeloid, Acute0200720228.8low000382
Leukemia, Promyelocytic, Acute01991201718.5low0031110
Leukemia, T-Cell02011201411.5low000020
Leukostasis02004200420.0low000100
Libman-Sacks Disease0200620199.3low000120
Liposarcoma0202120213.0low000001
Liver Cirrhosis0201320226.0low100043
Liver Diseases01984202320.5low021521
Liver Diseases, Alcoholic02008200816.0low000100
Liver Diseases, Parasitic02002200222.0low000100
Liver Dysfunction01984202320.5low021521
Liver Failure, Acute02014201410.0low000010
Liver Neoplasms01963202317.7low110512247
Liver Steatosis02011201511.0low000020
Local Neoplasm Recurrence0201720215.0low000011
Long QT Syndrome01993201223.3low4081210
Lung Abscess01962196262.0low010000
Lung Adenocarcinoma0201220208.3low000060
Lung Diseases01989201221.8low011210
Lung Diseases, Interstitial0202220222.0low000001
Lung Injury, Acute0200920229.8low000171
Lung Injury, Ventilator-Induced02010201014.0low000100
Lung Neoplasms01963202213.8low3133116610
Lupus Erythematosus, Systemic0200620199.3low000120
Lupus Nephritis02006200817.0low000200
Lymph Node Metastasis02006200618.0low000100
Lymphatic Diseases02006200618.0low000100
Lymphoma01963199741.7low042000
Lymphoma, B-Cell02006201515.0low000210
Lymphoma, Large B-Cell, Diffuse01998200920.5low001100
Lymphoma, Non-Hodgkin01971201128.0low010110
Lymphoma, Primary Effusion0201620168.0low000020
Lymphoma, T-Cell01996199628.0low001000
Malaria01946202242.2low1374451331
Malaria, Avian01975197549.0low010000
Malaria, Falciparum01991202026.9low3801122060
Malaria, Vivax01947200630.3low9120200
Malignant Melanoma01976202213.1low0202113
Medulloblastoma0201620187.0low000020
Melanoma01976202213.1low0202113
Memory Disorders02007201613.0low000320
Meningitis, Bacterial02003200321.0low000100
Mental Disorders02007201613.2low000220
Mesothelioma01985198539.0low010000
Metabolic Diseases0202120213.0low000001
Metabolic Syndrome02005201711.7low000120
Metastase01970202019.6low2504120
Migraine Disorders0202120213.0low000001
Mitochondrial Diseases02014201410.0low000010
MODS0201720186.5low000020
Morphine Abuse01969197154.0low120000
Morphine Dependence01969197154.0low120000
Mouth Neoplasms01970202121.9low030231
MPTP Neurotoxicity Syndrome02007200717.0low000100
MS (Multiple Sclerosis)02011201113.0low000010
Mucositis0202020213.5low000011
Mucositis, Oral01964196460.0low010000
Multiple Myeloma02005202011.5low0006130
Multiple Organ Failure0201720186.5low000020
Multiple Sclerosis02011201113.0low000010
Muscle Contraction01968202217.9low022262
Muscle Disorders02001200123.0low000100
Muscle Pain0202220222.0low000001
Muscle Relaxation01993200425.5low001100
Muscle Spasm01955197059.0low030000
Muscular Atrophy0201720205.0low000030
Muscular Atrophy, Spinal02012201212.0low000010
Muscular Diseases02001200123.0low000100
Myalgia0202220222.0low000001
Myelodysplastic Syndromes02005201614.0low000210
Myelopathy02004200519.5low000200
Myeloproliferative Disorders02010201014.0low000100
Myocardial Infarction01981202216.4low021762
Myocardial Ischemia01996201715.8low001520
Myocarditis0201920195.0low000010
Myoclonic Jerk01974197450.0low010000
Myositis0202220222.0low000001
Myotonia01971197153.0low010000
Nasopharyngeal Carcinoma0201520216.8low000041
Nasopharyngeal Neoplasms01974202119.9low030151
Nausea01982202122.5low010001
Necrosis01993201915.1low001860
Neglected Diseases02012201212.0low000010
Neoplasm Metastasis01970202019.6low2504120
Neoplasm Regression, Spontaneous01971197153.0low010000
Neoplasms01946202319.4low119121478
Neoplasms, Bronchial01968196856.0low010000
Nephritis01999201316.6low101130
Nephritis, Interstitial01996200224.2low103500
Nephrosis01974200833.0low010100
Nephrotic Syndrome02011201113.0low000010
Nerve Degeneration02005201415.4low000410
Nerve Pain02012201910.2low000040
Nervous System Diseases02004200619.0low000200
Nervous System Disorders02004200619.0low000200
Neuralgia02012201910.2low000040
Neurilemmoma02012201212.0low000010
Neurilemoma02012201212.0low000010
Neuroblastoma0199820239.7low0013122
Neurodegenerative Diseases0200220227.8low000233
Neuroretinitis02003200321.0low000100
Nicotine Addiction0201820186.0low100010
No-Reflow Phenomenon0201520159.0low000010
Non-alcoholic Fatty Liver Disease0201720214.8low000032
Obesity02002202111.8low000431
Opioid-Related Disorders02001200123.0low000100
Opisthorchiasis02002200222.0low000100
Opisthorchis felineus Infection02002200222.0low000100
Orthomyxoviridae Infections01970197054.0low010000
Osteoarthritis0201020217.1low000142
Osteogenic Sarcoma0201320227.4low0000101
Osteolysis0201520159.0low000020
Osteomyelitis01964196460.0low010000
Osteoporosis0201020208.5low000130
Osteoporosis, Postmenopausal02008201512.5low000110
Osteosarcoma0201320227.4low0000101
Ovarian Neoplasms0200820227.1low0002184
Overweight0202220222.0low000001
Pain02001201613.8low000330
Pain, Chronic0201220179.5low000020
Palmoplantaris Pustulosis01975201819.6low110130
Palsy01971200237.5low010100
Pancreatic Neoplasms0200620228.9low000124510
Pancreatitis02005202212.8low000311
Pancreatitis, Chronic0202020204.0low000010
Papilloma01962201841.5low080210
Papilloma, Squamous Cell01962201841.5low080210
Papillomavirus Infections02014201410.0low000010
Paraganglioma02012201212.0low000010
Paraganglioma, Gangliocytic02012201212.0low000010
Paralysis01971200237.5low010100
Parasitemia01995201424.3low4010110
Parkinson Disease02001202213.2low000741
Parkinson Disease, Secondary0201920195.0low000010
Parkinsonian Disorders02006201215.3low000210
Patency of the Ductus Arteriosus02011201113.0low000010
Peptic Ulcer01968201639.7low120010
Perforated Appendicitis01993199430.5low002000
Pericementitis02003200321.0low000100
Periodontitis02003200321.0low000100
Peripheral Arterial Disease0201920195.0low000010
Peripheral Arterial Diseases0201920195.0low000010
Peripheral Nerve Injuries02012201411.0low000020
Peripheral Nerve Injury02012201411.0low000020
Peritoneal Diseases0201920195.0low000010
Peritonitis02001200322.0low000400
Pheochromocytoma02012201212.0low000010
Pheochromocytoma, Extra-Adrenal02012201212.0low000010
Pituitary Neoplasms02000201812.3low001020
Plant Poisoning01963196361.0low010000
Plasmodium falciparum Malaria01991202026.9low3801122060
Plasmodium vivax Malaria01947200630.3low9120200
Pleurisy01998199826.0low001000
Pneumococcal Infections01967196757.0low020000
Pneumonia0201020209.6low000140
Pneumonia, Aspiration02011201113.0low000010
Pneumonia, Bacterial02005200519.0low000100
Pneumonia, Viral0202020204.0low000010
Poisoning01999201517.0low001010
Poliomyelitis01962197058.0low020000
Polyarthritis01964202126.6low020311
Polycystic Kidney Diseases02007201811.5low000110
Polycystic Kidney, Autosomal Dominant02008202110.8low000211
Polycystic Ovarian Syndrome0200820227.7low000142
Polycystic Ovary Syndrome0200820227.7low000142
Polyploid0201920195.0low000010
Postoperative Complications01999201912.3low001150
Pouch Ileitis0201720177.0low000010
Pouchitis0201720177.0low000010
Poultry Diseases02013201311.0low000010
Pre-Eclampsia02005201711.8low000140
Precancerous Conditions01975201127.0low012110
Precursor Cell Lymphoblastic Leukemia-Lymphoma02004201612.0low000260
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma02013201510.0low000020
Pregnancy01967202324.3low01777165
Premature Birth0202220222.0low000002
Pressure Ulcer01964196460.0low010000
Preterm Birth0202220222.0low000002
Primary Myelofibrosis0201920195.0low000010
Primary Ovarian Insufficiency0201520206.5low000020
Primary Peritonitis02001200322.0low000400
Prostatic Hyperplasia0201720177.0low000010
Prostatic Neoplasms02007202110.2low0003241
Prostatic Neoplasms, Castration-Resistant0201420178.5low000020
Protein Aggregation, Pathological0201620177.5low000020
Protein Folding Diseases02014201410.0low000010
Proteinuria01974201917.6low120560
Pruritus01989199134.3low221000
Pseudomonas Infections02005200519.0low000100
Psoriasis01975201819.6low110130
Psychoses, Drug02003200321.0low000100
Puerperal Disorders01969196955.0low010000
Pulmonary Arterial Remodeling0201620168.0low000010
Pulmonary Disease, Chronic Obstructive0201820205.0low000020
Pulmonary Edema01998201119.5low001010
Pulmonary Fibrosis0199420229.3low001171
Pulmonary Hypertension02000202214.7low002531
Pus01963196759.5low140000
Pyrexia01969201637.0low242110
Radiation Pneumonitis0201520159.0low000010
Recrudescence01980201128.5low6318510
Renal Insufficiency01996201920.4low101310
Renal Insufficiency, Chronic0201020199.5low000110
Reperfusion Injury02002202112.6low00017142
Respiratory Distress Syndrome01994202116.5low001001
Respiratory Distress Syndrome, Newborn01998199826.0low001000
Respiratory Insufficiency0201520159.0low000010
Respiratory Syndrome, Acute, Severe02010201014.0low000100
Respiratory Tract Diseases02000200322.5low001100
Respiratory Tract Neoplasms01970197054.0low010000
Retinal Degeneration0201720215.0low000011
Retinal Detachment0202120213.0low000001
Retinal Pigment Epithelial Detachment0202120213.0low000001
Retinitis02003200321.0low000100
Rhabdomyosarcoma01970197352.7low030000
Rheumatoid Arthritis01969202211.4low616132711
Rhinitis, Allergic, Seasonal02010201014.0low000100
Root Resorption0201920195.0low000010
Salmonella Infections, Animal01970197054.0low010000
Sarcoidosis01970197054.0low010000
Sarcoma01953200248.0low030100
Sarcoma 18001955200851.8low040100
Sarcoma 3701953195371.0low010000
Sarcoma, Epithelioid01953200248.0low030100
Sarcoma, Kaposi02012201610.0low000020
Scarlet Fever01977198045.0low030000
Schistosoma mansoni Infection02013201311.0low000010
Schistosomiasis02013201410.5low000020
Schistosomiasis mansoni02013201311.0low000010
Schizophrenia02013201311.0low000010
Scleroderma, Systemic02007200717.0low000100
Sclerosis, Systemic02007200717.0low000100
Sebaceous Gland Diseases0201620168.0low000010
Seizures01969197452.3low130000
Seizures, Febrile01992199232.0low001000
Sensitivity and Specificity01994202118.9low00124081
Sepsis02003202010.4low000270
Severe Acute Respiratory Syndrome02010201014.0low000100
Shock02002200222.0low000200
Shock, Septic01993202112.8low001112
Silicosis0201920204.5low000020
Skin Diseases01972200729.0low010200
Skin Neoplasms01963202238.1low0392461
Sleepiness0202120213.0low100001
Smoking Cessation0201820224.0low100011
Soft Tissue Neoplasms01985198539.0low010000
Spasm01955197059.0low030000
Spinal Cord Diseases02004200519.5low000200
Spinal Cord Injuries02006202210.2low000351
Spondylitis, Ankylosing0201820224.3low000021
Squamous Cell Carcinoma of Head and Neck0201920213.7low000012
Staphylococcal Infections01970202116.2low010112
Staphylococcal Skin Infections01999199925.0low001000
Starvation02006200618.0low000100
Status Epilepticus02014201410.0low000010
Sterility, Male02002201912.8low000220
Stomach Neoplasms01983202316.3low014673
Stomach Ulcer01969197253.5low120000
Stomatitis01964196460.0low010000
Streptococcal Infections02003202112.0low000101
Stroke02001202211.3low100672
Subarachnoid Hemorrhage0201620168.0low000010
Substance Withdrawal Syndrome01967201830.8low220210
Substance-Related Disorders01966196956.5low020000
Sunburn02003200321.0low000100
Symptom Cluster0202220222.0low000001
Syncope01994199430.0low001000
Syndrome0202220222.0low000001
Systemic Inflammatory Response Syndrome02006200618.0low000100
T-Cell Lymphoma01996199628.0low001000
Tachycardia, Ventricular01994200126.5low001100
Thrombocythemia, Essential0201920195.0low000010
Thrombocytopenia02012201212.0low000010
Thrombopenia02012201212.0low000010
Thrombophilia0202120213.0low000001
Thrombosis01984201820.3low010110
Thyroid Cancer, Anaplastic0202120213.0low000002
Thyroid Carcinoma, Anaplastic0202120213.0low000002
Thyroid Neoplasms0200920218.3low000223
Tobacco Use Disorder0201820186.0low100010
Tongue Neoplasms0201420178.5low000020
Tonsillitis01966196658.0low010000
Torsade de Pointes01993200525.5low002200
Tracheal Neoplasms01968196856.0low010000
Tracheal Stenosis0201620168.0low000010
Triple Negative Breast Neoplasms0201320215.7low000061
Triploid0201620168.0low000010
Trypanosomiasis01952200163.5low050100
Trypanosomiasis, African01954195470.0low010000
Tuberculosis01955200741.2low020200
Uremia01984198440.0low010000
Ureteral Neoplasms01999200124.0low001100
Ureteral Obstruction0201120189.5low000020
Urinary Bladder Neoplasms01972202118.1low011231
Urinary Tract Infections01991199133.0low001000
Urticaria01975199539.0low011000
Uterine Cervical Neoplasms01995201915.4low001540
Uterine Neoplasms01995199529.0low001000
Uveitis02001200322.0low000200
Vascular Calcification0201920204.5low000020
Vascular Diseases02002202013.0low000120
Vasospasm, Intracranial0201820186.0low000010
Ventricular Fibrillation01997199727.0low001000
Vibrio cholerae Infection01974197450.0low010000
Viral Diseases01980198044.0low010000
Virus Diseases01980198044.0low010000
Vomiting01975202131.0low121001
Weight Gain01961201036.0low011100
Weight Loss01999202015.0low001110
Weight Reduction01999202015.0low001110
Wilms Tumor0201920195.0low000010
Xeroderma Pigmentosum01975198046.5low020000

Safety/Toxicity (281)

ArticleYear
Endophytic Bacillus sp. R1 and Its Roles in Assisting Phytoremediation and Alleviating the Toxicity of Aluminum Combined Phenanthrene Contaminations in Brassica napus.
Current microbiology, , Oct-31, Volume: 80, Issue:12
2023
Integument colour change: Tracking delayed growth of Oppia nitens as a sub-lethal indicator of soil toxicity.
Environmental pollution (Barking, Essex : 1987), , Dec-15, Volume: 339
2023
Microplastics reduced bioavailability and altered toxicity of phenanthrene to maize (Zea mays L.) through modulating rhizosphere microbial community and maize growth.
Chemosphere, , Volume: 345
2023
The efficacy and safety of sodium tanshinone ⅡA sulfonate injection in the treatment of unstable angina pectoris: A systematic review and meta-analysis.
PloS one, , Volume: 18, Issue:8
2023
Recent advances in the pharmacological applications and liver toxicity of triptolide.
Chemico-biological interactions, , Sep-01, Volume: 382
2023
Cardiac toxicity of phenanthrene depends on developmental stage in Atlantic cod (Gadus morhua).
The Science of the total environment, , Jul-10, Volume: 881
2023
A comprehensive review on celastrol, triptolide and triptonide: Insights on their pharmacological activity, toxicity, combination therapy, new dosage form and novel drug delivery routes.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, , Volume: 162
2023
Mechanistic insights into phenanthrene-triggered oxidative stress-associated neurotoxicity, genotoxicity, and behavioral disturbances toward the brandling worm (Eisenia fetida) brain: The need for an ecotoxicological evaluation.
Journal of hazardous materials, , 05-15, Volume: 450
2023
Investigating the adverse outcome pathways (AOP) of neurotoxicity induced by DBDPE with a combination of in vitro and in silico approaches.
Journal of hazardous materials, , 05-05, Volume: 449
2023
Triptolide and l-ascorbate palmitate co-loaded micelles for combination therapy of rheumatoid arthritis and side effect attenuation.
Drug delivery, , Volume: 29, Issue:1
2022
Neuroprotection of Triptolide against Amyloid-Beta1-42-induced toxicity via the Akt/mTOR/p70S6K-mediated Autophagy Pathway.
Anais da Academia Brasileira de Ciencias, , Volume: 94, Issue:2
2022
ROS-independent cytotoxicity of 9,10-phenanthrenequinone inhibits cell cycle progression and spindle assembly during meiotic maturation in mouse oocytes.
Journal of hazardous materials, , 08-15, Volume: 436
2022
New mechanism of nephrotoxicity of triptolide: Oxidative stress promotes cGAS-STING signaling pathway.
Free radical biology & medicine, , 08-01, Volume: 188
2022
Promotion of the biodegradation of phenanthrene adsorbed on microplastics by the functional bacterial consortium QY1 in the presence of humic acid: Bioavailability and toxicity evaluation.
Environmental pollution (Barking, Essex : 1987), , Aug-15, Volume: 307
2022
Antibiotic pretreatment promotes orally-administered triptolide absorption and aggravates hepatotoxicity and intestinal injury in mice.
Journal of ethnopharmacology, , Jun-28, Volume: 292
2022
Establishment of cytochrome P450 1a gene-knockout Javanese medaka, Oryzias javanicus, which distinguishes toxicity modes of the polycyclic aromatic hydrocarbons, pyrene and phenanthrene.
Marine pollution bulletin, , Volume: 178
2022
Remediation of phenanthrene phytotoxicity by the interaction of rice and endophytic fungus P. liquidambaris in practice.
Ecotoxicology and environmental safety, , Apr-15, Volume: 235
2022
Efficient biodegradation of phenanthrene using Pseudomonas stutzeri LSH-PAH1 with the addition of sophorolipids: Alleviation of biotoxicity and cometabolism studies.
Environmental pollution (Barking, Essex : 1987), , May-15, Volume: 301
2022
Moderate acidification mitigates the toxic effects of phenanthrene on the mitten crab Eriocheir sinensis.
Chemosphere, , Volume: 294
2022
Toxic mechanism on phenanthrene-triggered cell apoptosis, genotoxicity, immunotoxicity and activity changes of immunity protein in Eisenia fetida: Combined analysis at cellular and molecular levels.
The Science of the total environment, , May-01, Volume: 819
2022
Folate-modified triptolide liposomes target activated macrophages for safe rheumatoid arthritis therapy.
Biomaterials science, , Jan-18, Volume: 10, Issue:2
2022
Microplastics increase the accumulation of phenanthrene in the ovaries of marine medaka (Oryzias melastigma) and its transgenerational toxicity.
Journal of hazardous materials, , 02-15, Volume: 424, Issue:Pt D
2022
Targeting tryptophan metabolism reveals Clematichinenoside AR alleviates triptolide-induced hepatotoxicity.
Journal of pharmaceutical and biomedical analysis, , Jan-20, Volume: 208
2022
Developmental toxicity of cryptotanshinone on the early-life stage of zebrafish development.
Human & experimental toxicology, , Volume: 40, Issue:12_suppl
2021
Role of MicroRNA-155 in Triptolide-induced hepatotoxicity via the Nrf2-Dependent pathway.
Journal of ethnopharmacology, , Dec-05, Volume: 281
2021
Biodegradation and detoxification of phenanthrene in in vitro and in vivo conditions by a newly isolated ligninolytic fungus Coriolopsis byrsina strain APC5 and characterization of their metabolites for environmental safety.
Environmental science and pollution research international, , Volume: 29, Issue:41
2022
Acute and chronic toxicity of microcystin-LR and phenanthrene alone or in combination to the cladoceran (Daphnia magna).
Ecotoxicology and environmental safety, , Sep-01, Volume: 220
2021
Toxic mechanism on phenanthrene-induced cytotoxicity, oxidative stress and activity changes of superoxide dismutase and catalase in earthworm (Eisenia foetida): A combined molecular and cellular study.
Journal of hazardous materials, , 09-15, Volume: 418
2021
Toxicity of two representative petroleum hydrocarbons, toluene and phenanthrene, to five Atlantic coral species.
Marine pollution bulletin, , Volume: 169
2021
Toxicity evaluation of the metabolites derived from the degradation of phenanthrene by one of a soil ubiquitous PAHs-degrading strain Rhodococcus qingshengii FF.
Journal of hazardous materials, , 08-05, Volume: 415
2021
Gamma-aminobutyric acid improves phenanthrene phytotoxicity tolerance in cucumber through the glutathione-dependent system of antioxidant defense.
Ecotoxicology and environmental safety, , Jul-01, Volume: 217
2021
Effects of polystyrene microplastics on uptake and toxicity of phenanthrene in soybean.
The Science of the total environment, , Aug-20, Volume: 783
2021
Cryptotanshinone Ameliorates Doxorubicin-Induced Cardiotoxicity by Targeting Akt-GSK-3β-mPTP Pathway In Vitro.
Molecules (Basel, Switzerland), , Mar-08, Volume: 26, Issue:5
2021
Triptolide and atorvastatin synergistically promote hepatotoxicity in cultured hepatocytes and female Sprague-Dawley rats by inhibiting pregnane X receptor-mediated transcriptional activation of CYP3A4.
Toxicology letters, , May-15, Volume: 342
2021
Effects of Phenanthrene Exposure on Cholesterol Homeostasis and Cardiotoxicity in Zebrafish Embryos.
Environmental toxicology and chemistry, , Volume: 40, Issue:6
2021
Triptolide delivery: Nanotechnology-based carrier systems to enhance efficacy and limit toxicity.
Pharmacological research, , Volume: 165
2021
Immune toxicity of phenanthrene and its combined effects of white spot syndrome virus on the survival of kuruma shrimp (Penaeus Japonicus).
Ecotoxicology and environmental safety, , Jan-15, Volume: 208
2021
Synthesis of glutathione as a central aspect of PAH toxicity in liver cells: A comparison between phenanthrene, Benzo[b]Fluoranthene and their mixtures.
Ecotoxicology and environmental safety, , Jan-15, Volume: 208
2021
Construction of a pH-responsive, ultralow-dose triptolide nanomedicine for safe rheumatoid arthritis therapy.
Acta biomaterialia, , Volume: 121
2021
[Arctiin antagonizes triptolide-induced renal toxicity in rats via anti-inflammatory pathway].
Nan fang yi ke da xue xue bao = Journal of Southern Medical University, , Oct-30, Volume: 40, Issue:10
2020
Measured and predicted acute toxicity of phenanthrene and MC252 crude oil to vertically migrating deep-sea crustaceans.
Environmental science and pollution research international, , Volume: 27, Issue:36
2020
Catalpol coordinately regulates phase I and II detoxification enzymes of Triptolide through CAR and NRF2 pathways to reduce Triptolide-induced hepatotoxicity.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, , Volume: 129
2020
Circadian clock regulates hepatotoxicity of Tripterygium wilfordii through modulation of metabolism.
The Journal of pharmacy and pharmacology, , Volume: 72, Issue:12
2020
Attenuation of doxorubicin-induced cardiotoxicity by
Aging, , 05-26, Volume: 12, Issue:10
2020
TFEB-NF-κB inflammatory signaling axis: a novel therapeutic pathway of Dihydrotanshinone I in doxorubicin-induced cardiotoxicity.
Journal of experimental & clinical cancer research : CR, , May-24, Volume: 39, Issue:1
2020
Cisplatin nephrotoxicity is induced via poly(ADP-ribose) polymerase activation in adult zebrafish and mice.
American journal of physiology. Regulatory, integrative and comparative physiology, , 05-01, Volume: 318, Issue:5
2020
Gut microbiota protects from triptolide-induced hepatotoxicity: Key role of propionate and its downstream signalling events.
Pharmacological research, , Volume: 155
2020
Sodium tanshinone IIA sulfonate protects against Aβ-induced cell toxicity through regulating Aβ process.
Journal of cellular and molecular medicine, , Volume: 24, Issue:6
2020
Molecularly Engineering Triptolide with Aptamers for High Specificity and Cytotoxicity for Triple-Negative Breast Cancer.
Journal of the American Chemical Society, , 02-12, Volume: 142, Issue:6
2020
miR398 is involved in the relief of phenanthrene-induced oxidative toxicity in wheat roots.
Environmental pollution (Barking, Essex : 1987), , Volume: 258
2020
Combined treatment of melatonin and sodium tanshinone IIA sulfonate reduced the neurological and cardiovascular toxicity induced by deltamethrin in zebrafish.
Chemosphere, , Volume: 243
2020
Low level of polystyrene microplastics decreases early developmental toxicity of phenanthrene on marine medaka (Oryzias melastigma).
Journal of hazardous materials, , 03-05, Volume: 385
2020
Key role of organic cation transporter 2 for the nephrotoxicity effect of triptolide in rheumatoid arthritis.
International immunopharmacology, , Volume: 77
2019
Triptolide-loaded nanoparticles targeting breast cancer in vivo with reduced toxicity.
International journal of pharmaceutics, , Dec-15, Volume: 572
2019
[Study on difference of liver toxicity and its molecular mechanisms caused by Tripterygium wilfordii multiglycoside and equivalent amount of triptolid in rats].
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, , Volume: 44, Issue:16
2019
Combined toxic effects of microcystin-LR and phenanthrene on growth and antioxidant system of duckweed (Lemna gibba L.).
Ecotoxicology and environmental safety, , Dec-15, Volume: 185
2019
Toxic effects of triptolide on adrenal steroidogenesis in H295R cells and female rats.
Journal of biochemical and molecular toxicology, , Volume: 33, Issue:11
2019
Mitochondria-dependent apoptosis in triptolide-induced hepatotoxicity is associated with the Drp1 activation.
Toxicology mechanisms and methods, , Volume: 30, Issue:2
2020
Understanding the cardiac toxicity of the anthropogenic pollutant phenanthrene on the freshwater indicator species, the brown trout (Salmo trutta): From whole heart to cardiomyocytes.
Chemosphere, , Volume: 239
2020
The role of inflammasome activation in Triptolide-induced acute liver toxicity.
International immunopharmacology, , Volume: 75
2019
Triptolide-induced hepatotoxicity via apoptosis and autophagy in zebrafish.
Journal of applied toxicology : JAT, , Volume: 39, Issue:11
2019
Triptolide induces toxicity in inner ear stem cells via promoting DNA damage.
Toxicology in vitro : an international journal published in association with BIBRA, , Volume: 61
2019
Partitioning of chemical contaminants to microplastics: Sorption mechanisms, environmental distribution and effects on toxicity and bioaccumulation.
Environmental pollution (Barking, Essex : 1987), , Volume: 252, Issue:Pt B
2019
Protective Effect of Vitamin C on Triptolide-induced Acute Hepatotoxicity in Mice through mitigation of oxidative stress.
Anais da Academia Brasileira de Ciencias, , Jun-19, Volume: 91, Issue:2
2019
High-content analysis boosts identification of the initial cause of triptolide-induced hepatotoxicity.
Journal of applied toxicology : JAT, , Volume: 39, Issue:9
2019
Phenanthrene, but not its isomer anthracene, effectively activates both human and mouse nuclear receptor constitutive androstane receptor (CAR) and induces hepatotoxicity in mice.
Toxicology and applied pharmacology, , 09-01, Volume: 378
2019
Neurodevelopmental toxicity assessments of alkyl phenanthrene and Dechlorane Plus co-exposure in zebrafish.
Ecotoxicology and environmental safety, , Sep-30, Volume: 180
2019
In vivo protective effects of chlorogenic acid against triptolide-induced hepatotoxicity and its mechanism.
Pharmaceutical biology, , Volume: 56, Issue:1
2018
MicroRNA expression, targeting, release dynamics and early-warning biomarkers in acute cardiotoxicity induced by triptolide in rats.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, , Volume: 111
2019
The Study of Cellular Mechanism of Triptolide in the Treatment of Cancer, Bone Loss and Cardiovascular Disease and Triptolide's Toxicity.
Current stem cell research & therapy, , Volume: 15, Issue:1
2020
The drought and high wet soil condition impact on PAH (phenanthrene) toxicity towards nitrifying bacteria.
Journal of hazardous materials, , 04-15, Volume: 368
2019
Catalpol and panax notoginseng saponins synergistically alleviate triptolide-induced hepatotoxicity through Nrf2/ARE pathway.
Toxicology in vitro : an international journal published in association with BIBRA, , Volume: 56
2019
Increased ZnO nanoparticle toxicity to wheat upon co-exposure to phenanthrene.
Environmental pollution (Barking, Essex : 1987), , Volume: 247
2019
Selenium alleviates phytotoxicity of phenanthrene and pyrene in Alternanthera Philoxeroides.
International journal of phytoremediation, , Volume: 20, Issue:14
2018
A new perspective of triptolide-associated hepatotoxicity: Liver hypersensitivity upon LPS stimulation.
Toxicology, , 02-15, Volume: 414
2019
Drp1-associated mitochondrial dysfunction and mitochondrial autophagy: a novel mechanism in triptolide-induced hepatotoxicity.
Cell biology and toxicology, , Volume: 35, Issue:3
2019
The effect of pH on the acute toxicity of phenanthrene in a marine microalgae Chlorella salina.
Scientific reports, , 12-04, Volume: 8, Issue:1
2018
Galactosylated chitosan triptolide nanoparticles for overcoming hepatocellular carcinoma: Enhanced therapeutic efficacy, low toxicity, and validated network regulatory mechanisms.
Nanomedicine : nanotechnology, biology, and medicine, , Volume: 15, Issue:1
2019
Possible role of hepatic macrophage recruitment and activation in triptolide-induced hepatotoxicity.
Toxicology letters, , Dec-15, Volume: 299
2018
Poly(ADP-ribosyl)ated PXR is a critical regulator of acetaminophen-induced hepatotoxicity.
Cell death & disease, , 07-26, Volume: 9, Issue:8
2018
Cytotoxicity of Air Pollutant 9,10-Phenanthrenequinone: Role of Reactive Oxygen Species and Redox Signaling.
BioMed research international, , Volume: 2018
2018
Metabolic alterations in triptolide-induced acute hepatotoxicity.
Biomedical chromatography : BMC, , Volume: 32, Issue:10
2018
Licorice root extract and magnesium isoglycyrrhizinate protect against triptolide-induced hepatotoxicity via up-regulation of the Nrf2 pathway.
Drug delivery, , Volume: 25, Issue:1
2018
Isoliquiritigenin protects against triptolide-induced hepatotoxicity in mice through Nrf2 activation.
Die Pharmazie, , Jul-07, Volume: 71, Issue:7
2016
Atractylodes lancea rhizome water extract reduces triptolide-induced toxicity and enhances anti-inflammatory effects.
Chinese journal of natural medicines, , Volume: 15, Issue:12
2017
Triptolide-induced hepatotoxicity can be alleviated when combined with Panax notoginseng saponins and Catapol.
Journal of ethnopharmacology, , Mar-25, Volume: 214
2018
Protective effects of silymarin on triptolide-induced acute hepatotoxicity in rats.
Molecular medicine reports, , Volume: 17, Issue:1
2018
Characterization of Triptolide-Induced Hepatotoxicity by Imaging and Transcriptomics in a Novel Zebrafish Model.
Toxicological sciences : an official journal of the Society of Toxicology, , 10-01, Volume: 159, Issue:2
2017
Cytotoxicity of anticancer drugs and PJ-34 (poly(ADP-ribose)polymerase-1 (PARP-1) inhibitor) on HL-60 and Jurkat cells.
Advances in clinical and experimental medicine : official organ Wroclaw Medical University, , Volume: 26, Issue:3
A novel topoisomerase 2a inhibitor, cryptotanshinone, suppresses the growth of PC3 cells without apparent cytotoxicity.
Toxicology and applied pharmacology, , 09-01, Volume: 330
2017
Inhibition of Poly(ADP-ribose) Polymerase-1 Enhances Gene Expression of Selected Sirtuins and APP Cleaving Enzymes in Amyloid Beta Cytotoxicity.
Molecular neurobiology, , Volume: 55, Issue:6
2018
UPLC/ESI-QTOF-MS-based metabolomics survey on the toxicity of triptolide and detoxication of licorice.
Chinese journal of natural medicines, , Volume: 15, Issue:6
2017
Neurotoxicity of alkylated polycyclic aromatic compounds in human neuroblastoma cells.
Journal of toxicology and environmental health. Part A, , Volume: 80, Issue:5
2017
Self-protection against triptolide-induced toxicity in human hepatic cells via Nrf2-ARE-NQO1 pathway.
Chinese journal of integrative medicine, , Volume: 23, Issue:12
2017
Toxicity of triptolide and the molecular mechanisms involved.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, , Volume: 90
2017
Potentially reversible acute cerebellar toxicity associated with Minnelide.
Neuroradiology, , Volume: 59, Issue:4
2017
Effect of multi-walled carbon nanotubes on phytotoxicity of sediments contaminated by phenanthrene and cadmium.
Chemosphere, , Volume: 172
2017
Enhancement of the bioavailability of a novel anticancer compound (acetyltanshinone IIA) by encapsulation within mPEG-PLGA nanoparticles: a study of formulation optimization, toxicity, and pharmacokinetics.
Oncotarget, , Feb-14, Volume: 8, Issue:7
2017
Triptolide Induces hepatotoxicity via inhibition of CYP450s in Rat liver microsomes.
BMC complementary and alternative medicine, , Jan-05, Volume: 17, Issue:1
2017
Effects of nanoplastics and microplastics on toxicity, bioaccumulation, and environmental fate of phenanthrene in fresh water.
Environmental pollution (Barking, Essex : 1987), , Volume: 219
2016

Long-term Use (10)

ArticleYear
Fosdagrocorat (PF-04171327) versus prednisone or placebo in rheumatoid arthritis: a randomised, double-blind, multicentre, phase IIb study.
RMD open, , Volume: 5, Issue:1
2019
Pharmacokinetics and pharmacodynamics of orally administered acetylenic tricyclic bis(cyanoenone), a highly potent Nrf2 activator with a reversible covalent mode of action.
Biochemical and biophysical research communications, , Sep-25, Volume: 465, Issue:3
2015
Tripchlorolide improves age-associated cognitive deficits by reversing hippocampal synaptic plasticity impairment and NMDA receptor dysfunction in SAMP8 mice.
Behavioural brain research, , Jan-01, Volume: 258
2014
Improved retinal ganglion cell survival through retinal microglia suppression by a chinese herb extract, triptolide, in the DBA/2J mouse model of glaucoma.
Ocular immunology and inflammation, , Volume: 21, Issue:5
2013
Disseminated cutaneous Kaposi sarcoma in a patient receiving triptolide/tripdiolide for rheumatoid arthritis.
Medical science monitor : international medical journal of experimental and clinical research, , Volume: 18, Issue:8
2012
[Effects of triptolide on hypothalamic-pituitary-adrenal axis of rats].
Fa yi xue za zhi, , Volume: 26, Issue:4
2010
Inhibition by miltirone of up-regulation of GABAA receptor alpha4 subunit mRNA by ethanol withdrawal in hippocampal neurons.
European journal of pharmacology, , Jun-28, Volume: 494, Issue:2-3
2004
Chronic aristolochic acid toxicity in rabbits: a model of Chinese herbs nephropathy?
Kidney international, , Volume: 59, Issue:6
2001
Quantitative analysis of aristolochic acids, toxic compounds, contained in some medicinal plants.
Journal of ethnopharmacology, , Volume: 64, Issue:2
1999
Miltirone, a central benzodiazepine receptor partial agonist from a Chinese medicinal herb Salvia miltiorrhiza.
Neuroscience letters, , Jun-24, Volume: 127, Issue:2
1991

Pharmacokinetics (86)

ArticleYear
Pharmacokinetics, distribution and efficacy of triptolide PLGA microspheres after intra-articular injection in a rat rheumatoid arthritis model.
Xenobiotica; the fate of foreign compounds in biological systems, , Volume: 51, Issue:6
2021
Pharmacokinetic, bioavailability, and metabolism studies of lusianthridin, a dihydrophenanthrene compound, in rats by liquid chromatography/electrospray ionization tandem mass spectrometry.
Journal of pharmaceutical and biomedical analysis, , Feb-20, Volume: 195
2021
Dihydrotanshinone I Increase Amyloid-β Clearance and Decrease Tau Phosphorylation via Enhancing Autophagy.
Pharmacology, , Volume: 105, Issue:5-6
2020
Comparative pharmacokinetics and tissue distribution of cryptotanshinone, tanshinone IIA, dihydrotanshinone I, and tanshinone I after oral administration of pure tanshinones and liposoluble extract of Salvia miltiorrhiza to rats.
Biopharmaceutics & drug disposition, , Volume: 41, Issue:1-2
2020
Sodium tanshinone IIA sulfonate: A review of pharmacological activity and pharmacokinetics.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, , Volume: 118
2019
A network pharmacology integrated pharmacokinetics strategy for uncovering pharmacological mechanism of compounds absorbed into the blood of Dan-Lou tablet on coronary heart disease.
Journal of ethnopharmacology, , Oct-05, Volume: 242
2019
Dihydromyricetin affect the pharmacokinetics of triptolide in rats.
Xenobiotica; the fate of foreign compounds in biological systems, , Volume: 50, Issue:3
2020
Lower clearance of sodium tanshinone IIA sulfonate in coronary heart disease patients and the effect of total bilirubin: a population pharmacokinetics analysis.
Chinese journal of natural medicines, , Volume: 17, Issue:3
2019
Transdermal drug delivery of triptolide-loaded nanostructured lipid carriers: Preparation, pharmacokinetic, and evaluation for rheumatoid arthritis.
International journal of pharmaceutics, , Jan-10, Volume: 554
2019
Preclinical Pharmacokinetics of Triptolide: A Potential Antitumor Drug.
Current drug metabolism, , Volume: 20, Issue:2
2019
Effects of Danshen capsules on the pharmacokinetics and pharmacodynamics of clopidogrel in healthy volunteers.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, , Volume: 119
2018
CYP3A4 inducer and inhibitor strongly affect the pharmacokinetics of triptolide and its derivative in rats.
Acta pharmacologica Sinica, , Volume: 39, Issue:8
2018
Development of triptolide-nanoemulsion gels for percutaneous administration: physicochemical, transport, pharmacokinetic and pharmacodynamic characteristics.
Journal of nanobiotechnology, , Dec-04, Volume: 15, Issue:1
2017
Population Pharmacokinetics of Fosdagrocorat (PF-04171327), a Dissociated Glucocorticoid Receptor Agonist, in Patients With Rheumatoid Arthritis.
Clinical and translational science, , Volume: 11, Issue:1
2018
Association of polycyclic aromatic hydrocarbons exposure with atherosclerotic cardiovascular disease risk: A role of mean platelet volume or club cell secretory protein.
Environmental pollution (Barking, Essex : 1987), , Volume: 233
2018
Dissociated Agonist of Glucocorticoid Receptor or Prednisone for Active Rheumatoid Arthritis: Effects on P1NP and Osteocalcin Pharmacodynamics.
CPT: pharmacometrics & systems pharmacology, , Volume: 6, Issue:7
2017
Triptolide Promotes the Clearance of α-Synuclein by Enhancing Autophagy in Neuronal Cells.
Molecular neurobiology, , Volume: 54, Issue:3
2017
Determination of Sodium Tanshinone IIA Sulfonate in human plasma by LC-MS/MS and its application to a clinical pharmacokinetic study.
Journal of pharmaceutical and biomedical analysis, , Mar-20, Volume: 121
2016
In situ investigation into surfactant effects on the clearance of polycyclic aromatic hydrocarbons adsorbed onto soybean leaf surfaces.
Environmental pollution (Barking, Essex : 1987), , Volume: 210
2016
Assessment of pharmacokinetic compatibility of short acting CDRI candidate trioxane derivative, 99-411, with long acting prescription antimalarials, lumefantrine and piperaquine.
Scientific reports, , Nov-25, Volume: 5
2015
Simultaneous determination of tanshinones and polyphenolics in rat plasma by UPLC-MS/MS and its application to the pharmacokinetic interaction between them.
Drug testing and analysis, , Volume: 8, Issue:7
2016
Pharmacokinetics and pharmacodynamics of orally administered acetylenic tricyclic bis(cyanoenone), a highly potent Nrf2 activator with a reversible covalent mode of action.
Biochemical and biophysical research communications, , Sep-25, Volume: 465, Issue:3
2015
Influence of Verapamil on Pharmacokinetics of Triptolide in Rats.
European journal of drug metabolism and pharmacokinetics, , Volume: 41, Issue:4
2016
Pharmacokinetics and tissue distribution study in mice of triptolide-loaded lipid emulsion and accumulation effect on pancreas.
Drug delivery, , Volume: 23, Issue:4
2016
Triptolide: progress on research in pharmacodynamics and toxicology.
Journal of ethnopharmacology, , Aug-08, Volume: 155, Issue:1
2014
Nanostructured lipid carriers as a novel oral delivery system for triptolide: induced changes in pharmacokinetics profile associated with reduced toxicity in male rats.
International journal of nanomedicine, , Volume: 9
2014
Effects of triptolide on the pharmacokinetics of cyclophosphamide in rats: a possible role of cytochrome P3A4 inhibition.
Chinese journal of integrative medicine, , Volume: 20, Issue:7
2014
Simultaneous determination of triptolide and its prodrug MC002 in dog blood by LC-MS/MS and its application in pharmacokinetic studies.
Journal of ethnopharmacology, , Oct-28, Volume: 150, Issue:1
2013
A rapid UFLC-MS/MS method for simultaneous determination of formononetin, cryptotanshinone, tanshinone IIA and emodin in rat plasma and its application to a pharmacokinetic study of Bu Shen Huo Xue formula.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, , Aug-01, Volume: 932
2013
Population pharmacokinetics of halofantrine in healthy volunteers and patients with symptomatic falciparum malaria.
The Journal of pharmacy and pharmacology, , Volume: 64, Issue:11
2012
Prediction of the pharmacokinetic parameters of triptolide in rats based on endogenous molecules in pre-dose baseline serum.
PloS one, , Volume: 7, Issue:8
2012
Intravenous dosing conditions may affect systemic clearance for highly lipophilic drugs: implications for lymphatic transport and absolute bioavailability studies.
Journal of pharmaceutical sciences, , Volume: 101, Issue:9
2012
[Pharmacokinetics of triptolide in Triptergium wilfordii microemulsion gel].
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, , Volume: 36, Issue:2
2011
[Effects of combination of Salvia miltiorrhiza and Panax notoginseng on the pharmacokinetics of their major bioactive components in Beagle dog].
Yao xue xue bao = Acta pharmaceutica Sinica, , Volume: 45, Issue:11
2010
Derivatization of (5R)-hydroxytriptolide from benzylamine to enhance mass spectrometric detection: application to a Phase I pharmacokinetic study in humans.
Analytica chimica acta, , Mar-09, Volume: 689, Issue:1
2011
Simultaneous determination of danshensu, rosmarinic acid, cryptotanshinone, tanshinone IIA, tanshinone I and dihydrotanshinone I by liquid chromatographic-mass spectrometry and the application to pharmacokinetics in rats.
Journal of pharmaceutical and biomedical analysis, , Nov-02, Volume: 53, Issue:3
2010
Effect of fluconazole on the pharmacokinetics of halofantrine in healthy volunteers.
Journal of clinical pharmacy and therapeutics, , Volume: 34, Issue:6
2009
Pharmacokinetic interaction studies of tanshinones with tolbutamide, a model CYP2C11 probe substrate, using liver microsomes, primary hepatocytes and in vivo in the rat.
Phytomedicine : international journal of phytotherapy and phytopharmacology, , Volume: 17, Issue:3-4
2010
Determination of lumefantrine in rat plasma by liquid-liquid extraction using LC-MS/MS with electrospray ionization: assay development, validation and application to a pharmacokinetic study.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, , Apr-15, Volume: 877, Issue:11-12
2009
Lactadherin and clearance of platelet-derived microvesicles.
Blood, , Feb-05, Volume: 113, Issue:6
2009
Determination of tanshinone I in rat plasma by high-performance liquid chromatography and its application to pharmacokinetic studies.
Journal of chromatographic science, , Volume: 46, Issue:8
2008
Pharmacokinetic interaction between tanshinones and polyphenolic extracts of salvia miltinorrhiza BUNGE after intravenous administration in rats.
Biological & pharmaceutical bulletin, , Volume: 31, Issue:8
2008
[Comparative research on pharmacodynamics of Danshen co-microemulsion on hemorheology in rats with hyperlipidemia].
Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials, , Volume: 31, Issue:4
2008
Plasma and urinary tanshinol from Salvia miltiorrhiza (Danshen) can be used as pharmacokinetic markers for cardiotonic pills, a cardiovascular herbal medicine.
Drug metabolism and disposition: the biological fate of chemicals, , Volume: 36, Issue:8
2008
Pharmacokinetic characterization of hydroxylpropyl-beta-cyclodextrin-included complex of cryptotanshinone, an investigational cardiovascular drug purified from Danshen (Salvia miltiorrhiza).
Xenobiotica; the fate of foreign compounds in biological systems, , Volume: 38, Issue:4
2008
The prediction of the hepatic clearance of tanshinone IIA in rat liver subcellular fractions: accuracy improvement.
Current drug metabolism, , Volume: 9, Issue:1
2008
Simultaneous determination of tanshinone I, dihydrotanshinone I, tanshinone IIA and cryptotanshinone in rat plasma by liquid chromatography-tandem mass spectrometry: application to a pharmacokinetic study of a standardized fraction of Salvia miltiorrhiza,
Biomedical chromatography : BMC, , Volume: 22, Issue:5
2008
Preclinical factors affecting the pharmacokinetic behaviour of tanshinone IIA, an investigational new drug isolated from Salvia miltiorrhiza for the treatment of ischaemic heart diseases.
Xenobiotica; the fate of foreign compounds in biological systems, , Volume: 38, Issue:2
2008
Effect of kolanut on the pharmacokinetics of the antimalarial drug halofantrine.
European journal of clinical pharmacology, , Volume: 64, Issue:1
2008
Effects of the coexisting diterpenoid tanshinones on the pharmacokinetics of cryptotanshinone and tanshinone IIA in rat.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, , Volume: 32, Issue:4-5
2007
Simultaneous determination and pharmacokinetic study of water-soluble and lipid-soluble components of danshen in rat plasma using HPLC-UV method.
Biomedical chromatography : BMC, , Volume: 21, Issue:11
2007
Simultaneous determination of danshensu, ferulic acid, cryptotanshinone and tanshinone IIA in rabbit plasma by HPLC and their pharmacokinetic application in danxiongfang.
Journal of pharmaceutical and biomedical analysis, , Sep-03, Volume: 44, Issue:5
2007
[Pharmacokinetic interactions between the main components in the extracts of Salvia miltiorrhiza Bge. in rat].
Yao xue xue bao = Acta pharmaceutica Sinica, , Volume: 42, Issue:3
2007
[Pharmacokinetics of triptolide in Beagle dogs].
Yao xue xue bao = Acta pharmaceutica Sinica, , Volume: 42, Issue:1
2007
Ion-pair reversed-phase HPLC method for determination of sodium tanshinone IIA sulfonate in biological samples and its pharmacokinetics and biodistribution in mice.
Chemical & pharmaceutical bulletin, , Volume: 55, Issue:5
2007
Pharmacokinetic study of triptolide, a constituent of immunosuppressive chinese herb medicine, in rats.
Biological & pharmaceutical bulletin, , Volume: 30, Issue:4
2007
Pharmacokinetics, absorption and tissue distribution of tanshinone IIA solid dispersion.
Planta medica, , Volume: 72, Issue:14
2006
Liquid chromatographic/mass spectrometry assay of triptolide in dog plasma and its application to pharmacokinetic study.
Journal of pharmaceutical and biomedical analysis, , May-03, Volume: 41, Issue:2
2006
Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use.
Journal of clinical pharmacology, , Volume: 45, Issue:12
2005
Preparation and pharmacokinetic evaluation of Tashinone IIA solid lipid nanoparticles.
Drug development and industrial pharmacy, , Volume: 31, Issue:6
2005
Effects of tetracycline on the pharmacokinetics of halofantrine in healthy volunteers.
British journal of clinical pharmacology, , Volume: 58, Issue:1
2004
Efficacy and pharmacokinetics of intravenous nanocapsule formulations of halofantrine in Plasmodium berghei-infected mice.
Antimicrobial agents and chemotherapy, , Volume: 48, Issue:4
2004
Biodegradation kinetics of volatile hydrophobic organic compounds in cultures with variable fractional volumes.
Biotechnology and bioengineering, , Mar-20, Volume: 85, Issue:6
2004
Pharmacokinetics, efficacy and toxicity of parenteral halofantrine in uncomplicated malaria.
British journal of clinical pharmacology, , Volume: 36, Issue:6
1993
[Determination of tanshinone IIA in rat plasma and the pharmacokinetics by RP-HPLC method].
Yao xue xue bao = Acta pharmaceutica Sinica, , Volume: 38, Issue:5
2003
Does stereoselective lymphatic absorption contribute to the enantioselective pharmacokinetics of halofantrine In Vivo?
Biopharmaceutics & drug disposition, , Volume: 24, Issue:4
2003
Pharmacokinetic and pharmacodynamic interaction between grapefruit juice and halofantrine.
Clinical pharmacology and therapeutics, , Volume: 72, Issue:5
2002
The influence of lipids on stereoselective pharmacokinetics of halofantrine: Important implications in food-effect studies involving drugs that bind to lipoproteins.
Journal of pharmaceutical sciences, , Volume: 91, Issue:8
2002
Stereoselective pharmacokinetics of desbutylhalofantrine, a metabolite of halofantrine, in the rat after administration of the racemic metabolite or parent drug.
Biopharmaceutics & drug disposition, , Volume: 21, Issue:9
2000
Pharmacokinetics of halofantrine in the rat: stereoselectivity and interspecies comparisons.
Biopharmaceutics & drug disposition, , Volume: 20, Issue:3
1999
Altered pharmacokinetics of halofantrine by an antacid, magnesium carbonate.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, , Volume: 46, Issue:3
1998
Association of halofantrine with postprandially derived plasma lipoproteins decreases its clearance relative to administration in the fasted state.
Journal of pharmaceutical sciences, , Volume: 87, Issue:8
1998
Pharmacology and pharmacokinetics of new antimalarials.
Medecine tropicale : revue du Corps de sante colonial, , Volume: 55, Issue:4 Suppl
1995
Clinical efficacy and pharmacokinetics of micronized halofantrine for the treatment of acute uncomplicated falciparum malaria in nonimmune patients.
The American journal of tropical medicine and hygiene, , Volume: 51, Issue:2
1994
Clinical pharmacokinetics in the treatment of tropical diseases. Some applications and limitations.
Clinical pharmacokinetics, , Volume: 27, Issue:2
1994
Clinical pharmacokinetics of halofantrine.
Clinical pharmacokinetics, , Volume: 27, Issue:2
1994
Pharmacokinetics of an extended-dose halofantrine regimen in patients with malaria and in healthy volunteers.
Clinical pharmacology and therapeutics, , Volume: 57, Issue:5
1995
Effect of fasting, induction, sex and age on clearance of benz(a)anthracene and chrysene by isolated perfused rat liver.
Toxicology letters, , Volume: 19, Issue:1-2
Numerical taxonomy of phenanthrene-degrading bacteria isolated from the Chesapeake Bay.
Applied and environmental microbiology, , Volume: 48, Issue:5
1984
Clinical pharmacokinetics of antimalarial drugs.
Clinical pharmacokinetics, , Volume: 10, Issue:3
[Pharmacokinetics of antimalarials: quinine and mefloquine, halofantrine, qinghaosu, amino-4-quinolines].
Medecine tropicale : revue du Corps de sante colonial, , Volume: 46, Issue:4
In vitro pharmacodynamic assay for cancer drug development: application to crisnatol, a new DNA intercalator.
Cancer research, , Dec-01, Volume: 49, Issue:23
1989
Pharmacokinetics of halofantrine in man: effects of food and dose size.
British journal of clinical pharmacology, , Volume: 28, Issue:1
1989
Pharmacokinetics of halofantrine in Thai patients with acute uncomplicated falciparum malaria.
British journal of clinical pharmacology, , Volume: 31, Issue:4
1991
Pharmacokinetics of halofantrine and n-desbutylhalofantrine in patients with falciparum malaria following a multiple dose regimen of halofantrine.
European journal of clinical pharmacology, , Volume: 41, Issue:2
1991
Halofantrine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic potential.
Drugs, , Volume: 43, Issue:2
1992

Bioavailability (278)

ArticleYear
Pharmacological activity and clinical progress of Triptolide and its derivatives LLDT-8, PG490-88Na, and Minnelide: a narrative review.
European review for medical and pharmacological sciences, , Volume: 27, Issue:21
2023
Microplastics reduced bioavailability and altered toxicity of phenanthrene to maize (Zea mays L.) through modulating rhizosphere microbial community and maize growth.
Chemosphere, , Volume: 345
2023
The role of microplastics in the process of laccase-assisted phytoremediation of phenanthrene-contaminated soil.
The Science of the total environment, , Dec-20, Volume: 905
2023
Adsorption of Phenanthrene on Multi-Walled Carbon Nanotubes in the Presence of Nonionic Surfactants.
International journal of environmental research and public health, , 02-18, Volume: 20, Issue:4
2023
Tandemly duplicated CYP82Ds catalyze 14-hydroxylation in triptolide biosynthesis and precursor production in Saccharomyces cerevisiae.
Nature communications, , 02-16, Volume: 14, Issue:1
2023
Differences in structure and composition of soil humic substances and their binding for polycyclic aromatic hydrocarbons in different climatic zones.
Environmental pollution (Barking, Essex : 1987), , Apr-01, Volume: 322
2023
Metabolic fates and response strategies of microorganisms to aromatic compounds with different structures.
Bioresource technology, , Volume: 366
2022
Evaluation of biostimulation, bioaugmentation, and organic amendments application on the bioremediation of recalcitrant hydrocarbons of soil.
Chemosphere, , Volume: 307, Issue:Pt 1
2022
Promotion of the biodegradation of phenanthrene adsorbed on microplastics by the functional bacterial consortium QY1 in the presence of humic acid: Bioavailability and toxicity evaluation.
Environmental pollution (Barking, Essex : 1987), , Aug-15, Volume: 307
2022
Interfacial biodegradation of phenanthrene in bacteria-carboxymethyl cellulose-stabilized Pickering emulsions.
Applied microbiology and biotechnology, , Volume: 106, Issue:9-10
2022
Mechanochemical preparation of triptolide-loaded self-micelle solid dispersion with enhanced oral bioavailability and improved
Drug delivery, , Volume: 29, Issue:1
2022
Ball-milled biochar can act as a preferable biocompatibility material to enhance phenanthrene degradation by stimulating bacterial metabolism.
Bioresource technology, , Volume: 350
2022
Inhalable cryptotanshinone spray-dried swellable microparticles for pulmonary fibrosis therapy by regulating TGF-β1/Smad3, STAT3 and SIRT3 pathways.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, , Volume: 172
2022
Folate-modified triptolide liposomes target activated macrophages for safe rheumatoid arthritis therapy.
Biomaterials science, , Jan-18, Volume: 10, Issue:2
2022
[Preparation of triptolide-loaded dissolving microneedles and its transdermal penetration].
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, , Volume: 46, Issue:20
2021
Self-assembled fungus-biochar composite pellets (FBPs) for enhanced co-sorption-biodegradation towards phenanthrene.
Chemosphere, , Volume: 286, Issue:Pt 3
2022
Rhizosphere interactions between PAH-degrading bacteria and Pteris vittata L. on arsenic and phenanthrene dynamics and transformation.
Chemosphere, , Volume: 285
2021
Sorption mechanism of naphthalene by diesel soot: Insight from displacement with phenanthrene/p-nitrophenol.
Journal of environmental sciences (China), , Volume: 106
2021
Long-term exposure to environmental levels of phenanthrene disrupts spermatogenesis in male mice.
Environmental pollution (Barking, Essex : 1987), , Sep-15, Volume: 285
2021
Expression profile of a novel glutathione S-transferase gene in the marine polychaete Perinereis aibuhitensis in short-term responses to phenanthrene, fluoranthene, and benzo[α]pyrene.
Marine pollution bulletin, , Volume: 169
2021
Bioaugmentation treatment of polycyclic aromatic hydrocarbon-polluted soil in a slurry bioreactor with a bacterial consortium and hydroxypropyl-β-cyclodextrin.
Environmental technology, , Volume: 43, Issue:21
2022
γ-Cyclodextrin metal-organic framework as a carrier to deliver triptolide for the treatment of hepatocellular carcinoma.
Drug delivery and translational research, , Volume: 12, Issue:5
2022
Triptolide delivery: Nanotechnology-based carrier systems to enhance efficacy and limit toxicity.
Pharmacological research, , Volume: 165
2021
Pharmacokinetic, bioavailability, and metabolism studies of lusianthridin, a dihydrophenanthrene compound, in rats by liquid chromatography/electrospray ionization tandem mass spectrometry.
Journal of pharmaceutical and biomedical analysis, , Feb-20, Volume: 195
2021
Responses of phenanthrene degradation to the changes in bioavailability and microbial community structure in soils amended with biochars pyrolyzed at low and high temperatures.
Journal of hazardous materials, , 05-15, Volume: 410
2021
Non-targeted metabolomics reveal the impact of phenanthrene stress on root exudates of ten urban greening tree species.
Environmental research, , Volume: 196
2021
Microbial vanadate reduction coupled to co-metabolic phenanthrene biodegradation in groundwater.
Water research, , Nov-01, Volume: 186
2020
Therapeutic applications and delivery systems for triptolide.
Drug delivery and translational research, , Volume: 10, Issue:6
2020
Mechanism of the biodemulsifier-enhanced biodegradation of phenanthrene by Achromobacter sp. LH-1.
Colloids and surfaces. B, Biointerfaces, , Volume: 195
2020
Competitive Adsorption of Polycyclic Aromatic Hydrocarbons to Carbon Nanotubes and the Impact on Bioavailability to Fathead Minnow (Pimephales promelas).
Environmental toxicology and chemistry, , Volume: 39, Issue:9
2020
Functional oral nanoparticles for delivering silibinin and cryptotanshinone against breast cancer lung metastasis.
Journal of nanobiotechnology, , May-30, Volume: 18, Issue:1
2020
Phytoremediation effect of Medicago sativa colonized by Piriformospora indica in the phenanthrene and cadmium co-contaminated soil.
BMC biotechnology, , 04-28, Volume: 20, Issue:1
2020
Therapeutic targets of thunder god vine (Tripterygium wilfordii hook) in rheumatoid arthritis (Review).
Molecular medicine reports, , Volume: 21, Issue:6
2020
Different bioavailability of phenanthrene to two bacterial species and effects of trehalose lipids on the bioavailability.
Journal of environmental science and health. Part A, Toxic/hazardous substances & environmental engineering, , Volume: 55, Issue:3
2020
[Research progress on triptolide functionalized nanoparticulate drug delivery systems for tumor treatment].
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, , Volume: 44, Issue:21
2019
Non-bioavailability of extracellular 1-hydroxy-2-naphthoic acid restricts the mineralization of phenanthrene by Rhodococcus sp. WB9.
The Science of the total environment, , Feb-20, Volume: 704
2020
Low level of polystyrene microplastics decreases early developmental toxicity of phenanthrene on marine medaka (Oryzias melastigma).
Journal of hazardous materials, , 03-05, Volume: 385
2020
Design, Synthesis, and in Vitro Biological Evaluation of 14-Hydroxytylophorine-dichloroacetate Co-drugs as Antiproliferative Agents.
Chemical & pharmaceutical bulletin, , Nov-01, Volume: 67, Issue:11
2019
Partitioning of chemical contaminants to microplastics: Sorption mechanisms, environmental distribution and effects on toxicity and bioaccumulation.
Environmental pollution (Barking, Essex : 1987), , Volume: 252, Issue:Pt B
2019
Triptolide: Medicinal chemistry, chemical biology and clinical progress.
European journal of medicinal chemistry, , Aug-15, Volume: 176
2019
Cubic and hexagonal liquid crystals as drug carriers for the transdermal delivery of triptolide.
Drug delivery, , Volume: 26, Issue:1
2019
Triptolide and Its Derivatives as Cancer Therapies.
Trends in pharmacological sciences, , Volume: 40, Issue:5
2019
Natural and assisted dissipation of polycyclic aromatic hydrocarbons in a long-term co-contaminated soil with creosote and potentially toxic elements.
The Science of the total environment, , Apr-10, Volume: 660
2019
Biodegradation of phenanthrene by biodemulsifier-producing strain Achromobacter sp. LH-1 and the study on its metabolisms and fermentation kinetics.
Ecotoxicology and environmental safety, , Nov-15, Volume: 163
2018
[Sorption of Phenanthrene to Soybean and Wheat Roots and the Bioavailability of Sorbed Phenanthrene].
Huan jing ke xue= Huanjing kexue, , Jun-08, Volume: 38, Issue:6
2017
Rhamnolipid influences biosorption and biodegradation of phenanthrene by phenanthrene-degrading strain Pseudomonas sp. Ph6.
Environmental pollution (Barking, Essex : 1987), , Volume: 240
2018
Reduced bioavailability and plant uptake of polycyclic aromatic hydrocarbons from soil slurry amended with biochars pyrolyzed under various temperatures.
Environmental science and pollution research international, , Volume: 25, Issue:17
2018
Investigations of microbial degradation of polycyclic aromatic hydrocarbons based on
Environmental science and pollution research international, , Volume: 25, Issue:7
2018
Transepithelial transfer of phenanthrene, but not of benzo[a]pyrene, is inhibited by fatty acids in the proximal intestine of rainbow trout (Oncorhynchus mykiss).
Comparative biochemistry and physiology. Toxicology & pharmacology : CBP, , Volume: 204
2018
Interactions between Pteris vittata L. genotypes and a polycyclic aromatic hydrocarbon (PAH)-degrading bacterium (Alcaligenes sp.) in arsenic uptake and PAH-dissipation.
Environmental pollution (Barking, Essex : 1987), , Volume: 230
2017
Solution or suspension - Does it matter for lipid based systems? In vivo studies of chase dosing lipid vehicles with aqueous suspensions of a poorly soluble drug.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, , Volume: 117
2017
Response of low-molecular-weight organic acids in mangrove root exudates to exposure of polycyclic aromatic hydrocarbons.
Environmental science and pollution research international, , Volume: 24, Issue:13
2017
Assessment of microplastic-sorbed contaminant bioavailability through analysis of biomarker gene expression in larval zebrafish.
Marine pollution bulletin, , Mar-15, Volume: 116, Issue:1-2
2017
Enhancement of the bioavailability of a novel anticancer compound (acetyltanshinone IIA) by encapsulation within mPEG-PLGA nanoparticles: a study of formulation optimization, toxicity, and pharmacokinetics.
Oncotarget, , Feb-14, Volume: 8, Issue:7
2017
Effects of dissolved organic matter derived from forest leaf litter on biodegradation of phenanthrene in aqueous phase.
Journal of hazardous materials, , Feb-15, Volume: 324, Issue:Pt B
2017
Phenanthrene Bioavailability and Toxicity to Daphnia magna in the Presence of Carbon Nanotubes with Different Physicochemical Properties.
Environmental science & technology, , 11-15, Volume: 50, Issue:22
2016
Specific adsorption of cadmium on surface-engineered biocompatible organoclay under metal-phenanthrene mixed-contamination.
Water research, , Nov-01, Volume: 104
2016
Influence of temperature on phenanthrene toxicity towards nitrifying bacteria in three soils with different properties.
Environmental pollution (Barking, Essex : 1987), , Volume: 216
2016
Mycoremediation of manganese and phenanthrene by Pleurotus eryngii mycelium enhanced by Tween 80 and saponin.
Applied microbiology and biotechnology, , Volume: 100, Issue:16
2016
[Aging Law of PAHs in Contaminated Soil and Their Enrichment in Earthworms Characterized by Chemical Extraction Techniques].
Huan jing ke xue= Huanjing kexue, , Volume: 36, Issue:12
2015
Carbon Nanotube Properties Influence Adsorption of Phenanthrene and Subsequent Bioavailability and Toxicity to Pseudokirchneriella subcapitata.
Environmental science & technology, , Mar-01, Volume: 50, Issue:5
2016
Influences of humic acid on the bioavailability of phenanthrene and alkyl phenanthrenes to early life stages of marine medaka (Oryzias melastigma).
Environmental pollution (Barking, Essex : 1987), , Volume: 210
2016
Electrokinetic-Enhanced Remediation of Phenanthrene-Contaminated Soil Combined with Sphingomonas sp. GY2B and Biosurfactant.
Applied biochemistry and biotechnology, , Volume: 178, Issue:7
2016
Effects of root exudates on the leachability, distribution, and bioavailability of phenanthrene and pyrene from mangrove sediments.
Environmental science and pollution research international, , Volume: 23, Issue:6
2016
The Effect of Digestion and Drug Load on Halofantrine Absorption from Self-nanoemulsifying Drug Delivery System (SNEDDS).
The AAPS journal, , Volume: 18, Issue:1
2016
Extractive biodegradation and bioavailability assessment of phenanthrene in the cloud point system by Sphingomonas polyaromaticivorans.
Applied microbiology and biotechnology, , Volume: 100, Issue:1
2016
Simultaneous determination of tanshinones and polyphenolics in rat plasma by UPLC-MS/MS and its application to the pharmacokinetic interaction between them.
Drug testing and analysis, , Volume: 8, Issue:7
2016
Effects of cowpea (Vigna unguiculata) root mucilage on microbial community response and capacity for phenanthrene remediation.
Journal of environmental sciences (China), , Jul-01, Volume: 33
2015
Extracellular polymeric substances govern the development of biofilm and mass transfer of polycyclic aromatic hydrocarbons for improved biodegradation.
Bioresource technology, , Volume: 193
2015
Heavy metal-immobilizing organoclay facilitates polycyclic aromatic hydrocarbon biodegradation in mixed-contaminated soil.
Journal of hazardous materials, , Nov-15, Volume: 298
2015
Absorption and Metabolism Characteristics of Triptolide as Determined by a Sensitive and Reliable LC-MS/MS Method.
Molecules (Basel, Switzerland), , May-18, Volume: 20, Issue:5
2015
Fluorene and Phenanthrene Uptake and Accumulation by Wheat, Alfalfa and Sunflower from the Contaminated Soil.
International journal of phytoremediation, , Volume: 17, Issue:12
2015
Simultaneous quantification of proposed anti-malarial combination comprising of lumefantrine and CDRI 97-78 in rat plasma using the HPLC-ESI-MS/MS method: application to drug interaction study.
Malaria journal, , Apr-22, Volume: 14
2015
The influence of multiwalled carbon nanotubes on polycyclic aromatic hydrocarbon (PAH) bioavailability and toxicity to soil microbial communities in alfalfa rhizosphere.
Ecotoxicology and environmental safety, , Volume: 116
2015
Comparing the genotoxicity of a potentially carcinogenic and a noncarcinogenic PAH, singly, and in binary combination, on peripheral blood cells of the European sea bass.
Environmental toxicology, , Volume: 31, Issue:11
2016
Characterising the exchangeability of phenanthrene associated with naturally occurring soil colloids using an isotopic dilution technique.
Environmental pollution (Barking, Essex : 1987), , Volume: 199
2015
Cysteine-β-cyclodextrin enhanced phytoremediation of soil co-contaminated with phenanthrene and lead.
Environmental science and pollution research international, , Volume: 22, Issue:13
2015
Fullerene-associated phenanthrene contributes to bioaccumulation but is not toxic to fish.
Environmental toxicology and chemistry, , Volume: 34, Issue:5
2015
In silico understanding of the cyclodextrin-phenanthrene hybrid assemblies in both aqueous medium and bacterial membranes.
Journal of hazardous materials, , Mar-21, Volume: 285
2015
Dissipation of phenanthrene and pyrene at the aerobic-anaerobic soil interface: differentiation induced by the rhizosphere of PAH-tolerant and PAH-sensitive rice (Oryza sativa L.) cultivars.
Environmental science and pollution research international, , Volume: 22, Issue:5
2015
The impact of biochar on the bioaccessibility of (14)C-phenanthrene in aged soil.
Environmental science. Processes & impacts, , Volume: 16, Issue:11
2014
Role of desorption kinetics in the rhamnolipid-enhanced biodegradation of polycyclic aromatic hydrocarbons.
Environmental science & technology, , Sep-16, Volume: 48, Issue:18
2014
Enhancing plant-microbe associated bioremediation of phenanthrene and pyrene contaminated soil by SDBS-Tween 80 mixed surfactants.
Journal of environmental sciences (China), , May-01, Volume: 26, Issue:5
2014
Combined effects of DOM and biosurfactant enhanced biodegradation of polycylic armotic hydrocarbons (PAHs) in soil-water systems.
Environmental science and pollution research international, , Volume: 21, Issue:17
2014
Hydroxypropyl-β-cyclodextrin extractability and bioavailability of phenanthrene in humin and humic acid fractions from different soils and sediments.
Environmental science and pollution research international, , Volume: 21, Issue:14
2014
Bioavailability of hydrocarbons to bacterial consortia during Triton X-100 mediated biodegradation in aqueous media.
Acta biochimica Polonica, , Volume: 60, Issue:4
2013
Potential use of a self-dying reporter bacterium to determine the bioavailability of aged phenanthrene in soil: comparison with physicochemical measures.
Journal of hazardous materials, , Jan-30, Volume: 265
2014
The variability of standard artificial soils: behaviour, extractability and bioavailability of organic pollutants.
Journal of hazardous materials, , Jan-15, Volume: 264
2014
Isolation and characterization of a novel phenanthrene (PHE) degrading strain Psuedomonas sp. USTB-RU from petroleum contaminated soil.
Journal of hazardous materials, , Dec-15, Volume: 263 Pt 2
2013
Utilizing surfactants to control the sorption, desorption, and biodegradation of phenanthrene in soil-water system.
Journal of environmental sciences (China), , Jul-01, Volume: 25, Issue:7
2013
Polycyclic aromatic hydrocarbon degradation of phytoplankton-associated Arenibacter spp. and description of Arenibacter algicola sp. nov., an aromatic hydrocarbon-degrading bacterium.
Applied and environmental microbiology, , Volume: 80, Issue:2
2014
Effects of sterile storage, cation saturation and substrate additions on the degradability and extractability of nonylphenol and phenanthrene in soil.
Chemosphere, , Volume: 93, Issue:9
2013
Identification of soil bacteria able to degrade phenanthrene bound to a hydrophobic sorbent in situ.
Environmental pollution (Barking, Essex : 1987), , Volume: 180
2013
Partitioning of phenanthrene into surfactant hemi-micelles on the bacterial cell surface and implications for surfactant-enhanced biodegradation.
Water research, , Sep-01, Volume: 47, Issue:13
2013
Bioaccumulation-depuration kinetics and effects of phenanthrene on Mediterranean mussel (Mytilus galloprovincialis).
Journal of environmental science and health. Part A, Toxic/hazardous substances & environmental engineering, , Volume: 48, Issue:9
2013
A mouse model to evaluate the impact of species, sex, and lipid load on lymphatic drug transport.
Pharmaceutical research, , Volume: 30, Issue:12
2013
Reduction in the earthworm metabolomic response after phenanthrene exposure in soils with high soil organic carbon content.
Environmental pollution (Barking, Essex : 1987), , Volume: 175
2013
Mineralization of phenanthrene sorbed on multiwalled carbon nanotubes.
Environmental toxicology and chemistry, , Volume: 32, Issue:4
2013
Synthesis and biological evaluation of tylophorine-derived dibenzoquinolines as orally active agents: exploration of the role of tylophorine e ring on biological activity.
Journal of medicinal chemistry, , Dec-13, Volume: 55, Issue:23
2012
Population pharmacokinetics of halofantrine in healthy volunteers and patients with symptomatic falciparum malaria.
The Journal of pharmacy and pharmacology, , Volume: 64, Issue:11
2012

Dosage (180)

ArticleYear
Microbe combined with Fe
Environmental science and pollution research international, , Volume: 30, Issue:53
2023
Impact of phenanthrene co-administration on the toxicokinetics of benzo[a]pyrene in humans. UPLC-accelerator mass spectrometry following oral microdosing.
Chemico-biological interactions, , Sep-01, Volume: 382
2023
Taxonomic and functional responses of soil and root bacterial communities associated with poplar exposed to a contamination gradient of phenanthrene.
FEMS microbiology ecology, , 05-31, Volume: 99, Issue:6
2023
A comprehensive review on celastrol, triptolide and triptonide: Insights on their pharmacological activity, toxicity, combination therapy, new dosage form and novel drug delivery routes.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, , Volume: 162
2023
A pH-responsive phosphoprotein washing fluid for the removal of phenanthrene from contaminated peat moss in the cold region.
Chemosphere, , Volume: 313
2023
Hydrophobic microporous extraction on polyurethane sponges for convenient and sensitive analysis of organic molecules in water.
Rapid communications in mass spectrometry : RCM, , Nov-15, Volume: 36, Issue:21
2022
Urinary polycyclic aromatic hydrocarbon metabolites were associated with hypertension in US adults: data from NHANES 2009-2016.
Environmental science and pollution research international, , Volume: 29, Issue:53
2022
Novel CD44-targeting and pH/redox-dual-stimuli-responsive core-shell nanoparticles loading triptolide combats breast cancer growth and lung metastasis.
Journal of nanobiotechnology, , Jun-23, Volume: 19, Issue:1
2021
Toxicity of two representative petroleum hydrocarbons, toluene and phenanthrene, to five Atlantic coral species.
Marine pollution bulletin, , Volume: 169
2021
Pharmacokinetics, distribution and efficacy of triptolide PLGA microspheres after intra-articular injection in a rat rheumatoid arthritis model.
Xenobiotica; the fate of foreign compounds in biological systems, , Volume: 51, Issue:6
2021
A pilot study of golexanolone, a new GABA-A receptor-modulating steroid antagonist, in patients with covert hepatic encephalopathy.
Journal of hepatology, , Volume: 75, Issue:1
2021
Alkylated phenanthrene distributions in black rockfish (Sebastes schlegelii) and biotransformation into hydroxylated metabolites after intragastric administration.
The Science of the total environment, , Mar-25, Volume: 762
2021
Measured and predicted acute toxicity of phenanthrene and MC252 crude oil to vertically migrating deep-sea crustaceans.
Environmental science and pollution research international, , Volume: 27, Issue:36
2020
Circadian clock regulates hepatotoxicity of Tripterygium wilfordii through modulation of metabolism.
The Journal of pharmacy and pharmacology, , Volume: 72, Issue:12
2020
Therapeutic targets of thunder god vine (Tripterygium wilfordii hook) in rheumatoid arthritis (Review).
Molecular medicine reports, , Volume: 21, Issue:6
2020
Pharmacological and molecular docking assessment of cryptotanshinone as natural-derived analgesic compound.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, , Volume: 126
2020
Gut microbiota protects from triptolide-induced hepatotoxicity: Key role of propionate and its downstream signalling events.
Pharmacological research, , Volume: 155
2020
Sodium tanshinone IIA sulfonate protects against Aβ
International journal of biological macromolecules, , May-15, Volume: 151
2020
Assessment of schwertmannite, jarosite and goethite as adsorbents for efficient adsorption of phenanthrene in water and the regeneration of spent adsorbents by heterogeneous fenton-like reaction.
Chemosphere, , Volume: 244
2020
[Effect of triptolide on Th17/Treg cells in spleen].
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, , Volume: 44, Issue:15
2019
Degradation of phenanthrene and fluoranthene in a slurry bioreactor using free and Ca-alginate-immobilized Sphingomonas pseudosanguinis and Pseudomonas stutzeri bacteria.
Journal of environmental management, , Nov-01, Volume: 249
2019
Effects of phenanthrene on oxidative stress and inflammation in lung and liver of female rats.
Environmental toxicology, , Volume: 35, Issue:1
2020
Dihydromyricetin affect the pharmacokinetics of triptolide in rats.
Xenobiotica; the fate of foreign compounds in biological systems, , Volume: 50, Issue:3
2020
Removal of phenanthrene and pyrene from contaminated sandy soil using hydrogen peroxide oxidation catalyzed by basic oxygen furnace slag.
Environmental science and pollution research international, , Volume: 26, Issue:9
2019
Dual-function of triptriolide in podocytes injury: inhibiting of apoptosis and restoring of survival.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, , Volume: 109
2019
Identification of hepatotoxic and nephrotoxic potential markers of triptolide in mice with delayed-type hypersensitivity.
Journal of pharmaceutical and biomedical analysis, , Oct-25, Volume: 160
2018
[Triptolide induces oxidative stress and apoptosis and activates PIK3/Akt signaling pathway in TM4 sertoli cells].
Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences, , Aug-18, Volume: 50, Issue:4
2018
Preclinical Pharmacokinetics of Triptolide: A Potential Antitumor Drug.
Current drug metabolism, , Volume: 20, Issue:2
2019
[Preparation and transdermal permeation of triptolide and ferulic acid ethosomes gel
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, , Volume: 43, Issue:6
2018
[Effects of Triptolide Combined with Homoharringtonine on Proliferation and Apoptosis of KG-1α Cells].
Zhongguo shi yan xue ye xue za zhi, , Volume: 26, Issue:2
2018
Renal and Hematologic Comparative Effects of Dissociated Agonist of the Glucocorticoid Receptor and Prednisone in Dogs With and Without Food Restriction.
International journal of toxicology, , Volume: 37, Issue:3
In-situ examination of graphene and graphene oxide impact on the depuration of phenanthrene and fluoranthene adsorbed onto spinach (Spinacia oleracea L.) leaf surfaces.
Environmental pollution (Barking, Essex : 1987), , Volume: 237
2018
EFFECT OF TRIPTOLIDE ON PROLIFERATION AND APOPTOSIS OF ANGIOTENSIN II-INDUCED CARDIAC FIBROBLASTS
African journal of traditional, complementary, and alternative medicines : AJTCAM, , Volume: 14, Issue:1
2017
Solution or suspension - Does it matter for lipid based systems? In vivo studies of chase dosing lipid vehicles with aqueous suspensions of a poorly soluble drug.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, , Volume: 117
2017
JTP-117968, a novel selective glucocorticoid receptor modulator, exhibits improved transrepression/transactivation dissociation.
European journal of pharmacology, , May-15, Volume: 803
2017
Response of phenolic metabolism to cadmium and phenanthrene and its influence on pollutant translocations in the mangrove plant Aegiceras corniculatum (L.) Blanco (Ac).
Ecotoxicology and environmental safety, , Volume: 141
2017
Analysis of 3D Prints by X-ray Computed Microtomography and Terahertz Pulsed Imaging.
Pharmaceutical research, , Volume: 34, Issue:5
2017
Protective effects of triptolide on TLR4 mediated autoimmune and inflammatory response induced myocardial fibrosis in diabetic cardiomyopathy.
Journal of ethnopharmacology, , Dec-04, Volume: 193
2016
Triptolide inhibits cell growth and GRP78 protein expression but induces cell apoptosis in original and radioresistant NPC cells.
Oncotarget, , Aug-02, Volume: 7, Issue:31
2016
Adsorption and bioaccessibility of phenanthrene on carbon nanotubes in the in vitro gastrointestinal system.
The Science of the total environment, , Oct-01, Volume: 566-567
2016
Predicting the probability of successful efficacy of a dissociated agonist of the glucocorticoid receptor from dose-response analysis.
Journal of pharmacokinetics and pharmacodynamics, , Volume: 43, Issue:3
2016
Applying quantitative and semi-quantitative histopathology to address the interaction between sediment-bound polycyclic aromatic hydrocarbons in fish gills.
Ecotoxicology and environmental safety, , Volume: 131
2016
The Effect of Digestion and Drug Load on Halofantrine Absorption from Self-nanoemulsifying Drug Delivery System (SNEDDS).
The AAPS journal, , Volume: 18, Issue:1
2016
Pharmacokinetics and pharmacodynamics of orally administered acetylenic tricyclic bis(cyanoenone), a highly potent Nrf2 activator with a reversible covalent mode of action.
Biochemical and biophysical research communications, , Sep-25, Volume: 465, Issue:3
2015
A high throughput passive dosing format for the Fish Embryo Acute Toxicity test.
Chemosphere, , Volume: 139
2015
Reproductive and transgenerational toxicities of phenanthrene on female marine medaka (Oryzias melastigma).
Aquatic toxicology (Amsterdam, Netherlands), , Volume: 162
2015
How does predation affect the bioaccumulation of hydrophobic organic compounds in aquatic organisms?
Environmental science & technology, , Apr-21, Volume: 49, Issue:8
2015
Enterocarpam-III induces human liver and breast cancer cell apoptosis via mitochondrial and caspase-9 activation.
Asian Pacific journal of cancer prevention : APJCP, , Volume: 16, Issue:5
2015
Gender Differences in the Toxicokinetics of Triptolide after Single- and Multiple-dose Administration in Rats.
Drug research, , Volume: 65, Issue:11
2015
Cryptotanshinone, an orally bioactive herbal compound from Danshen, attenuates atherosclerosis in apolipoprotein E-deficient mice: role of lectin-like oxidized LDL receptor-1 (LOX-1).
British journal of pharmacology, , Volume: 172, Issue:23
2015
Two new anxiolytic phenanthrenes found in the medullae of Juncus effusus.
Natural product communications, , Volume: 9, Issue:8
2014
Enhancing plant-microbe associated bioremediation of phenanthrene and pyrene contaminated soil by SDBS-Tween 80 mixed surfactants.
Journal of environmental sciences (China), , May-01, Volume: 26, Issue:5
2014
Simultaneous control of phenanthrene and drought by dual exposure system: the degree of synergistic interactions in springtails was exposure dependent.
Environmental science & technology, , Aug-19, Volume: 48, Issue:16
2014
[Adsorption of phenanthrene from aqueous solution on cetylpyridinium bromide (CPB) -modified zeolite].
Huan jing ke xue= Huanjing kexue, , Volume: 35, Issue:2
2014
Oxidative stress and DNA damage responses to phenanthrene exposure in the estuarine guppy Poecilia vivipara.
Marine environmental research, , Volume: 98
2014
Nanostructured lipid carriers as a novel oral delivery system for triptolide: induced changes in pharmacokinetics profile associated with reduced toxicity in male rats.
International journal of nanomedicine, , Volume: 9
2014
Efficacy of triptolide for children with moderately severe Henoch-Schönlein purpura nephritis presenting with nephrotic range proteinuria: a prospective and controlled study in China.
BioMed research international, , Volume: 2013
2013
Accelerated follicle depletion in vitro and in vivo in Sprague-Dawley rats using the combination of 4-vinylcyclohexene diepoxide and triptolide.
Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians, , Volume: 44, Issue:4 Suppl
2013
Tanshinone VI inhibits the expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1.
International journal of immunopathology and pharmacology, , Volume: 26, Issue:4
Adsorption of phenanthrene on multilayer graphene as affected by surfactant and exfoliation.
Environmental science & technology, , Volume: 48, Issue:1
2014
Physiological and molecular responses of springtails exposed to phenanthrene and drought.
Environmental pollution (Barking, Essex : 1987), , Volume: 184
2014
Phenanthrene binding by humic acid-protein complexes as studied by passive dosing technique.
Environmental pollution (Barking, Essex : 1987), , Volume: 184
2014
A novel passive dosing system for determining the toxicity of phenanthrene to early life stages of zebrafish.
The Science of the total environment, , Oct-01, Volume: 463-464
2013
Herbal compound triptolide synergistically enhanced antitumor activity of amino-terminal fragment of urokinase.
Molecular cancer, , Jun-08, Volume: 12
2013
The impact of lymphatic transport on the systemic disposition of lipophilic drugs.
Journal of pharmaceutical sciences, , Volume: 102, Issue:7
2013
CDA: combinatorial drug discovery using transcriptional response modules.
PloS one, , Volume: 7, Issue:8
2012
Using resin to generate a non-invasive intestinal bile-depleted rat model was unsuccessful.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, , Sep-29, Volume: 47, Issue:2
2012
Comparison of toxicokinetic and tissue distribution of triptolide-loaded solid lipid nanoparticles vs free triptolide in rats.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, , Nov-20, Volume: 47, Issue:4
2012
Intravenous dosing conditions may affect systemic clearance for highly lipophilic drugs: implications for lymphatic transport and absolute bioavailability studies.
Journal of pharmaceutical sciences, , Volume: 101, Issue:9
2012
Pulmonary surfactant suppressed phenanthrene adsorption on carbon nanotubes through solubilization and competition as examined by passive dosing technique.
Environmental science & technology, , May-15, Volume: 46, Issue:10
2012
Effects of triptolide on the synaptophysin expression of hippocampal neurons in the AD cellular model.
International immunopharmacology, , Volume: 13, Issue:2
2012
Influence of bile on the absorption of halofantrine from lipid-based formulations.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, , Volume: 81, Issue:2
2012
Dynamic passive dosing for studying the biotransformation of hydrophobic organic chemicals: microbial degradation as an example.
Environmental science & technology, , May-01, Volume: 46, Issue:9
2012
In vitro and in vivo performance of novel supersaturated self-nanoemulsifying drug delivery systems (super-SNEDDS).
Journal of controlled release : official journal of the Controlled Release Society, , May-30, Volume: 160, Issue:1
2012
Chronic exposure to phenanthrene influences the spermatogenesis of male Sebastiscus marmoratus: U-shaped effects and the reason for them.
Environmental science & technology, , Dec-01, Volume: 45, Issue:23
2011
In vitro properties of surface-modified solid lipid microspheres containing an antimalarial drug: halofantrine.
Asian Pacific journal of tropical medicine, , Volume: 4, Issue:4
2011
A high-sensitivity UPLC-MS/MS method for simultaneous determination and confirmation of triptolide in zebrafish embryos.
Biomedical chromatography : BMC, , Volume: 25, Issue:8
2011
Effect of bile on the oral absorption of halofantrine in polyethylene glycol 400 and polysorbate 80 formulations dosed to bile duct cannulated rats.
The Journal of pharmacy and pharmacology, , Volume: 63, Issue:6
2011
Metabolism of [D10]phenanthrene to tetraols in smokers for potential lung cancer susceptibility assessment: comparison of oral and inhalation routes of administration.
The Journal of pharmacology and experimental therapeutics, , Volume: 338, Issue:1
2011
EROD activity in peripheral blood lymphocytes and 1-hydroxypyrene in urine and milk as biomarkers of PAH exposure in dairy ruminants.
Environmental toxicology and chemistry, , Volume: 30, Issue:6
2011
[Absorption mechanism of tanshinone II A, cryptotanshinone, tanshinone I and tanshinones extract in rat small intestine in vivo].
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, , Volume: 35, Issue:21
2010
A novel excipient, 1-perfluorohexyloctane shows limited utility for the oral delivery of poorly water-soluble drugs.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, , Mar-18, Volume: 42, Issue:4
2011
Bioaccumulation of 14C60 by the earthworm Eisenia fetida.
Environmental science & technology, , Dec-01, Volume: 44, Issue:23
2010
Effects of polysorbate 80 on the in-vitro precipitation and oral bioavailability of halofantrine from polyethylene glycol 400 formulations in rats.
The Journal of pharmacy and pharmacology, , Volume: 62, Issue:1
2010
Sex differences in subacute toxicity and hepatic microsomal metabolism of triptolide in rats.
Toxicology, , Apr-30, Volume: 271, Issue:1-2
2010
Transfer kinetics to egg yolk and modeling residue recovered in yolk of readily metabolized molecules: polycyclic aromatic hydrocarbons orally administered to laying hens.
Chemosphere, , Volume: 78, Issue:8
2010
Effects of phenanthrene on hepatic enzymatic activities in tilapia (Oreochromis niloticus female x O. aureus male).
Journal of environmental sciences (China), , Volume: 21, Issue:6
2009
Lymphatic transport of Methylnortestosterone undecanoate (MU) and the bioavailability of methylnortestosterone are highly sensitive to the mass of coadministered lipid after oral administration of MU.
The Journal of pharmacology and experimental therapeutics, , Volume: 331, Issue:2
2009
Sodium tanshinone IIA sulfonate increased intestinal hemodynamics without systemic circulatory changes in healthy newborn piglets.
American journal of physiology. Heart and circulatory physiology, , Volume: 297, Issue:4
2009
Triptolide functions as a potent angiogenesis inhibitor.
International journal of cancer, , Jan-01, Volume: 126, Issue:1
2010
Double-tagged fluorescent bacterial bioreporter for the study of polycyclic aromatic hydrocarbon diffusion and bioavailability.
Environmental microbiology, , Volume: 11, Issue:9
2009
Impact of recurring intermediate insulin-induced hypoglycemia on hypothalamic paraventricular corticotropin-releasing hormone, oxytocin, vasopressin and glucokinase gene profiles: role of type II glucocorticoid receptors.
Experimental brain research, , Volume: 195, Issue:4
2009
[Suppression of murine EAE by triptolide is related to downregulation of INF-gamma and upregulation of IL-10 secretion in splenic lymphocytes].
Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology, , Volume: 25, Issue:3
2009
Identification of surrogate measures of diesel exhaust exposure in a controlled chamber study.
Environmental science & technology, , Dec-01, Volume: 42, Issue:23
2008
The effect of experimental hyperlipidemia on the stereoselective tissue distribution, lipoprotein association and microsomal metabolism of (+/-)-halofantrine.
Journal of pharmaceutical sciences, , Volume: 98, Issue:7
2009
Multigeneration exposure of the springtail Folsomia candida to phenanthrone: from dose-response relationships to threshold concentrations.
Environmental science & technology, , Sep-15, Volume: 42, Issue:18
2008
Intestinal lymphatic transport of halofantrine in rats assessed using a chylomicron flow blocking approach: the influence of polysorbate 60 and 80.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, , Oct-02, Volume: 35, Issue:3
2008
Pharmacokinetic interaction between tanshinones and polyphenolic extracts of salvia miltinorrhiza BUNGE after intravenous administration in rats.
Biological & pharmaceutical bulletin, , Volume: 31, Issue:8
2008
Effect of oxidant dosage on integrated electrochemical remediation of contaminant mixtures in soils.
Journal of environmental science and health. Part A, Toxic/hazardous substances & environmental engineering, , Jul-01, Volume: 43, Issue:8
2008
Preclinical factors affecting the pharmacokinetic behaviour of tanshinone IIA, an investigational new drug isolated from Salvia miltiorrhiza for the treatment of ischaemic heart diseases.
Xenobiotica; the fate of foreign compounds in biological systems, , Volume: 38, Issue:2
2008

Interactions (20)

ArticleYear
Microbe combined with Fe
Environmental science and pollution research international, , Volume: 30, Issue:53
2023
Effects and mechanisms of trifluridine alone or in combination with cryptotanshinone in inhibiting malignant biological behavior of gastric cancer.
Cell cycle (Georgetown, Tex.), , Volume: 22, Issue:12
2023
Quantitative analysis of polycyclic aromatic hydrocarbons (PAHs) in water by surface-enhanced Raman spectroscopy (SERS) combined with Random Forest.
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, , Feb-15, Volume: 287, Issue:Pt 1
2023
Detoxification strategies of triptolide based on drug combinations and targeted delivery methods.
Toxicology, , 03-15, Volume: 469
2022
Identification of lusianthridin metabolites in rat liver microsomes by liquid chromatography combined with electrospray ionization time-of-flight mass spectrometry.
Biomedical chromatography : BMC, , Volume: 35, Issue:3
2021
Study on the molecular interactions of hydroxylated polycyclic aromatic hydrocarbons with catalase using multi-spectral methods combined with molecular docking.
Food chemistry, , Mar-30, Volume: 309
2020
Comparison of the effect of three different topoisomerase II inhibitors combined with cisplatin in human glioblastoma cells sensitized with double strand break repair inhibitors.
Molecular biology reports, , Volume: 46, Issue:4
2019
Ghrelin combined with sodium tanshinone IIA sulfonate pretreatment reduces apoptosis and fractalkine expression induced by high-dose glucose in human umbilical vein endothelial cells.
Minerva endocrinologica, , Volume: 45, Issue:1
2020
[Effects of Triptolide Combined with Homoharringtonine on Proliferation and Apoptosis of KG-1α Cells].
Zhongguo shi yan xue ye xue za zhi, , Volume: 26, Issue:2
2018
Dihydroisotanshinone I combined with radiation inhibits the migration ability of prostate cancer cells through DNA damage and CCL2 pathway.
BMC pharmacology & toxicology, , 01-31, Volume: 19, Issue:1
2018
AMD3100 combined with triptolide inhibit proliferation, invasion and metastasis and induce apoptosis of human U2OS osteosarcoma cells.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, , Volume: 86
2017
Electrokinetic-Enhanced Remediation of Phenanthrene-Contaminated Soil Combined with Sphingomonas sp. GY2B and Biosurfactant.
Applied biochemistry and biotechnology, , Volume: 178, Issue:7
2016
Treatment of murine cerebral malaria by artemisone in combination with conventional antimalarial drugs: antiplasmodial effects and immune responses.
Antimicrobial agents and chemotherapy, , Volume: 58, Issue:8
2014
Low-dose triptolide in combination with idarubicin induces apoptosis in AML leukemic stem-like KG1a cell line by modulation of the intrinsic and extrinsic factors.
Cell death & disease, , Dec-05, Volume: 4
2013
In vivo effect of triptolide combined with glycyrrhetinic acid on rat cytochrome P450 enzymes.
Yao xue xue bao = Acta pharmaceutica Sinica, , Volume: 48, Issue:7
2013
[Triptolide combined with irbesartan synergistically blocks podocyte injury in a type 2 diabetes rat model].
Zhonghua nei ke za zhi, , Volume: 51, Issue:2
2012
Metabolite identification of triptolide by data-dependent accurate mass spectrometric analysis in combination with online hydrogen/deuterium exchange and multiple data-mining techniques.
Rapid communications in mass spectrometry : RCM, , Oct-30, Volume: 25, Issue:20
2011
[Apoptosis of MR2 cells induced by Tanshinone II A combined with arsenic trioxide].
Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, , Volume: 40, Issue:5
2009
Synergistic effect of triptolide combined with 5-fluorouracil on colon carcinoma.
Postgraduate medical journal, , Volume: 83, Issue:979
2007
Degradation mechanisms of benzo[a]pyrene and its accumulated metabolites by biodegradation combined with chemical oxidation.
Chemosphere, , Volume: 67, Issue:7
2007

Natural Sources (10)

ArticleYear
Tanshinones inhibit NLRP3 inflammasome activation by alleviating mitochondrial damage to protect against septic and gouty inflammation.
International immunopharmacology, , Volume: 97
2021
Triptolide: Medicinal chemistry, chemical biology and clinical progress.
European journal of medicinal chemistry, , Aug-15, Volume: 176
2019
Discovery of thalicthuberine as a novel antimitotic agent from nature that disrupts microtubule dynamics and induces apoptosis in prostate cancer cells.
Cell cycle (Georgetown, Tex.), , Volume: 17, Issue:5
2018
Downregulation of Sp1 by Minnelide leads to decrease in HSP70 and decrease in tumor burden of gastric cancer.
PloS one, , Volume: 12, Issue:2
2017
A renal-targeted triptolide aminoglycoside (TPAG) conjugate for lowering systemic toxicities of triptolide.
Fitoterapia, , Volume: 103
2015
Structural and physiochemical characterization of rhamnolipids produced by Acinetobacter calcoaceticus, Enterobacter asburiae and Pseudomonas aeruginosa in single strain and mixed cultures.
Journal of biotechnology, , Jan-10, Volume: 193
2015
Triptolide-induced cell death in pancreatic cancer is mediated by O-GlcNAc modification of transcription factor Sp1.
The Journal of biological chemistry, , Nov-22, Volume: 288, Issue:47
2013
Coexisted components of Salvia miltiorrhiza enhance intestinal absorption of cryptotanshinone via inhibition of the intestinal P-gp.
Phytomedicine : international journal of phytotherapy and phytopharmacology, , Nov-15, Volume: 19, Issue:14
2012
Degradable rosin-ester-caprolactone graft copolymers.
Biomacromolecules, , Jun-13, Volume: 12, Issue:6
2011
Biodegradation of phenanthrene by fungi screened from nature.
Pakistan journal of biological sciences : PJBS, , Aug-01, Volume: 10, Issue:15
2007